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The accurate determination of biologically active compounds in the skin is of considerable 
importance when evaluating the penetration of skin health products through different layers of the 
skin. This thesis reports  on  the  characterisation and  quantitation of  biologically active 
compounds  in  simple model mixtures and complex mixtures which mimic that of a typical skin 
product, through the use of qNMR, pure shift NMR and DOSY techniques complemented by semi-
automated software packages. Characterisation and quantitation conditions were acquired over 
several heterogeneous samples allowing for analysis of how dynamic range and complexity of 
different sample mixtures affect the Limits of Detection (LOD) and Limits of Quantitation (LOQ) of 
biologically active compounds. NMR is of particular value in this task, as it is non-destructive, uses 
a primary ratio method for quantification, and tolerates a wide variety of hydrophilic and 
hydrophobic components within a given matrix. In this investigation we have attained a trueness 
level <10%, repeatability values of <1% and brought the limit of quantitation down to 100nM (˜limit 
of baseline range of several key biomarkers in the skin per litre seen in vivo), while commenting on 
the limitations observed, such as peak overlap and sensitivity limits. Pure shift optimised sequences 
allow us to reduce peak overlapping, allowing further characterisation of individual compounds 
and the separation of complex mixtures using NMR. These validated methodologies are then all 
brought together to develop a new methodology for ex-vivo analysis of skin layers. This analysis 
allowed for characterisation and quantitation of natural moisturising factors (NMF), biomarkers of 
hydration and skin health alongside construction of permeation profiles for common topical 
components in different formulations. Data analysis demonstrates results corroborate with results 
seen in previous validated methodologies which have more complex and time-consuming 









AI   Physiogel AI lipid formulation 
AMPs   Antimicrobial peptides 
ATR-FTIR  Attenuated Total Reflectance Fourier Transform Infrafred 
BIRD   Bilinear rotation decoupling 
BW   Bluewater formulation 
BW70   Bluewater formulation heat treated at 70oC 
CASE   Computer Assisted Structure Elucidation 
CNS   Central Nervous System 
COSY   Correlation Spectroscopy 
CTP   Coherence transfer pathway 
D1   Relaxation delay 
D2O   Deuterium Oxide 
D20   Diffusion delay 
DART   Direct Analysis in real time 
DLS   Dynamic Light Scattering 
DMSO-d6  Deuterated Dimethyl Sulfoxide 
DOSY   Diffusion Ordered Spectroscopy 
EM   Cryo electron microscopy 
ESR   Electron spin resonance 
FCF   Full cream formulation 
FID   Free Induction Decay 
FLIM   Fluorescence lifetime imaging 
HMBC   Hetero multiple quantum coherence 
HSQC   Hetero single quantum coherence 
IR   Infrared 
LED   Longitudinal eddy-current delay 
LOD   Limit of detection 
LOQ   Limit of quantitation 
MALDI   Matrix assisted laser desorption ionization 
MeOD   Deuterated Methanol 
MPT   Multiphoton laser tomography 
MS   Mass Spectrometry 




NMR   Nuclear Magnetic Resonance 
NOE   Nuclear Overhauser Effect 
NOESY   Nuclear Overhauser effect spectroscopy 
NS   Number of scans 
OTTER   Opto-thermal transient emission radiometry 
P   Physiogel 
P30   Gradient Pulse duration for diffusion 
PCA   Pyrollidone Carboxylate 
PCA   Principal Component Analysis 
PFG-NMR  Pulsed Field Gradient NMR 
pH   Potential of hydrogen 
PPM   Parts per million 
PSYCHE  Pure shift yielded by chirp excitation 
qNMR   Quantitative NMR 
RF   Radio frequency 
RG   Receiver gain 
ROESY   Rotating-frame Overhauser Spectroscopy 
RT-PCR   Real time Polymerase chain reaction 
S/N   Signal to noise 
SW   Sweep width 
T1   Spin-lattice relaxation time 
T2   Spin-spin relaxation time 
TEWL   Trans Epidermal Water Loss 
TOCSY   Total Correlation Spectroscopy 
TLR   Toll like receptors 
TSE   Triple spin echo 
TSP   Trimethylsilylpropanoic acid 
V   Bluewater Vehicle 
XRC   X-Ray Crystallography 
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1.1 The Skin: function, structure and pathologies  
1.1.1 Basic structure of the skin 
Skin is unique as an organ in that it has great heterogeneity depending on site, ethnicity, gender 
and age. Where such large variations in other organs would be considered diseased or in an 
abnormal state. For example, on the head, there is an abundance of pilosebaceous structures 
relative to skin on the palms and soles of feet which have a distinct lack of pilosebaceous structures. 
Despite the great differences seen between different sites of the body the skin has some universal 
features in its structure. 
 
The skin has a surface, which is slightly acidic, with an average pH value of 5.5. This allows a resident 
skin biome to exist that resists the colonisation by pathogenic microorganisms. This ‘Acid Mantle’ 
is made acidic by the presence of acidic compounds present in perspiration and sebum. Below this 
surface of the skin there is the epidermis which is the outermost layer of skin, with the dermis 
below. This is where nerve endings exist, so that heat, cold, pain, and itching sensations can be felt. 
The dermis also holds the sebaceous glands, which produce sweat and oils providing protective and 
homeostatic functions for the skin. It also has a reservoir of immune cells present, with a larger role 
in the active immune system. Below the dermis there is subcutaneous fat, which is the most 
variable layer between individuals, and has a role in temperature management. It also supports the 
connection between the dermis, muscle and bone. These three areas of the skin show a high degree 
of differentiation between hairy skin, which covers more than 90% of the body and glabrous skin, 
which is hair free and exists on the soles of feet and palms of hand. The differentiation between 
these areas is for the specialised function of each type of skin. Hairy skin is specialised in response 
to tactile sensations that involve social exchanges and its ability to detect foreign objects before 
they cause harm or injury to the skin surface. Glabrous skin on the other hand has a large abundance 
of specialised nerves that better understand tactile details alongside being generally thicker (1). 




Figure 1 Structure of the epidermis; adapted from Gould J. 2018 (1) 
The epidermis ranges from flat anucleated cells at the surface in the Stratum corneum, to 
continuously dividing basal cells at the Stratum basale layer. From a functional point of view the 
epidermis acts as the mechanical and antimicrobial barrier of the skin. The outermost layer of the 
skin is sometimes considered the natural microbiota of the skin, rather than the Stratum corneum. 
Because of the unique environment of the skin surface (dry, acidic and nutrient poor) an individually 
unique mixture of bacteria, fungi and virus reside. This mixture then acts as a first line of defence 
to fend off invading species by competing for nutrients and moisture. Alongside this, it also helps 
to communicate with immune cells in deeper layers of the skin through a chemical response to 
attack. The Stratum corneum is designated the role of protector from physical, rather than 
biological infarction. This is through the composition of the Stratum corneum being predominantly 
of dead, flattened cells that will protect the body from friction effects and also control water loss 
through the skin. A unique layer to glabrous skin is the Stratum lucidum which like the Stratum 
corneum is composed of dead cells but is also packed with lipid-rich eleiden, a water proofing 
component. In hairy skin the role of waterproofing is fulfilled by the Stratum granulosum, which 
consists predominantly of mature keratinocytes that are moving from the Stratum basale to the 
Stratum corneum. This is followed by the Stratum spinosum, which produces the protein keratin for 
the keratinization of skin cells at the surface of the skin. It also has active immune cells called 
Langerhan cells that help to inform the immune system when microbes are attacking the skin. The 
bottom layer of the epidermis is the Stratum basale. This layer is where continually dividing basal 
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cells will start pushing older cells upward to the skin surface. This layer, being the start point of 
epidermis cell differentiation, also contains malanocytes which controls the pigmentation of the 
skin. This makes the Stratum basale important when considering exposure to ultraviolet radiation 
and potential cancer risks.   
 
As the cells are moved from the Stratum basale through the stratum spinosum and Stratum 
granulosum to the Stratum corneum the basale cells transform into keratinocytes and become 
increasingly keratinized as they progress before finally becoming corneocytes and leaving the skin 
surface through desquamation. The keratinization involves the elimination of organelles and 
formation of corneodesmosomes from cadherins, desmosomes and desmocollins. Around 95% of 
the skin surface is made up of keratinocytes cells and these are normally cycled through every 15 
to 30 days. An aspect of keratinocyte movement towards the surface is the rate of differentiation 
of keratinocytes towards the surface of the skin, which is an indicator of cell age and pathology. 
 
1.1.2 Stratum corneum 
The Stratum corneum is composed of corneocytes that move towards the surface of the skin from 
the base of the Stratum corneum over 14 days. At the base, corneocytes have adherent cell 
membranes with an abundance of corneodesmosomes, desmoglein 1 and desmocollin 1. As the 
cells move to the surface they loosen and fall off with an increase in the abundance of 
corneodesmosomes, cornified cell envelope and desmosomal plates between corneocytes. The 
formation of corneodesmosomes in the upper cells is from complete reorganization of the 
intracellular space. This involves the cell organelles being completely dismantled and its keratin 
filaments forming into dense macrofibrils, which are held together by filaggrin (filament 
aggregating protein). This change gives an opportunity for analysis of the depth of the Stratum 
corneum, where depth of cornified layers can be correlated to the relative abundances of filaggrin 
and corneodesmosome break down components. The deeper layers of the epidermis: Stratum 
granulosum; Stratum spinosum and Stratum basale, in comparison, have a wide range of 
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desmogleins, desmosomes, tight junctions and cadherins with a complete lack of keratin present in 
Stratum basale cells.  
 
When considering the corneocytes of the Stratum corneum as the bricks that build the wall that is 
our cornified layer of the skin, then intercellular lipids are the glue. This complex lipid mixture is a 
combination of cholesterol, cholesterol sulphates, ceramides and free fatty acids. These 
intercellular lipids are crucial to the correct functioning of the skin and to understanding of the 
trans-dermal delivery of drugs and topical components as this is the predominant pathway for 
delivery. 
 
1.1.3 Keratinocytes, corneocytes and keratin in the epidermis 
Keratinocytes are cells that produce the protein keratin. Keratin forms ropelike bundles in the 
cytoplasm, which crisscross with one another. These bundles are connected to other keratin 
bundles in adjacent cells via desmosome junctions that gives groups of these cells very high tensile 
strength and explains why the Stratum corneum, where desmosome and keratin abundance is 
highest, has  resistance against friction and physical infarction. What causes differentiation of 
keratinocytes to corneocytes, is the process of anucleation, corneodesmosome formation, and 
formation of the horny layer. Focus from the change at the basal layer to the surface layer on how 
the fibrinogen forms and breaks down is a key factor in this. As described previously, keratinocytes 
start to differentiate from basal cells once they have left the Stratum basale. Once basal cells have 
left the Stratum basale they come into contact with a much greater number of keratinocytes and 
begin forming extensive inter-cell contacts and produce keratin. In the Stratum spinosome these 
contacts form spinous extensions which terminate at desmosome junctions. Once these contacts 
have formed and keratinocytes are moved into the Stratum granulosum, the cells still contain all 
organelles but are differentiated with the appearance of basophilic, keratohyalin granules which 
contain the filaggrin progenitor pre-filaggrin. Once cells transition between the Stratum 
granulosum and Stratum corneum, there is an elimination of nuclei and organelles within and their 
structures subsequently changing to a flattened polyhedron shape. This stage is where the cells 
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change from keratinocytes to corneocytes, which are connected by desmosome junctions called 
corneodesmosomes. These are simply modified desmosomes, which contain corneodesmosin. 
Corneocytes are unique in that they contain a densely packed network of keratin filaments which 
is surrounded by an envelope consisting of cross-linked, by transglutaminases, structural proteins. 
Shedding of skin from the Stratum corneum is accomplished by the disruption of cohesion between 
corneocytes through proteolysis of the corneodesmosome junction proteins that is tightly 
regulated, to process the desquamation of cells (2). 
 
1.1.4 Filaggrin and its role in keratin binding, Natural Moisturisiing 
Factor (NMF), acidification of acid mantle and genetic studies  
Filaggrin is an intermediate filament associated protein whose primary role is binding to 
intermediate keratin fibers in keratinocytes to form macrofibrils. It has also been demonstrated to 
have a role in the cornified envelope, and corneocytes of the epidermis. Filaggrin however is not 
synthesised in the outer cells but in the deeper layers and transported to the surface layers in 
keratohyalin granules in a progenitor form. The keratohyalin granules present in the Stratum 
granulosum of the epidermis is made up of profilaggrin, a highly phosphorylated protein that 
contains 10-12 tandemly repeated filaggrin monomers. The processing of profilaggrin to filaggrin 
monomers commences through dephosphorylation at specific points along the repeats and 
subsequent proteolysis during terminal differentiation of epidermal cells to corneocytes at the 
Stratum granulosum to Stratum corneum boundary. 




Figure 2 Breakdown process of profilaggrin to NMF, adapted from Hoste E et al 2011 (3) 
Once in the surface layers of the Stratum corneum, filaggrin is itself broken down into its constituent 
free amino acids that function as mediators of epidermal flexibility. Some free amino acids are also 
modified to become more hygroscopic, specifically histidine to urocanate and glutamic acid to 
pyrrolidone carboxylic acid. These amino acids alongside chloride, sodium, lactate and urate are 
the compounds that are commonly grouped together to describe the natural moisturizing factors 
(NMFs) of the skin. The NMFs have been shown to be important in determining the hydration of 
the Stratum corneum under normal circumstances (4). 
 
Early studies of skin, focusing on filaggrin, identified that the breakdown of filaggrin to NMF through 
proteolysis in the upper layers of the Stratum corneum is induced by a water gradient present in 
the Stratum corneum. This finding is very interesting as it can directly correlate NMF values to the 
water gradient within the Stratum corneum (5). 
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1.1.5 Innate immune responses of the Stratum corneum 
The immune system of the skin consists of two distinct systems, namely the innate immune system 
and the adaptive immune system. The innate immune system covers the immune responses, at the 
onset of physical, chemical or biological attack to the skin, from agents already present in the skin. 
It also signals the activation of the adaptive immune system through release of signalling agents 
and receptor responses such as toll-like receptors (TLRs), mannose receptors and helicases, which 
activate production of antimicrobial peptides (AMPs). TLRs are activated specifically by the 
lipopolysaccharides of gram-negative bacteria, the lipoteichoic acid and peptidoglycans from gram-
positive bacteria, alongside mannans from yeast and fungi, and nucleic acids produced from our 
own cells. Smaller compounds within the skin, in particular the extracellular matrix, can have their 
levels affected by the disruption to microbiota homeostasis. For example, infection by pathogenic 
microorganisms or infarction of external agents through physical damage from the environment, 
with tetanus as a specific example demonstrates this response in the way that tissue damage can 
create an anaerobic environment. This environmental change of the skin prevents the normal 
functioning of small immune system compounds and allows the colonisation by Clostridium tetani 
which releases the neurotoxin tetanospasmin and gives the characteristic symptoms of Tetanus 
(Trismus and reflex spasms) (6). Colonisation of the skin by non-native biota can further affect the 
homeostasis of the skin and can be measured either through biopsy or screening methodologies. A 
crucial protective aspect of the innate immune system is the presence of antimicrobial agents 
synthesized in the Stratum granulosum, which are packed into lamellar bodies and transported to 
the Stratum corneum. AMPs are also produced by sebocytes, mast cells and neutrophils in healthy 
human skin with sebocytes being the proposed source of the AMPs present in the sebum of sweat.  
 
Keratinocytes of the epidermis have also been shown to induce inflammatory responses within the 
skin. When allergens, ultraviolet light or physical insult impacts the skin, keratinocytes act as signal 
transducers which converts these external stimuli into the production of pro-inflammatory 
cytokines, adhesion molecules and autocrine/paracrine chemotactic factors. 
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1.2 Biomarkers of the skin and topical formulation design  
Biomarkers which have been measured and identified to evaluate the health and functions of layers 
of the skin include genes, enzymes and their respective activities, proteins and smaller molecules 
such as vitamins, NMFs and ions (Cl-. Na+, K+, Ca2+, Mg2+, PO43-). Studies on genetic biomarkers are 
widespread and heavily researched in the investigation of skin ageing, disease states and water 
retention potential. It has been shown that genome affecting biomarkers of the skin correlate to 
endogenous ageing, while also highlighting the Wnt signaling transduction pathways (7).  In the 
ageing process. It has also been suggested to use these genetic biomarkers as an alternative to CNS 
sampling when investigating ageing (8). Techniques for analysing genetic biomarkers testing are 
undertaken in a high throughput fashion, for example with the use of quantitative real time 
polymerase chain reaction (RT-PCR), which has been used to verify nine genetic biomarkers out of 
158 characterised human skin cell genes of the skin which attempted to identify molecular targets 
for drugs and therapeutic treatments (9). Enzymes and proteins as biomarkers have also been 
evaluated to monitor skin ageing and the appearance of senescent cells, which have been 
suggested to be indicative of premature cell ageing and deterioration of the skin through thickening 
of the skin layers and loss of desquamation function which leads to the observed structure of ageing 
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Specific proteins of interest are proteases that have a crucial role in desquamation of skin; these 
can be monitored through measurement of their activity in the skin. Smaller peptides, specifically 
AMPs, are also an important biomarker to determine the functioning of the skin, immune system 
and wound healing responses. Smaller molecule biomarkers have been studied, which include 
NMFs, free amino acids, metabolic breakdown products and ions. Ions and charged metabolic 
products have an effect on the physiological conditions of the skin, such as pH, which can be 
measured as a biomarker. One study has used these biomarkers to compare between infants and 
adults and showed significant differences between infant skin and adult skin. The results showed 
that the biomarkers measured which had roles in filaggrin processing, protease inhibition and 
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innate immune system function were upregulated during physiological transitions after birth that 
drove changes in skin pH and increased water-binding NMF components, while suppressing 
desquamation of skin through downregulation of protease activity. This study highlights the 
significance of biomarker characterisation and quantitation in the skin (11). A specific protease that 
is showing significant importance in the processing of filaggrin to NMF is that of Kallikrein (KLK), 
which is mainly functional through the actions of KLK5 and KLK7. KLK5 and KLK7 play crucial roles 
in the maintenance of the epidermal barrier and are heavily imlicatied in inflammatory skin 
diseases. Measurement of Kallikrein activity versus NMF levels could help to elucidate the specific 
steps and interactions of compounds leading to the development of novel treatments for 
inflammatory diseases (12).  
 
1.2.1 Vitamin D 
In the skin, vitamin D has a role in regulating the formation of the skin barrier through processing 
of the long chain glycosylceramides in the extracellular lipid mixture. The photo-production of 
vitamin D all takes place in the skin. Once in the epidermis, it diffuses to the dermal capillary bed, 
where it is transported to the liver by the vitamin D binding protein (13). Once in the liver vitamin 
D is hydroxylated to the active form 25-(OH) vitamin D and then oxidized in the kidneys to give the 
active form 1α,25(OH)2vitamin D which alongside calcium function, helps to regulate skin 
differentiation, apoptosis and inhibition of cell proliferation (14).  
 
It has been shown that an induction effect of Toll like receptor 2 and its co-receptor CDl4 is induced 
by vitamin D, therefore initiating the innate immune response in the skin, leading to CYP27B1 and 
cathelicidin production (15,16). Furthermore, the induction, of cathelicidin (LL-37) production by 
1,25-(OH)2D highlights another role of vitamin D in facilitating wound healing and tissue repair. This 
is demonstrated by the up regulation of cathelicidin during wound healing (17), modulation of 
inflammation (18), induction of angiogenesis (19) and improving re-epitheliasation (20).  
 
Chapter 1 Introduction 
31 
 
1.2.2 Main targets for analysis in skin  
The integrity of the skin and its ability to retain water has been shown to correlate to levels of NMF 
in the Stratum corneum, with disease states demonstrated to have different NMF values to healthy 
states. NMF compounds are breakdown products of Filaggrin that exist in the extracellular lipid 
matrix. The NMF compounds exist at varying concentrations with free amino acids being the most 
abundant at 40% w/w, Pyrollidone carboxylic acid at 12% w/w, lactate at 12% w/w, Ammonia, Uric 
acid, glucosamine and creatine at 1.5% w/w, with the least abundant compounds Citrate and 
Formate at 0.5% w/w (20).  
 
Lactate has been suggested, together with potassium, to have a role in supporting the barrier 
effectiveness of the Stratum corneum in healthy skin. A study, using tape stripping of the skin, 
quantified lactate and correlated levels of lactate with potassium, however the exact relationship 
between keratinocyte proliferation and lactate is still uncertain. Despite this, lactate is known as an 
end product of glycolysis which is the main energy source in the epidermis, so is a promising marker 
for monitoring of skin health and function (21). 
 
Pyrollidone carboxylate (PCA) is a cyclized derivative of glutamate and is included with glutamate 
in the calculation of NMF levels and can be used to investigate further by ratio correlation 
measurements with ratio studies in the skin of glutamate from proteolysed filaggrin to PCA to 
better understand the metabolism of amino acids in the different layers of the skin. PCA has been 
heavily studied as it has been shown that PCA concentration correlates to the functioning of the 
filaggrin genotype. This has led to several tape stripping papers, where the method of adhesive 
tapes being pressed onto the sampling site of the skin and subsequently abruptly removed to collect 
the stratum corneum layer of the skin at the sampling site for analysis is employed.  that utilise this 
relationship to monitor not only its relationship to genetic variants of the FLG gene but also 
correlations to hydration, variation in ethnicity and anatomical site, and damage to the skin (22) 
(23). 
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The amino acids, which are most abundant in the NMF consist predominantly of amino acids from 
the proteolysis of filaggrin. A consequence of investigating the composition of filaggrin is it will help 
guide researchers to amino acid selection for analysis in the terminal layers of the Stratum corneum. 
The Uniprot data base for filaggrin (24) shows a compositional bias in the filaggrin repeats of serine, 
histidine and alanine. This marks these amino acids as compounds of interest in the analysis of the 
skin, especially serine which highlights the role of serine proteases in the management of the skin. 
(25). In the skin it has been illustrated that there is further specific processing of amino acids after 
proteolysis of filaggrin. This includes the conversion of histidine to urocanate via the elimination of 
ammonium through the action of histidine ammonialyase (26). Arginine is also converted to 
citrulline through the deamination during the post translational modification of residues on several 
locations along the profilaggrin structure (27). These two modified amino acids are present in the 
Stratum corneum and have been correlated to filaggrin status in disease states (26). 
 
NMF compounds related to the energy cycles of the skin include formate, citrate and creatine. 
Formate is indicative of cellular and whole-body metabolism, which can cross the bridge between 
nutrition and toxicology measurements. Formate is a promising marker for analysis of human 
physiology and disease as a whole. (28). Citrate is known as the end product of the citric acid cycle, 
which has been classed as the most important metabolic pathway for energy in the body, 
functioning in the oxidation of carbohydrates, fats and amino acids from proteins. Measurement of 
citrate in the skin could give a measure of the metabolism in different layers of the skin (29). 
Creatine is normally only investigated as an energy precursor however it has been shown that cells 
that are exposed to higher levels of creatine has been shown to have increased protection from 
stress. Specifically oxidative stress and UV stress, which are pertinent areas of interest in skin 
research. Creatine has also been used in topical formulations for enhancement of skin protection. 
Analysis of the creatine-kinase system in the skin has therefore garnered quite a bit of interest (30). 
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1.2.3 Topical formulation design and active ingredient 
encapsulation and drug delivery 
Topical treatments made for the skin are primarily evaluated for the potential to improve water 
retention and strength of the barrier of the skin towards irritants, be they physical or chemical. The 
design of  topical  treatments  for  the  skin  looks  to  include  compounds  which show an ability to 
decrease Trans Epidermal Water Loss (TEWL) and therefore increase the moisture level of  the  skin. 
One of the best-known moisturising compounds is glycerol/glycerin. It is known that glycerol acts 
through the  drawing  of  water  to  the  surface  of  the  skin, through regulation  of  osmosis  within  
the intracellular milieu, alongside a role in the maintenance of the fluid structure of cell membranes 
and intercellular lipids (ICLs) (31). Panthenol, has demonstrated  significant  decreases  in  TEWL 
through  30  day  application  of  down  to  1%  solutions. It  was  also  shown  that  panthenol 
containing  formulations  showed  immediate  reduction  of  TEWL  after  application  when 
compared to controls and vehicle formulations (32). 
 
Permeation of active compounds in topical creams can be enhanced through several methods, from 
varying the formulation composition to chemical and physical effects applied upon the Stratum 
corneum during application. When formulation vehicle design does not give the permeation desired 
of a certain compound, permeation enhancers have been added to the formulations. The most 
common  of  these permeation  enhancers used  in  dermal  treatments  is that  of glycols, specifically  
propylene  glycol. However this  is  not  the  only  1,2-alkane  diol  that  has  been evaluated for this 
purpose. Pentylene glycol has also been shown to demonstrate anti-microbial activity alongside the 
desired moisturizing effects. Analysis of permeation profiles has shown that glycol-containing 
vehicles give a 100% increase in penetration to viable skin layers after 30 minutes. This analysis also 
gave an insight into the comparative effects of longer chain glycols which makes the method of 
permeation enhancement of glycols better understood (33). It has been shown that a relatively 
longer chain glycol, 1,2-pentanediol, at a low 5% proportion of formulation, showed a faster and 
greater penetration of caffeine in pig skin models., much like the permeation increase seen in 
dihydroavenanthramide D in the previous study (34). Further to  vehicle  design  and  the  addition  
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of  permeation  enhancers, it has also been demonstrated through  the  work  of McAuley  et  al, 
the  potential  of  using  heat alongside chemical enhancers to increase delivery of topical 
compounds. Through heating of scalp skin by around 12 kelvin over a 24 hour period of short 
duration heating pulses, it was shown that finasteride penetration into the human scalp and 
targeted hair follicles was significantly increased.  This  research  also  showed  that  particular  
combinations  of  penetration  enhancers were used for targeting of permeation with heat 
application as adjunct to increased and faster permeation to the target area(35 - 37). These  studies  
were, however,  limited  to showing  increased permeation  via  the  hair  follicles  to deeper  skin  
layers rather  than permeation through the extracellular lipid matrix of the Stratum corneum. It has 
been demonstrated that for binary systems composed of propylene glycol and fatty acids that 
permeation of the active Niacinamide in the human skin can be enhanced (38). 
 
1.3 Analytical Chemistry techniques for investigation of the 
skin 
Measured variation of certain biomarkers abundances throughout layers of the Stratum corneum 
can be indicative of how filaggrin forms and breaks down.  It  can also  detail  the  NMF  compound  
variability throughout  the  outer  layers  of  the  skin.  This information can give insight into the 
filaggrin formation and breakdown in healthy skin. It also allows for correlation of NMF compounds 
with skin changes from the inner layers to outer layers.  
 
1.3.1 Sampling models  
Various experimental models are employed in dermal and transdermal research. These are 
categorized as in vitro, ex vivo and in vivo, which covers the use of culture skin models, excised 
human or animal skin and whole animal models respectively. It has been shown that measurements 
of NMF levels correlate between in vitro and in vivo samples from animal and human models have 
been validated, however many of the models and suggested correlations between biomarkers still 
show large deviations in results between in vitro and ex/in vivo. There is a limitation in the number 
of reported correlations that have been validated which researchers suggest is mainly through the 
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active nature of in vivo skin, which has a circulatory system that introduces unknown variables into 
the system being investigated. Despite the limitations of in vitro experiments, research has 
highlighted the potential of porcine skin as a comparable model to human skin. Which alongside 
the benefits of acquisition and ethical considerations, has a functional benefit through more similar 
barrier properties to in vivo skin than that of in vitro human skin interestingly. This however does 
mean that human culture studies are limited to studies on irritation and metabolism (39). 
 
In vitro modelling is classically achieved through the development of keratinocyte cultures, either 
as monolayers of cells or as layers of keratinocytes with selective differentiation of keratinocytes 
which gives a much more complex model. The use of keratinocyte monolayers is restricted to 
investigation of the structural and functional features of keratinocytes by its simplistic nature, 
whereas full epidermal reconstructions can be used to interrogate differentiation of keratinocytes 
and formation of the cornified barrier. The epidermal reconstruction can also be designed in a way 
to compare how specific layer changes can affect the characteristics of the skin and is a very useful 
model for disease state investigations (40). 
 
The use of ex vivo tissue for analysis has been shown to give reliable results as the layers of the skin 
have been defined in vivo processes and keratinocyte characteristics are correct. The difficulty with 
ex vivo use is in making sure that extraction, storage and acquisition of results is consistent between 
studies as reproducibility of results could suffer greatly despite the seemingly simple method of 
extraction. Studies using ex vivo samples from humans are ethically sounder than those from animal 
samples as informed consent can be given after cosmetic procedures and amputations as done in 
this study. These reasons make ex vivo tissue sampling a fruitful area for interrogation of not only 
skin features but also permeation profiling of formulations used for topical or cosmetic applications 
(41). 
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In vivo sampling of the skin is the most reliable model for investigation of the skin, as it is not limited 
by assumptions made about skin and lack of a microcirculatory system. However, in vivo skin is 
limited by researcher control, in the way that unknowns and their effects on treatments have to be 
elucidated as much as possible before conclusions can be made from findings. In vivo studies have 
also been predominantly undertaken on animal models rather than human models as these can be 
designed to an extent and are also a lot cheaper and controllable than human in vivo studies. 
Rodents are the animal of choice as they are relatively inexpensive, have validated methods of 
handling and are also small, so large sample based studies can be readily set up (42). One issue of 
animal modelling in in vivo studies is that the composition of free fatty acids, triglycerides and hair 
follicles must be considered when comparing the skin barriers of rodents compared to humans. 
This has more value in permeation models as these components are part of the main transdermal 
delivery pathway, with structural characterisation of keratinocytes and genetic effects being more 
comparable in animal models to human models as genes related to specific functions are commonly 
conserved in species (43). 
 
Correlations between the different modelling methodologies and validation of in vitro/ex vivo 
findings and in vivo findings have been studied through the implementation of mathematical 
methods. Looking at mathematical laws can help us to better explain findings and discover 
correlations which may have been hidden before. Fick’s Diffusion law which has been implemented 
in describing transport of permeable solutes through the non-viable layer of the Stratum corneum. 
Fick’s law helps us to determine partition coefficients, diffusion coefficient, and thickness of barrier 
with consideration of  in vivo Stratum corneum conditions such as viable epidermis, interfacial 








C0 is the donor concentration; K is the partition coefficient (measures the ratio of concentration of 
compound between two areas, here it is used for each side of membrane; D is the diffusion 
Chapter 1 Introduction 
37 
 
coefficient (rate of diffusion for compounds through membrane being used); and h is the thickness 
of the barrier (44). Mathematical methods have been exploited to build several databases detailing 
compound permeation of the skin through in vitro studies and also in analyses of permeability of 
different species and anatomical sites of the skin, comparing their functional properties for 
different modelling types. One of the most comprehensive databases was made by Flynn which 
details the permeability coefficients of 94 compounds (45). 
1.3.1.1 Tape stripping 
Characterisation and quantification of active compounds allows us to follow the response of the 
skin elicited by topical or prescription application. A validated way of doing this is through tape 
stripping of the skin, where layers of keratinocyte cells are removed via the application of cellulose 
acetate strips to the chosen skin site and removed in a manner to keep the layer’s depth, volume 
and mass as consistent as possible. Once removed, several analytical techniques can be used to 
evaluate the concentrations of specific active compounds within the skin. Squame Scans, a 
colorimetrical determination technique which indirectly measures the total Stratum corneum (SC) 
protein content on tape strips through measuring optical absorption at 850nm (infrared) can be 
used followed by further separation and analytical tests to determine the mass of specific 
compounds, peptides, proteins per mass of total protein removed to give normalized values 
between tape strips. Sonication tests have shown that sonication for a minimum of 10 minutes is 
sufficient to remove 85-90% of total protein from the tape strip, and a low rpm centrifugation 
removes any cell debris from the supernatant containing proteins, peptides and active compounds 
of the cells and extracellular matrix extracted which gives a reliable method of extraction. 
 
The methodology of tape stripping has been used to analyse SC protein, enzyme activities and TEWL 
(46). Further studies measuring SC proteins from tape stripping have shown clear variation in the 
biochemistry of sensitive skin individuals (47). Tape stripping has also been used to measure NMF 
levels derived from filaggrin. These levels indicate changes in the development of the epidermis 
from basal layer to outer layers. Regional Tape stripping has been used to show regional and  
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temporal  differences  in  NMF  levels,  alongside  protease  activities which  is suggested as a 
prediction tool for atopic dermatitis in early childhood (48). 
 
The use of tape stripping, where removal of uniform complete cell layers of corneocytes is achieved 
non-invasively, has been validated in the comparison of skin properties between different 
anatomical sites and ethnic groups. It was shown that the Stratum corneum of the face is 
structurally distinguishable from the Stratum corneum of the forearm, through measurement of 
Stratum corneum removed per tape strip. Differences in the furrowing of skin and relative layer 
thickness can begin to explain these differences, but function and exposure of these different skin 
types gives an interesting angle to these findings. It was also demonstrated that the regression 
between different anatomical sites and ethnicity was similar which suggests a reliable 
measurement and good reproducibility between groups. They also showed that the correlations 
between site and Stratum corneum matched those shown in previously published data on body 
sites not investigated in this study. They also generated calibration curves on the acquired data 
which paves the way for a potential rapid indirect protein assessment method (49). 
 
The wealth and variety of the use of tape stripping in the analysis of skin exemplifies its robust and 
simple methodology. This assumption however must be taken with a grain of salt and caution must 
be practiced before tape stripping is employed. Tape stripping must have several parameters 
considered before and during implementation to make sure that the Stratum corneum is extracted 
in a homogenous way to avoid issues with repeatability and reproducibility. It has also been 
recommended to determine the amount of Stratum corneum removed for all tape strips to increase 
validity of conclusions. With these considerations in place the potential of tape stripping is huge, 
especially in the field of dermatological and pharmacological studies. Combination of this technique 
with skin biopsies and further developing imaging methodologies can also help to validate and 
compare correlations seen between different modeling systems (50). 
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1.3.2  Detection techniques; Spectroscopic methodologies  
Vibrational spectroscopic methods, most commonly infrared (IR) spectroscopy, have been widely 
used in the analysis of the skin. Mid-infrared pulsed photoacoustic spectroscopy has also shown an 
ability to monitor glucose in the human epidermis (51). 
 
IR is routinely used to measure the CH symmetric and asymmetric stretch (2850-2920cm-1), 
carbonyl stretch, amide 1 and 2 bands in the skin as this give information about the lipid and protein 
conformation within in vitro models of the skin and ex/in vivo extracts/areas of the skin. Most IR 
studies use attenuated total reflectance Fourier transform IR (ATR-FTIR) and study the skin of the 
forearm, but there have been studies on other areas of the body such as the face. A study using 
skin tape strip samples from the face demonstrated the use of ATR-FTIR to monitor the composition 
and organization of SC lipids in vivo. (52). 
 
An important finding by several studies using IR methodologies was through measuring permeation 
of different topical additives, such as octadecanoic acids and oleic acid, was that hydrated skin was 
more permeable (53, 54). The exact reasons are unclear, but research showed that phase separated 
pools can be formed in the Stratum corneum by permeation enhancers (55). Alongside this it was 
evidenced that the extracellular lipid pathway was the primary permeation route as studies on 
water diffusion through porcine skin showed water permeability being highly correlated to the –CH 
stretch of lipids within the pathway (56). ATR-FTIR has also been implemented in combination with 
in vivo tape stripping to assess the delivery and availability of drugs within the Stratum corneum 
(57). IR methods have shown potential in analysis of the skin however is very limited for screening 
as complex mixtures are almost impossible to distinguish and non-broadband irradiation is used for 
targeting of specific functional groups of compounds. 
 
Electronic spectroscopic methods include UV, Fluorescence and NMR, with NMR addressed later 
on. The surface of the skin has been analyzed by diffuse reflectance UV spectroscopy however any 
deeper analysis is limited by the natural barrier of the skin to UV radiation. Despite this limitation 
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it has been observed that researchers moved the UV range closer to visible radiation to prevent cell 
damage through irradiation. To get around shorter transmission distance of visible light through 
skin, fibre optics are employed to apply the radiation source deeper in the skin. A study has used 
these techniques to measure penetration time of aminolevulinic acid in the forearm (58). This work 
is promising in the development of electronic monitors which persist in the skin and characterize 
skin properties (59).  
 
Fluorescence methods are much more common when compared to UV methods. This is 
predominantly through the exploitation of fluorescence probes. The membrane fluorophore 1,6-
diphenyl-1,3,5-hexatriene has been exploited to measure the effects of oleic acid on the skin and 
the transport of benzoic acid using fluorescence lifetime and limiting anisotropy methodologies 
(60). Transfer from ex vivo to in vivo fluorescence imaging has also been demonstrated for the 
investigation of skin lesions (61). MPT/FLIM studies on excised lesions corroborated with results 
from conventional dermatological techniques and histological techniques (62). Fluorescence is 
limited however by the predominant need for probes which limit the range of applications to 
predominantly larger tissue effects and cell area affects on skin and not the biomolecular changes 
that occur in the skin after chemical or physical infarction. 
 
The use of mass spectrometry in the analysis of skin samples and extracts has predominantly been 
done using matrix assisted laser desorption ionization mass spectrometry (MALDI-MS) (63). The use 
of MALDI-MS has been demonstrated to measure levels of ketoconazole in porcine skin, the 
absorption profile of imipramine with an artificial model of the epidermis, and characterisation of 
lipid species present in ex vivo samples of the human skin. (64 - 66). A more recent MS method that 
has potential in the analysis of skin hydration and disease state is ‘Direct analysis in real time mass 
spectrometry’ (DART-MS). This technique has been used to directly quantify amino acids present in 
the Stratum corneum and is a very exciting technique for future analysis of NMF compounds and 
their correlations to varying Stratum corneum conditions (67). 




Figure 3 Flow chart of DART MS methodology for us in NMF determination, adapted from Maeno K et al. 2017 (100) 
 
Other spectroscopic techniques used in the analysis of skin include Opto-Thermal Transient 
Emission Radiometry (OTTER) (68), Impedance Spectroscopy (69), Laser-Induced Breakdown 
Spectroscopy (zinc absorption in vivo) (70, 71) and Photoacoustic Spectroscopy (72). These 
techniques have predominantly been utilized to measure the permeation of actives, with OTTER 
being used  to measure hydration of the skin in vitro and in vivo (73)(74) . Impedance spectroscopy 
has also been used for studies on the effects of mechanical and chemical damage to cadaver skin 
which gives some fascinating insights into possibilities of spectroscopic techniques on the skin from 
a different focus point (75)(76).  
 
Use of HPLC for analysis of tape strip extractions is extensively used, with extraction procedures for 
studies investigating physiology and biochemistry of the stratum corneum (101), NMFs (102) and 
penetration of ferulic acid and UV filters (103) detailed in figure 4. 
 




Figure 4 HPLC extraction procedures used in tape strip based studies (101 – 103) 
Electron Spin Resonance (ESR), a technique based on the same principles as NMR, exploits unpaired 
electrons present in paramagnetic molecules which can absorb energy when in an applied magnetic 
field. It has been employed in skin research through measurements of diffusion of oxygen in the 
Stratum corneum (77), and measuring degree of disorder in lipid bilayers of the Stratum corneum 
caused by n-decymethyl sulphoxide application (78). Most interestingly for this work it was used in 
collaboration with tape stripping techniques to evaluate the effectiveness of different vesicle types 
(core multishell nanotransporter and invasomes) in delivering 3-carboxy-2,2,5,5-tetramethyl-1-
pyrrolidinyloxy to layers of the Stratum corneum (79). 
 
 
1.3.3 Nuclear Magnetic Resonance (NMR) 
 
NMR is unique as an analytical technique in that it takes two very distinct forms, spectrometry (solid 
or liquid state, in vitro) and imaging which has the potential to image skin in vitro, ex vivo and even 
in vivo. Firstly the use of NMR as a spectrometric technique, predominantly used technique in in 
vitro models of the skin, will be reviewed. 
 
NMR metabolomics is a useful tool for greater understanding of the metabolism that occurs in the 
human epidermis. A demonstrated use in determining nanotoxicology effects upon the skin was 
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demonstrated by a study of silver nanoparticles incident on keratinocytes. In this study 
keratinocytes of the epidermis were exposed to 48hrs of 30nm citrate-stabilized silver 
nanoparticles, at concentrations of 10 and 40 μg/mL. NMR was able to analyse specific metabolite 
concentration variations from intracellular and organic extracts, and extracellular culture media, 
which, in combination with multivariate analysis demonstrated that the keratinocytes exposed to 
the silver nanoparticles had upregulation in antioxidant protectors, and downregulation of energy 
depletion and cell membrane modification. This study also underlined the sensitivity of NMR 
metabolomics to be able to detect early biochemical events which change metabolite levels at 
lower concentrations of silver nano particles (80).   
 
Alongside toxicological studies of the skin in response to formulation treatment there are a larger 
number of studies utilizing NMR methods to interrogate the permeation effects of excipients and 
actives. One such active is Azone® which is shown to induce structural disorder of the intercellular 
lamellar lipid structure in the Stratum corneum through the use of 2H NMR. It was also suggested 
that fluid domains within the Stratum corneum are created in the lipid pathway which could explain 
the penetration enhancement effect (81). This early work led onto the use of other NMR 
methodologies for the analysis of formulation composition and respective effects on transdermal 
delivery of drug actives and topical compounds. PFG-NMR which determines self-diffusion 
coefficients of single molecules or groups of molecules was shown to be useful in optimizing 
microemulsions for transdermal delivery evaluating irritation to the skin (82). The demonstrated 
dependence of increased transdermal drug delivery on solubility and mobility within vehicle 
formulation through PFG-NMR was used in further studies for specific drugs including vinpocetine. 
(83).   
 
Proton NMR spectroscopy has been extensively employed in the study of animal skin with self-
diffusion, t1 and t2 values being measured to interrogate the hydration of water mobility in guinea 
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pig skin models (94)(95). Measurements of free and bound water in the human Stratum corneum 
has also been demonstrated through the application of proton NMR (96).  
 
Using other isotopes apart from 1H with NMR spectroscopy has also been utilized in the analysis of 
human, rat and porcine skin. The use of 19F has predominantly been used in combination with 
fluorine containing probes to measure permeation and develop formulations with greater drug 
encapsulation and increased transdermal delivery of actives. In vivo Human and rat skin has been 
used to measure flurbiprofen absorption in the skin (91). Tape stripping of the viable epidermis has 
also been used in combination with 19F NMR spectroscopy to measure the effectiveness of natural 
micro emulsions. (92).  
 
The heavy isotope of hydrogen, deuterium, has also been used in NMR spectroscopy to characterize 
polymorphism of Stratum corneum lipids and the lamellar structures that are formed by the 
extracellular lipid matrix that exists between the corneocytes and keratinocytes of the Stratum 
corneum (97 - 99).The use of 31P NMR spectroscopy has been employed in the monitoring of disease 
state in people suffering from psoriasis. It showed potential as a non-invasive in vivo tool which 
allowed for the monitoring of treatment options and the characterisation of skin when in a diseased 
state (93). 
 
Magnetic resonance imaging (MRI) has started to see more studies moving into ex vivo and in vivo 
areas, which is an exciting prospect for understanding of the skin layers and further increasing the 
resolution of imaging for smaller tissues. One such study which investigated nanoparticles and the 
skin looked at how semi-solid formulations could affect the skin penetration of iron oxide 
nanoparticles. This however used in vitro human epidermis/isolated Stratum corneum, to 
demonstrate that low-field pulsed NMR, which measured the t2 changes in the skin layers, gives a 
greater discrimination between permeation levels than the more commonly applied dynamic light 
scattering (DLS) methodology (84). 




An imaging technique called stray field NMR which uses the natural magnetic inhomogeneity of the 
applied magnetic field to give spatial resolution has been used in several studies of the skin. In vitro 
studies have used stray field NMR to measure skin hydration through detection of water in the skin 
(87), it has also been used in the following study to measure both water levels and monitor how 
cosmetic formulations interact with the skin (88). Its use in vivo has been reported by Ciampi et al 
to profile the permeation of a model moisturizer formulation into human skin (89). The use of stray 
field NMR has also determined self-diffusion values for water in both models of the Stratum 
corneum and in viable epidermis models (90). 
 
Transition from ex vivo skin layer discrimination to in vivo layer discrimination has led to 
construction of devices that can profile human skin in vivo. These devices are low-field pulsed NMR 
machines that are placed around the skin, commonly the arms or legs. These machines can then 
give contrast on the different skin layers through resolving the variation in relaxation times and 
diffusion coefficients in a specific direction, namely depth (85). These devices have then been 
shown to correlate dermal alterations to ageing and suggest the potential for a skin age assessment 
methodology through fingerprinting analysis of dermal alterations (86). 
 
Figure 5 (Left) Example prototype low field NMR device for in-vivo diffusion measurements and (right) Depth resolved 
distributions of diffusion coefficients of palm skin (85). 
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1.4 NMR  
The beginning of NMR research was sparked by the discovery in 1945 by Purcell, Torrey and Pound 
of weak radiofrequency signals generated by the nuclei of atoms in 1kg of paraffin wax (109), 
alongside the discovery of this same phenomenon in water by Bloch, Hansen and Packard (110). 
The potential of NMR in early experiments was not properly exploited until Fourier Transformed 
(FT) NMR where the conversion of signal as a function of time to a function of spatial or temporal 
frequency gave much easier interpretation and clearer results , started appearing in 1966 through 
work by Richard R. Ernst and co-workers (111). The basic anatomy of a NMR spectrometer contains 
a NMR sample tube space surrounded by shim coils and radio frequency coils for transmission and 
receiving with tuning capacitors present, all within a removable probe. This probe is then 
surrounded by a superconducting solenoid, which is cooled by liquid helium and a further cooling 
jacket of liquid nitrogen with a vacuum in place around the elements. The removable probe is 
connected to a console which controls the transmission and receiving switch, signal pre-amplifier, 
RF detector, analog / digital converter, which sends the data to a workstation computer. The 
workstation, through user control, determines the pulse programming through script selection and 
parameter set choice, alongside the pulse amplification through calibration of receiver gain (RG). 
NMR spectrometers can also contain additional elements to increase sensitivity and resolution with 
a few detailed as followed. Cryogenically cooled electronics and samples reduces the Johnson-
Nyquist noise and increases sensitivity by reducing the distribution of spin states in the Boltzmann 
distribution. (Mo  ≈  γ² h² Ns Bo / 4kT, where γ is the gyromagnetic ratio, h is Planck's constant, Ns 
is the number of spins, Bo is magnetic field strength, k is the Boltzmann constant, and T is absolute 
temperature). Through the Boltzmann distribution it is observed that if the magnetic field strength 
is increased through the use of larger superconducting magnets the sensitivity will also increase by 
B3/2. This increase however is very expensive as demonstrated by the recent 1.2GHz magnet 
installed at the University of Florence for $17.8 million in 2020. More commonly used and less costly 
techniques take advantage of the quantum mechanical properties of magnetic spin. These include 
dynamic nuclear polarisation, algorithmic cooling which increases the polarization of certain spins 
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and Quantum optimal control which shows significant sensitivity enhancement at the edge of 
spectra with reduced rf energy and pulse duration (112). 
In general NMR spectra represent a set of Hamiltonian eigenvalue differences which correspond to 
the energies of the allowed transitions, in response to electromagnetic irradiation. Information 
about the chemical environment is given by the line position, with details of inter-atomic distances, 
bond angles and bond types given by specific line splitting. Another powerful aspect of NMR spectra 
is that integrals of specific lines is proportional to the concentration of the respective compound 
that produces the spectra lines. 
The versatility of NMR is demonstrated by the ease of sample preparation, alongside the short 
experiment time required to acquire spectral data. NMR is a non-destructive process so samples 
can be reclaimed for analytes that are intermediates or have been synthesised in very small 
amounts. NMR is not affected by non-detectable impurities, like that of High Performance Liquid 
Chromatography (HPLC), Differential scanning calorimetry (DSC) and Capillary Electrophoresis (CE). 
It is observed that NMR when compared to HPLC has a benefit in its functionality as a primary 
method of quantification through integral ratio between target analyte and internal reference 
when deciding on a method for quantitative analysis. 
These reasons help to explain why its implementation in research is increasing with further 
investment in Instrumentation advancement, primarily to overcome sensitivity drawbacks 
(113)(114) and pulse program development, with great progress in improving resolution(115). 
These progressive steps are fast making NMR one of the most advantageous analytical techniques, 
alongside that of the ‘gold standard’ GC-MS. 
For 1D 1H qNMR acquisitions,, investigations on the limit of detection and quantitation is 
predominantly done with simple mixtures where the conditions for accurate quantitation can be 
met.This is because the calculation of peak areas for quantitation is impaired through overlapping 
peaks in more complex mixtures. 
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1.4.1 Quantitative NMR 
Quantitative NMR has progressed at a slower rate than that of qualitative NMR (Structural 
Elucidation) because of the further steps required to interpret results. The disparity between 
the use of qualitative NMR and quantitative NMR can be recognized in the literature for 
pharmaceutical development and drug discovery. This helps us to understand why new software 
advances for qNMR, which cannot keep up with hardware advances, are about 10 years behind that 
of qualitative NMR. 
Quantitation requires that the analyte of interest be completely dissolved in solvent for accurate 
quantitation. Another requirement is that the relaxation time (D1) between pulses be at least 5x-
7x the T1 of the longest T1 in the sample; therefore leading to comparatively longer experiments 
than qualitative experiments, unless novel techniques are implemented by a skilled user. This 
consideration for D1 allows complete relaxation to take place; therefore accurate integrals taken 
on complete signal decays. A 90-degree pulse is also preferred to a 30-degree pulse to allow 
maximum signal acquired in the transverse direction. 
With complex mixtures, there are other considerations, which must also be highlighted before a 
qNMR experiment can take place. These considerations fall mainly into two areas: Dynamic Range 
of the sample (concentration differences between analytes and other constituent parts); the 
number of constituents, which make up the sample (much greater chance of overlapping and 
mischaracterised spectra; leading to improper quantification). With these considerations in place 
for complex mixtures, several conclusions regarding S/N, RG values (Receiver Gain, ratio of output 
to input of a receiver, the higher this is, the greater the signal) and processing methods are come 
to. A suitable S/N is required for low concentration analytes to be quantified, for accurate integrals 
to be placed over them where the bias and slope is not significantly affected by the noise level. For 
accurate quantitation it is demonstrated that >50 S/N is required (107). Hand in hand with this there 
is a need to evaluate the RG value used; to allow for the certified reference materials concentration 
to be constant throughout the experiments, as in some it will be comparable to analyte but in other 
experiments it will be in the magnitude of 100,000x greater. This means a large RG is needed; 
Chapter 1 Introduction 
49 
 
however, consideration of baseline distortion with increased RG values must be given. Most NMR 
scanners do however have an automated RG value function, which starts at max RG then drops the 
value until spectral overload is no longer a factor in the transformation of the free induction decay.  
Even with the slower progress of qNMR compared to qualitative NMR techniques there has been a 
great deal of progress in qNMR research as its potential is being realised, especially in 
metabolomics, purity testing, counterfeit detection, and as a pharmaceutical tool (116). With 
greater automation being introduced by software manufacturers (MestreNova), qNMR is being 
exploited by more researchers as the Malz and Jancke equation is no longer required for personal 
calculations of concentrations through manual integral setting and peak characterisation to 
determine proton number,Equation 1.1 shows how the the determination of Concentration (M) 
from determined integrals and a known concentration of internal standard is achieved. This saves 
a lot of processing and analysis time as phase correction, baseline correction, peak picking and 
integral analysis all have to be done manually to allow for accurate quantitation whereas software 
such as MestreNova will use in built algorithms to determine concentration of known analyte peaks 











I and N are the integral area and number of nuclei for the compounds respectively, with the 
resultant molar ratio given M. 
1D 1H qNMR is set up to allow for accurate quantitation of simple mixtures with very little overlap 
between signals. Internal standardisation can be set up with a certified reference material, which 
is at a specified concentration alongside an unknown concentration of analyte; this is the most 
common method for determining the absolute amount of substances in qNMR. In mixtures that are 
more complex however peaks will overlap with one another therefore not allowing accurate 
integrals of peaks to be calculated, this can be resolved to a degree with deconvolution, as this will 
separate peaks from two similarly concentrated compounds, which do not overlap/underlie one 
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another. When a peak of interest is underlying a solvent or more concentrated compound, a second 
dimension can be added to the acquisition to resolve this unresolved peak or addition of 
suppression techniques if the larger peak is not of interest to the researcher. 
2D qNMR is suited to complex mixtures,  as it allows for the resolving of peaks that are lost through 
underlying peaks or are crowded by other more concentrated peaks. The issue with 2D qNMR is 
that for 2D NMR sequences a lot more variability to the relaxation of the protons is introduced. This 
means that the integral of a cross peak will not be quantifiable without a large degree of error and 
uncertainty present. One sequence that has demonstrated a way around this HSQC0 which takes 
repeats of HSQC scans. This sees an attenuation effect seen in the signal intensity from 1 scan to 
repeated scans through the effects of T2 relaxation, J coupling effects etc. However from these 
values the constant k value that is imposed at each repetition can be calculated and linearly back 
tracked to an imaginary number zero scan that has none of the effects of the repeated HSQC scans 
and therefore can be directly quantified with a certified reference material (117).  Speeding-up of 
HSQC data acquisition can be achieved through implementation of the ASAP-HSQC (Acceleration 
by sharing adjacent polarization) Experiments and non-uniform sampled Ultrafast HSQC techniques 
which reduce the long recycle delay needed to achieve a pre-equilibrium proton polarization and 
the number of variable linearly sampled t1 increments required for optimum resolution in the 
indirect F1 dimension (118). 
qNMR has also demonstrated its potential to quantify larger molecules such as peptides and 
proteins since it can provide direct traceability to the SI and impurity standards are not required 
unlike other techniques. Routinely however MS, LC, x-ray crystallography (XRC) and cryo electron 
microscopy (EM) are used for the analysis of protein structure. The gold standard technique XRC 
has limitations which may be resolved by NMR analysis, this include the necessity for samples in 
XRC to be in a solid crystalline state which is challenging for the peptides of interest in this project 
considering they interact with membranes and are intrinsically disordered native unfolded peptides 
(119) .This is not an issue with NMR techniques which allow for a similar atomic resolution but 
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avoids solid state sample requirements; be that as it may an isotopically labelled protein is often 
required.  
qNMR has also been shown to be a useful quantitative tool when used in tandem with other NMR 
techniques used primarily for characterisation. The combination of DOSY experiments and qNMR 
experiments has been used to characterise and quantify natural products within a complex mixture 
of compounds and shows great promise in this area of research (120). It is also shown that qNMR 
techniques have developed to allow determination of the quantitative structural and affinity 
information of interacting ligands. Saturation Transfer Difference NMR (STD NMR) is currently one 
of the most powerful NMR techniques for detection and subsequent characterization of transient 
receptor-ligand interaction in liquid state analysis. STD NMR has become a basic method in drug 
discovery, design and optimization (121 – 124). Quantitative analysis of STD NMR intensities has 
been developed, upon the modification of the complete relaxation and conformational exchange 
matrix (CORCEMA) from transferred NOE experiments (125)(126).  
1.4.1.1 Chenomxtm 
Chenomx is a NMR spectra metabolite identifier and quantification tool. It works through automatic 
identification of compounds in a sample mixture by means of NMR spectroscopy. The sample 
mixture to be analysed has its measured conditions input into the system, where the system can 
pick a set of reference spectra of database compounds which may be present in the sample mixture. 
This allows the production of a test spectrum from unique sample mixtures with different measured 
conditions, which alongside the selected sets of reference spectra produce composite spectra 
containing peaks of suspected compounds within the sample mixture. Detailed pathway of action 
and processing methodology is illustrated in the patent application (127). 
 
1.4.2 Broadband 1H homonuclear decoupled NMR Spectroscopy 
In the last decade, interest in increasing the resolution of NMR spectra for use in complex and 
biological mixtures of small molecules for metabolite analysis has greatly increased (115)(128). This 
had led to a race for researchers to develop novel and innovative broadband 1H homonuclear 
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decoupled methods that allow for high S/N, low number of artefacts and non-time consuming 
simplified JHH multiplet pattern for proton resonances. From newly developed methodologies, 
highly resolved 1H NMR spectra are beginning to be seen for mixtures, with clean, minimally 
overlapped spectra through collapsing of multiplets to singlets. These techniques show great 
potential in not only improving spectra analysis but also making it simpler, faster and easier for 
researchers to come to conclusions. 
 
The potential of decoupling through bond interactions for proton NMR is exemplified by the 
universal use of broadband heteronuclear 1H decoupling in 13C spectrum acquisition which shows 
substantial benefits through simplification of analysis (129 - 132). 1D 1H NMR however suffers much 
more from signal overlap and thus lower signal resolution. Even with the use of high magnetic fields 
for acquisition of 1D1H NMR spectra the resolution improvements do not counteract the limited 
range seen for 1H chemical shifts. Additional JHH couplings for individual protons also means further 
splitting that further exasperates the issue of overlapping peaks. Many researchers will however 
point to the structural information given by proton multiplet structure which correspond to specific 
bond relationships between atoms, such as their dihedral angle constraints or spin systems. These 
points however are mitigated again by signal overlap which prevents accurate elucidation of 
independent peak multiplets and can lead to improper characterisation. It has also been 
demonstrated by the development of multidimensional techniques that most J information, which 
is primarily analysed to determine peak correlations are shown more clearly in 2D techniques e.g. 
COSY, TOCSY, HSQC, HMBC, with even dihedral angles constraints being made less needed as ROESY 
and NOESY experiments demonstrate through space correlations between protons which will give 
greater understanding of molecular structure. It has also been seen that pure shift experiments 
benefit the use of Computer-assisted Structure Elucidation (CASE) software as more complex 
multiplet structures than expected can confuse the CASE calculation and give erroneous results. In 
figure 6, the collapsing of multiplets in the aliphatic region of Cholecalciferol is demonstrated, which 
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in a standard 1D1H acquisition is very hard to determine the number of individual proton 
environments but is clear when observing singlet peaks in the pure shift acquired spectra. 
 
Figure 6 (Top) 1D1H spectra acquired using standard pulse sequence, (Bottom) 1D1H spectra acquired using PSYCHE 
pulse sequence (219) 
 
 
1.4.2.1 Pure shift methodology and principles 
Despite the promise of pure shift methodology to improve NMR spectra resolution, it is not new 
and there are reasons, such as experiment time and inconsistent coupling suppression, which have 
previously hindered the use of pure shift NMR in complex mixture analysis (133-137). Recent 
research has however demonstrated the versatility of pure shift methodologies and how changes 
to pulse sequence building has improved artefact suppression, S/N and time required for 
acquisition. The new pulse sequences, with large investments of time and work into optimization 
and simplification of these techniques has led to subsequent concatenation of Pure shift 
methodologies with more commonly used  1D and 2D NMR pulse sequences which has opened the 
door for wider use of pure shift methodologies (115). 
 
Pure shift pulse sequences are built to manipulate spins, where the acquired signal only presents 
average evolution with effects from chemical shift, therefore giving it the name pure shift, this 
means that signals do not split due to coupling and present as a single peak for each proton 
environment. This is achieved most routinely through the use of two main pulse sequence types. 
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Pulse sequences where evolution affected by scaler coupling is refocused, called J-refocusing 
experiments and pulse sequences where the evolution affected by scalar couplings is kept constant, 
named constant time experiments.  
 
J-refocusing experiments utilise RF pulses to suppress scalar coupling (J) at a given evolution time. 
Several pulse sequences can be employed to apply this suppression of scalar couplings, where they 
group available spins either as active or passive. The signal seen at the end of acquisition is a 
product of the active spins, whereas passive spins are free to be manipulated to remove influence 
of scalar couplings. Manipulation of passive spins is achieved by inversion of spins by J -refocussing 
elements, which not only refocuses effect from couplings but beneficially leaves the phases of the 
active spin coherences unchanged for ease of processing. This action leaves the active spins 
decoupled and measured through processing of signal, while passive spins being the actively 
manipulated element are not present in the observable signal. Pulse sequences that employ J-
refocussing elements are based on the initial experiment by J.R. Garbow et al (135) called Bilinear 
Rotation Decoupling of homonuclear scalar interactions (BIRD), include the Zangger and Sterk 
method (ZS) (136), anti z-COSY experiments (138) and time reversal methods (139). ZS uses 
frequency and spatially selective refocusing whereas the anti-z COSY and time-reversal experiments 
utilise low-flip-angle pulse pairs to refocus J couplings. Despite the differences in how these 
experiments acquire data they all reverse the effects of J-coupling by suppression at specific 
evolution times. The first BIRD experiment mapped out signal evolution with suppression of J 
coupling point by point, however it took a relatively great amount of time to acquire the data. A 
benefit that has been shown is that slow evolution of spins under the effects of J-coupling means 
that measurements do not need to be taken at the instant of J-refocusing, rather a chunk of 
acquired data can be taken before and after the instant of J-refocusing. This ‘chunk’ of data is 
acquired over a time <<2/J where it is observed that the instance of J refocusing occurs at the 
midpoint of this ‘chunk’. When collecting a succession of these ‘chunks’ together with evolution 
times incremented by t1 (relaxation times) of individual molecules in a pseudo 2D way,  this allows 
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for subsequent combination of these results to build a composite signal where chemical shift 
evolution continues seamlessly between chunks with J coupling refocused at the center of each 
individual ‘chunk’. The combination of these ‘chunks’ together into one element is called an 
interferogram which is processed in the same way as a normal Free Induction Decay (FID), through 
Fourier transformation, filtering, phase correction and baseline correction, with the only real 
difference being that scalar couplings of peaks are suppressed and collapsed to purely the chemical 
shift element of the peak. Further spectral resolution improvements can be achieved through 
selection of a larger number of chunks which alongside giving a longer FID, leads to narrower line 
widths. Alongside number of chunks, the duration of chunks also affects the quality of spectra as 
there is less chance that J-refocusing will deviate between the exact centres of chunks if chunks are 
made shorter in the acquisition parameters. The acquisition methodology classically used for the 
pseudo-2D interferogram originally detailed by Zangger and Sterks work (140), acquires chunks of 
data independently of each other in a way determined by pulse script. Once the individual chunks 
have been acquired, a separate script within Bruker Topspin software can be used to build a 1D FID 
from the pseudo 2D FID chunks. A more complex method which several pure shift pulse sequences 
have been written with is ‘real-time’ acquisition, where one excitation pulse can be utilised to 
produce the whole interferogram instead of acquiring the data in chunks. The advantages of this 
technique means that there is no pseudo 2D acquisition meaning experimental time is only a matter 
of seconds longer than conventionally acquired 1D 1H spectra. It has been demonstrated that the 
most time-efficient way is to acquire chunks rather than acquisition on a point-by-point basis, which 
despite acquiring data without residual J-modulation is a lot slower than acquiring data in chunks 
(135). Acquisition of a pure shift interferogram with N number of points requires N number of 
experiments, this factor means that there is a large sensitivity penalty associated with pure shift 
interferogram acquisitions. This penalty can be avoided if whole Free Induction Decays (FID) are 
acquired and a 2D spectrum with decoupling in the second dimension is constructed.  
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It has been observed that with some of the earliest pure shift methods, that projection of integrals 
from 2D J-resolved spectra at 45 degrees to the frequency space, where self-correlations are taken, 
can be used to produce a 1D pure shift spectra. This method is however limited by reduced 
resolution and quantification potential.  The new method Pure Shift Yielded by CHirp Excitation 
(PSYCHE) is based upon a technique called the anti z-COSY experiment which uses a 45 degree 
projection of integrals with a selective method allowing for exclusion of the cross-peak resonances 
producing a absorbance mode spectra (141). 
 
1.4.2.2 PSYCHE 
Pure Shift Yielded by Chirp Excitation (PSYCHE) uses two small flip angle swept-frequency pulses 
which are used in combination with a weak pulsed field gradient to achieve homonuclear 
decoupling. PSYCHE NMR was chosen for this research as it is seen to be the most tolerant of strong 
coupling effects as well as being very easy to implement. 
 
1.4.2.3 Methodology 
The acquisition of a spectra with PSYCHE based homodecoupling requires the implementation of 
several key aspects for pulse sequence design and spin manipulation. These include the use of low 
flip angle pulses for homodecoupling, artefact suppression using spatio-temporal averaging, pulse 
sequences being swept frequency and saltire chirp pulses in design and the selection of the 
coherence transfer pathway (CTP) during these saltire chirp pulses. To describe the pulse sequence 
for a PSYCHE experiment, first the pulse sequence that predicated the PSYCHE pulse sequence, the 
Anti z-COSY experiment needs to be described. 
 
The Anti z-COSY experiment Is built upon a 2D exchange experiment of NOESY, where the flip angles 
of the 2 pulses between mixing time are reduced in angle. Oschkinat et al, suggested the use of 20 
degrees which did not allow exchange to happen and was simply implemented to eliminate CTPs in 
the different quantum coherences (single, multiple and zero), with retention of transfer processes 
through longitudinal magnetization like that given by z-filters, therefore the name anti z-COSY. The 
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experiment was used with resolved J-coupling systems where cross relaxation and exchange could 
be clearly observed (142).  
 
 
Figure 7 Anti z-COSY pulse sequence 
  
This experiment then allows the effect of low-flip angle pulses on the diagonal signals in the 
correlation spectra to be harnessed to achieve pure shift spectra from projection. When comparing 
a simplified version of the PSYCHE pulse sequences with the anti z-COSY pulse sequence a close 
resemblance between these pulse sequences is observed in figure 7 and 8. 
 
Figure 8 Simplified PSYCHE pulse sequence 
This resemblance allows us to determine the best flip angle to minimise the signal intensities of off 
diagonal cross peaks and keep sensitivity  of on diagonal cross peaks high which represent the pure 
shift spectra, as the same 2D correlation  spectroscopy model is used for PSYCHE as used for anti z-
COSY. This relationship between flip angle and relative intensities of cross peaks can be determined 
through charting of relative intensities of groups of cross peaks relative to flip angle degree. 




Figure 9 Anti z-COSY spectra and respective peak intensity depending on pulse angle, (Adapted from workshop on 
pure shift by the University of Manchester) 
The acquisition of PSYCHE sequences is hampered through acquisition of not only wanted 
decoupled signals, but also unwanted signals, including recoupling, zero-quantum and strong 
coupling signals alongside the COSY type responses from the pulse sequence used. Thankfully all of 
these unwanted signals have time-dependent phases which gives the opportunity to remove these 
signals through averaging of a number of transients of experiments with variations between 
coherence evolution times which allows for suppression when averaged together. This technique 
is what PSYCHE uses to minimise effects from these unwanted signals. The spatio-temporal 
averaging is determined by incrementing τA and decrementing τB as seen in the simplified PSYCHE 
pulse sequence above. When these variable delayed experiments are summed together the 
unwanted time-invariant phase signals are suppressed with wanted singlets remaining and 
amplified. 




Figure 10 Sum of pulse cycled spectra and individual pulse cycled spectra 
Additional acquisition artefacts exist for PSYCHE through the construction of the data interferogram 
which is subsequently processed to produce the pure shift spectra. These artefacts include 
chunking artefacts that can arise through improper selection of chunk number and duration within 
the acquisition time. These occur by loss of acquisition of whole chunks as the acquisition time cuts 
them short. Fast pulsing artefacts can arise when single quantum magnetisation is rephrased 
between transients that have reduced relaxation delay and effects on spins are not reset. Digital 
filter artefacts, also described as ringing artefacts, can arise from the large changes of single 
intensities between constructed interferograms between chunks, the main methods to remove this 
is to drop data points at the start of each acquisition chunk to minimise the large change digital 
filter effects between chunks. 
 
The main difference of course seen in PSYCHE is detailed in its name through the implementation 
of saltire chirp pulses with swept frequency. Swept frequency pulses have been primarily used in 
the use of broadband inversion and refocusing of spins.  They sweep the frequency across the 
spectral window determined by the user in a linear frequency, whereas in PSYCHE, swept-frequency 
low-flip angle pulses are used. Below, a normal (unidirectional) chirp pulse is illustrated, where the 
frequency sweeps from low-to-high with the equation determining the shape of pulse given by 
frequency range ΔF (Hz) from –ΔF/2 to +ΔF/2, during time τp (sec), and r.f. amplitude of A (Hz). 





Figure 11 (Top) Spectra annotated detailing swept frequency ranges from low to high, (Middle) Chirp Low to High 
frequency equation, wave form and simplified wave form, (Bottom) Chirp High  to Low frequency equation, Pulse 
shape and simplified pulse shape 
PSYCHE pulses use both High-to-Low and Low-to-High chirp pulses where frequency range is swept; 
ΔF (Hz) is from +ΔF/2 to –ΔF/2. When averaging these chirp pulses together, a pure real waveform, 
named a saltire chirp pulse is acquired. The saltire chirp pulse is an amplitude modulated pulse with 
constant phase through an absence of an imaginary part in its respective waveform. 
 
Figure 12 Average of low to high and high to low chirp pulses, Saltire Chirp pulse equation, Waveform and simplified 
waveform 
The design of the waveform means that the respective flip angle of pulses is representative of the 
integral of the amplitude envelope in respect to time. This is illustrated by the following equation, 
where amplitude is calculated from the r.f. amplitude of a saltire chirp pulse with a sweep-width of 









Further saltire chirp pulse optimization for use in the PSYCHE pulse sequence was done through 
averaging of two pairs of inversed sweeping unidirectional chirps to create a double saltire pulse 
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element. This gives advantages for saltire pulses through its linear dependence of r.f on flip angle 
which is greatly beneficial for PSYCHE low flip angle pulses, where very small r.f. amplitudes are 
needed. It also gives greater signal to noise relative to unidirectional sweeped chirp pulses. 
 
Figure 13 Simplified wave forms of averaging of inversed sweeping unidirectional chirp pulses to double saltire pulse 
used in PSYCHE pulse sequence 
The elimination of coherences with the PSYCHE pulse sequence has been accomplished not through 
elimination but through manipulation of the coherence transfer pathway during the saltire pulses. 
Using the double saltire PSYCHE element introduces two CTPS which are manipulated by encoding 
gradients during the pulses. The evolution of coherences during a saltire PSYCHE element can be 
represented as the superposition of two independent CTPs being enforced by the presence of the 
encoding gradient during the pulses. Where the encoding gradient affects the Saltire PSYCHE 
elements at different points, specifically at the low frequency part of the pulse where coherences 
are affected. These effects are illustrated below. 
 
Figure 14 Highlighted Coherence transfer pathways for PSYCHE pulse sequence separated into separate pairs of chirp 
pulses 
This means that the final pulse sequence for 1D 1H PSYCHE experiments, with features detailed 
above is as follows. 




Figure 15 Full PSYCHE pulse sequence 
When implementing the PSYCHE pulse sequences it becomes clear that several considerations must 
be taken to ensure good quality spectra are acquired. These included deciding upon how to 
compromise between maximizing sensitivity while still minimizing recoupling signals from evolving. 
The sweep-rate of the pulse, ΔF/τp, needs to be optimised so as to keep spectral purity as high as 
possible, but prevent misinterpretation through signal loss by relaxation and diffusion effects on 
spins. For spatial averaging of acquired data, gradient pulses are used, which means that attention 
needs to be paid to the time, shape and power of gradient, where values should be matched with 
the set bandwidth of the PSYCHE pulse for highest spectral quality. 
 
1.4.2.4 Application 
Pure shift yielded by chirp excitation (PSYCHE) is one of the most extensively used recent 1D 1H 
pure shift experiments as it has been shown to demonstrate superior sensitivity and artefact 
suppression when compared to other techniques. Its implementation is also assisted by tutorials 
on pulse sequence, parameters, processing and optimization given by the founders of the 
experiment at the University of Manchester NMR methodology group. Its use in complex mixtures 
has been demonstrated in a variety of studies ranging from organic chemistry applications to 
materials and metabolomics applications. In organic chemistry the use of PSYCHE has 
demonstrated an ability to improve the measurement of relaxation times within complex mixtures 
of organic chemical systems (143). PSYCHE has also been used in the study of soft corals, where 
comparative studies showed the potential of PSYCHE in materials science compared to classical 
proton NMR analysis (144). 
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Further analysis of a geographical materials nature has also been seen in studies where PSYCHE 
NMR is used in combination with selective excitation filters for improved analysis of waste-water 
(145). The main area that PSYCHE pulse sequences have been exploited is in the study of 
metabolomics, including in food quality analysis (146), metabolomics profiling (147) and 
metabolites (148). 
 
1.4.2.5 PSYCHE-Diffusion NMR 
The simple application of PSYCHE has led to its use in conjunction with other NMR techniques 
including PSYCHE-iTOCSY (Total Correlation SpectroscopY) and PSYCHE-iCOSY (Correlation 
Spectroscopy). In this study, PSYCHE is combined with the previously introduced DOSY NMR in a 
method known as PSYCHE-iDOSY (149). PSYCHE-iDOSY is a unique pseudo 3D method involving the 
combination of a diffusion encoded dimension within the PSYCHE pure shift pulse sequence.  
 
1.4.3 Diffusion Ordered Spectroscopy (DOSY) 
The use of DOSY allows for the resolution of compounds through elucidation of their diffusion 
constants. DOSY is predominantly used in a qualitative manner but has also been shown to give 
quantitative results through measurement of self-diffusion coefficients. Resolution through 
diffusion coefficients determination can be correlated with chemical shifts of compounds to give a 
2D DOSY spectra. Since all diffusion coefficients of nuclei present in a single molecule will be the 
same, molecules can be separated from one another in complex mixtures. Alongside mixture 
separation, measured self-diffusion coefficients can give molecular size information, 
monomer/dimer status and also encapsulation information through construction of an external 
calibration curve with normalized diffusion coefficients which takes molecular shape into account ( 
As always though several things must be considered when interpreting the results, including the 
strength of field gradient in the probe, and the limitations inherent in the application of the Stokes-
Einstein equation.  
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The pulse sequences used in DOSY are built upon a foundation where a pair of gradient pulses effect 
spins to the effect they are made to precess in one direction during the first gradient pulse followed 
by a reverse in direction at the second pulse. A non-uniform magnetic field is induced by a “gradient 
pulse” which creates inhomogeneity linearly along the z direction of the NMR sample. Spins will 
diffuse at different rates, so spins that diffuse at a greater rate during the set time period, (diffusion 
delay (D20)), between gradients experience a larger variability in magnetic field to spins that diffuse 
at a slower rate. This principle means that the intensity of different spins will be refocused at 
different degrees at the end of the second gradient pulse. This means that the final intensity shown 
by the NMR signal is affected, with variability in the reduction of individual molecule intensity 
dependent on diffusion properties. When translating these initial diffusion measurements into 
quantifiable measurements the diffusion constant of individual molecules (D) correlates to its 






T = Temperature; η = Viscosity; RH = hydrodynamic radius of the molecule; kB = Boltzmann constant 
Initial DOSY pulse sequences were designed with a spin echo (90-t-180-t-acquire) pulse sequence, 
where the gradients were used with the same sign. This works as the 180 degree pulse inverts the 
magnetisation which means that the second gradient refocuses the spins. Modifications were 
however needed for this experiment as the magnetization decayed with the time constant T2, not 
T1, which meant that the sensitivity of the experiment was very low. One of the classically used 
DOSY experiments now is the stimulated echo sequence which makes the magnetization stored 
along the z-axis, meaning that decay of magnetization is dependent on T1, giving larger signal 
intensity potential. The addition of a spoil gradient is needed to eliminate magnetization that does 
not return to the z-axis, therefore T2 effects are ameliorated. Longitudinal Eddy current Delay (LED) 
sequence DOSY experiments are essentially the same as a STE sequence but they have an additional 
dephasing of magnetization in the transverse plane which is followed by an additional delay. These 
additional elements are to allow for dephasing and rephasing of magnetization, with return to the 
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z direction, with the additional delay allowing for eddy currents, generated by large changes in 
magnetic field in coil, to decay before magnetization is translated into the transverse plane for 
acquisition of signal. The addition of a pair of gradient pulses with opposite polarity in lieu of the 
two individual gradient pulses can refocus static gradient terms, which consequently minimises the 
effects seen by eddy currents. It must however be considered that if the 180-degree pulse is not 
perfect, as it usually is through magnetic inhomogeneity, there will be signal left at the end of the 
sequence that is not diffusion encoded as there will be rephasing of magnetization unaffected by 
the 180 degree pulse by the second pair of gradient pulses. This is one of the factors of error seen 
when calculating self-diffusion coefficients as the final signal will have an error term. The use of 
spoil gradients reduces these effects but not completely, to remove this effect completely sixteen 
steps of phase cycling for each step would be required in the absence of bipolar gradients as this 
has been shown to average out the artefacts that present through the rephasing of magnetization.  
 
All the above reasons identify LED sequences with bipolar gradients as the most suitable 
experiments to use in DOSY acquisitions. This is demonstrated by their ability to deal with gradient 
eddy currents and imperfections seen in gradient pulses in an inexpensive manner when 
considering signal to noise as loss of signal is low since the additional delay is milliseconds and T1 
is the magnetization determining factor which is in the range of seconds so maximum signal is 
minimally affected.  
 
When optimizing DOSY pulse sequences, the main parameters to select for target compounds range 
of self-diffusion coefficients is the duration of time between pulse gradients and the delay between 
gradients which determines the time that molecules are allowed to diffuse through magnetic 
inhomogeneity before refocusing (D20; Δ) and the time that pulse gradients that creates the 
inhomogeneity in the magnetic field are applied (P30; δ). When selecting D20 and P30 values the 
aim is to see a significant reduction in signal when the gradient power is at 95%, compared to a 
small reduction in signal when the gradient power is at 5%. If these values are selected 
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appropriately then the decay curve of signals will be well described throughout the ranges of 
gradient strengths applied during the experiment and allow for a reduced error when fitting curves 
to a diffusion coefficient as illustrated in figure 16.  
 
Figure 16 A) in this Δ and δ are too small, B) Δ and δ are too big and in C) Δ and δ are at proper values for sampling 
across the whole decay curve 
 
Researchers must also be aware that the lock phase is set correctly, improper setting can result in 
lineshapes which are highly distorted and unphaseable in all gradient experiments. This problem 
however can be easily resolved through correction of lock phase manually or automatically before 
acquisition. An issue that is less about pulse design and more an intrinsic problem with the 
experiment itself is convection effects induced by rapid changes in magnetic fields through turning 
on and off gradients, which cause uneven temperatures in the samples. To try and avoid convection 
effects, stabilisation of temperature can be mediated through using a stable gas flow between 400 
and 535 L/h in the NMR probe. Also it is crucial that locking onto solvent is stabilised appropriately 
after rapid switching on and off of gradients. 
 
Translational diffusion of molecules in liquid states is a fundamental property of mass transport in-
vivo and in-vitro mixtures and determines the characteristics of most chemical processes. The 
ability of NMR to easily measure and exploit the translational diffusion of individual molecular 
species makes it a powerful tool in the analysis of mixtures and how changes in emulsion properties 
affect the properties of individual molecular species. This technique was demonstrated as early as 
1981 by Peter Stilbs through the assignment of self- diffusion coefficients in complex mixtures using 
Fourier-transformed pulsed-gradient spin-echo measurements which showed errors in diffusion 
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coefficients of just a few percent (150). These initial findings demonstrated the possible power of 
NMR as an analytical tool for separation of molecular species within complex mixtures. This 
experiment also built the basis for following pulse sequences which exploit the translational 
diffusion of molecular species through the design of pulse sequence. The most commonly used 
pulse sequences are described previously, with time where species are exposed to the linearly 
inhomogeneous magnetic field being different for different molecular species. This means that 
attenuation profiles for peaks of the same molecular species will match but profiles of different 
molecular species will be different and therefore give different calculated diffusion coefficients.  
The spectra produced through the determination of diffusion coefficients of peaks produces a 
pseudo-2D spectra that displays diffusion coefficient values against chemical shift values (ppm). 
The size of the 2D contours in a DOSY spectrum reflects the standard error in the calculation of the 
diffusion coefficients of respective peaks. In complex mixtures with poorly resolved proton 
spectrum, the DOSY spectrum can have multiple overlapping signals making separation poor in 
highly concentrated areas such as the aliphatic region of emulsion mixtures. This means that 
calculated diffusion coefficients for molecular species will have a larger error as the attenuation 
profiles will be calculated collectively of the overlapping peaks.  
 
Application of diffusion ordered spectroscopy in complex mixtures has seen recent advances, which 
make this technique more advantageous and promising for accurate separation of single molecules. 
These include selective DOSY through the use of excitation sculpting which has been primarily used 
for water suppression and the more interesting technique of exploiting property changes through 
the use of diffusography (151). DOSY has also been implemented in the characterization of complex 
mixtures through the detailing of structures present or formed by diffusing materials within a 
diverse range of samples and biological systems (152). Importantly to formulation and cell 
membrane modelling, DOSY has been used to characterize bicelle size and morphology alongside 
how different mixtures of lipids and detergents interact with one another (153). 
 




Since PSYCHE incorporates a stimulated echo in it pulse sequence it was exploited to design 
PSYCHEiDOSY where the PSYCHE pulse sequence plays a dual role in not only collapsing multiplets 
but also diffusion encoding the NMR sample. With diffusion encoding being internalized in the 
PSYCHE pulse sequence with a diffusion delay being inserted between the two saltire pulses and 
gradients either side of the elements being made incremented. This way of introducing diffusion 
encoding is superior to concatenating the pure shift sequence with diffusion encoding sequences 
through an increase in signal as transient number can be higher in a smaller amount of time through 
absence of a second stimulated echo. It also makes the pulse sequence relatively simple which 
reduces the chance of pulse imperfections and the requirement for phase cycling. This internal 
diffusion encoding creates a pseudo-3D experiment where the amplitude of incremented gradients 
creates a dimension and a third dimension is created by the PSYCHE element with time between 
gradient pulses being incremented separately. Data acquisition is done in the same way as the 
PSYCHE experiment through the construction of an interferogram where chunks have a duration of 
1/SW1. An interferogram is generated for each increment of the incremented gradient which is 
processed by a top-spin macro provided by Manchester University. The generated interferograms 
are then processed via normal 2D processing techniques to form a diffusion coefficient versus 
chemical shift spectra with coupling suppressed. The pulse sequence is the same as the PSYCHE 
pulse, however the incremented open half-sine shapes (G2) indicate gradient levels that are 
changed to give diffusion encoding. 
 
Figure 17 PSYCHEiDOSY pulse sequence 
This addition to the pulse sequence requires the Stejskal-Tanner equation used for determination 
of diffusion coefficients to be modified to account for diffusion encoding within the PSYCHE pulse 
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element. The corrected equation, once simplified shows a close resemblance to the classic Stejskal-
Tanner equation, where the difference is a gradient offset added to the listed diffusion gradients 
used in setting up the incremented gradients. 
 
 
Figure 18 Modified Stejskal-Tanner equation for Diffusion coefficient determination when using diffusion encoded 
PSYCHE experiments with added gradient offset in red 
 
The potential of PSYCHEiDOSY in improving diffusion coefficient error is extensive for biological 
mixture analysis as seen by the below spectra produced in the original paper (149). 
 
Figure 19 Diffusion resolution differences seen vitamin D3 and provitamin D3 for standard DOSY experiments 
compared to diffusion encoded PSYCHE experiments (149) 
It is yet to be studied extensively in complex mixture analysis as of yet but recently published papers 
from our group have used this methodology for investigations of a variety of complex mixtures in 
the field of Chemical Engineering and Dermatology demonstrating the versatility of the technique 
and relative ease of use between disciplines (Papers in appendix).  
 
1.4.4 Processing methodologies 
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1.4.4.1 Covariance Processing 
Covariance processing provides a measure of the strength of the correlation between two or more 
sets of random variates within a data matrix. This has been implemented in NMR to produce 
increased resolution indirect data values for correlation spectroscopy experiments. 
 
Covariance processing for indirect dimension resolution and reducing the required experiment time 
has been shown to be used in conjunction with PSYCHE methodologies for characterisation of 
complex mixtures. Interestingly covariance processing has demonstrated the ability to illustrate 
novel synthetic NMR spectral representations of small molecules through correlation of features of 
individual spectra in a fast, inexpensive way post acquisition e.g. HSQC-COSY acquisition.  
 
Figure 20 Use of Covariance processing with PSYCHE to acquire greater resolution spectra and improve interpretation 
of complex samples (154) 
 
 
Figure 21 Covariance processing of HSQC and COSY spectra of Vitamin D2 demonstrating an ability to show 
correlations between HSQC cross peaks (Red) through calculation from COSY coupling data (Yellow) using 
Mestrenova. 
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1.4.4.2 Non-Uniform Sampling (NUS) 
Sampling of 2D NMR experiments requires uniform sampling of data in the indirect dimension that 
allows for processing by discrete Fourier transformation. This number of increments in the f1 and 
f2 dimension determines the duration of the experiment. Non-uniform sampling aims to reduce the 
number of data points collected in the indirect dimensions to reduce experiment time. The use of 
NUS has been driven by the use of 3D experiments in biomolecular NMR but can also be exploited 
for use in 2D experiments (155) (156). NUS experiments classically acquire a subset of indirect data 
traces, with usually 50-25% of data points being sampled. This can lead to a time saving of two to 
four times which allows for increases in sensitivity and resolution of more complex mixtures and 




Features probed at the molecular level include bilayer packing, molecular interactions, diffusion 
rates, permeation of actives and formulation components within the epidermis. One of the most 
significant developments has been the move from in vitro techniques to ex and in vivo studies and 
here we aim to investigate how NMR can be utilised to improve sensitivity and resolution of these 
studies.  
The real time characterisation and monitoring of biologically active compounds and formulation 
components in models and ex vivo samples of the Stratum corneum is becoming more possible and 
accessible to researchers. Despite this progress, the lack of in vivo studies, limits these 
methodologies and further studies need to be done. Validation of in vivo studies with in vitro and 
ex vivo studies using mathematical models helps to develop a deeper understanding of the skin and 
how formulation design affects the permeation of biologically active compounds and the irritation 
levels of specific formulation components.  
 
1.5.1 Aims of Research 
Skin is the first line barrier that protects the body from infection, attack by chemicals, 
photochemical effects and physical stimulus. In its defence role the skin produces vitamins, 
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regulates temperature and has the ability to sense harm and indicate that visually; this constitutes 
an effective warning mechanism.  The physical appearance of skin disorders however, can also be 
a double-edged sword when it comes to the emotional and social aspects of a visible pathology. In 
an ever more connected world, the stigma attached to skin disorders is increasing and has led to 
increased pressure on medicine and industry to produce diagnostic tools and quick remedies to 
minimise any permanent effects on the individual. The accurate and rapid diagnosis of skin 
conditions and the evaluation of treatments for specific pathologies is crucial as delays in either of 
these steps can lead to temporary or permanent disabilities for the individual. This will mean the 
skin as a barrier can be permanently compromised.  
 
Figure 22 Skin conditions and their relative effects in different age group, measured by the disability-adjusted life 
year (DALY), which reflects a lost year of healthy life. Figure adapted from Gould J. 2018. Source: Inst. Health 
Metrics/Univ. Washington (2) 
Understanding what compounds enable the correct functioning and maintenance of the skin, be 
they proteins, peptides, vitamins or small biologically active compounds is important when 
evaluating skin health and state of any diagnosed disease condition.  The determination of the 
concentrations of these compounds required for optimal skin function can give insight to clinicians, 
researchers and the general population for skin health and care. If it is known that certain 
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biomarkers are present at higher levels in the Stratum corneum, compared with other layers of the 
skin, it allows for targeting of these biomarkers with tape strip extraction for evaluation of skin 
health. Knowing what these biomarkers are and whether they are specific to individuals or groups 
of people, can improve the specificity and selectivity of diagnostic testing. Alongside this, 
effectiveness of drug delivery can be enhanced when considering specific biomarkers at targeted 
locations within the skin. 
 
General understanding of biomarkers within the skin is predicated on reliable quantitative data, 
produced by the specific analytical technique used for monitoring. When a stimulus is applied to 
warrant an effect, the incorrect characterisation or quantitation of a compound can lead to false 
positives or false negatives, which can lead to the misdiagnosis and subsequently improper medical 
or topical prescription. This would then require the use of further screening methods to identify 
the underlying problem. These complications can lead to long waiting times and increased cost to 
the patient and clinic respectively. The most common current diagnostic techniques for many 
deficiencies, which are relevant for the Stratum corneum, are biopsies with histological staining or 
a blood test, such as for vitamin D deficiency which measures the serum level of 25-hydroxyvitamin 
D (active form of vitamin D). 
 
1.5.2 Project aims 
In this thesis the scope and limitation of NMR methodologies for dermatological analysis will be 
evaluated. From separation, characterisation and quantitative reliability of actives and formulation 
components of topical treatments in model cream emulsions to implementation of the determined 
optimised experimental parameters in real world applications. Once I have successfully shown 
analysis of model mixtures and real word cream emulsions I aim to evaluate the effectiveness of 
these creams in a clinical application through analysis of ex vivo skin sample tape strip extracts. The 
versatility of these techniques is also investigated through application to other modalities such as 
quantitation of actives in commercial formulations, investigation of squalenes role in 
comeodonegenesis, protocol development for native antimicrobial peptides evaluation and also 
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highlighting its potential in fields outside of dermatology with work done in a chemical engineering 
environment on pyrolysis oils. These studies however are beyond the scope of this thesis so are 
included in the appendix for reader’s reference.  
The experimental strategy involves the implementation, testing and evaluation of novel techniques 
previously mentioned for novel use in skin research and whether these techniques can lead 
innovation in the commercial sphere. Using a variety of techniques this research aims to elucidate 
molecular interactions in complex mixtures, and provide support pathways for formulation design, 
reverse engineering, formulation stability and delivery of actives with in-vitro and in-vivo models. 
The focus will be on qNMR, Diffusion ordered Spectroscopy and the growing area of ultrahigh 
resolution NMR for these aims while adhering to IUPAC methods as outlined in IUPAC 
recommendations 2019 (218).  
The Industry goals (GSK) of this research are to determine LOD and LOQ of NMR techniques for 
actives in their commercial products with RSD <1% (Chapter 3). Alongside this primary goal, 
evaluation of the novel techniques to determine whether actives of interest for their 
dermatological products can be characterised in-situ without destruction of samples and within a 
reasonable time scale leading to demonstration of practical applications on topical formulations in 
the bottle (Appendix 6.2.1), to application on the skin (Chapter 4) with corroboration seen to other 
gold standard methods currently used in this area such as HPLC and MS-DART for validation of 
proposed novel NMR techniques in this area. These main aims from GSK were supplemented are 
supplemented with additional aims to see the scope of our NMR instrumentation for monitoring 
skin health biomarker squalene (Appendix 6.2.3) and also developing knowledge of antimicrobial 




NMR is of particular value as a non-destructive analytical method. Its value as an analytical method 
is exemplified by its capacity to be used as a primary method for quantification, tolerance of a wide 
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variety of hydrophilic and hydrophobic elements within a given matrix alongside its large sample 
throughput by automation (104).  In this study steps were taken to attain a trueness level of <10%, 
repeatability RSD values of <1% and the LOQ down to 100nM (≈ limit of baseline range of Vitamin 
D2 and D3 per litre seen in vivo) (105). To get near this LOQ in complex mixtures some key limitations 
need to be addressed that are not present in idealised samples.  These limitations affect both 
assignment and quantitation of analytes of interest which may be present at low concentrations 
compared to formulation components. 
 
1.5.2.2 Mixture Model Analysis 
The accurate determination of the respective concentrations of biologically active compounds in 
the skin is becoming an increasingly important factor in the evaluation of key issues in policy 
making, health care and cosmetics. The scope and limitations for characterisation and quantitation 
of two biologically relevant compounds, which are currently garnering great interest in 
supplementation via dermal delivery mechanisms alongside oral supplementation, Vitamin D2 
(Ergocalciferol) and Vitamin D3 (Cholecalciferol),  in different cream formulations using 1D 1H 
qNMR, 2D NMR techniques (HSQC and DOSY) and pure shift acquisitions are investigated. When 
quantifying biologically active compounds in a model system for the Stratum corneum or topical 
creams, the aim is to evaluate the respective solubilities of different biologically active compounds 
within different formulation mixtures. As Vitamin D is not soluble in polar solvents, it is assumed 
there is micellation by a surfactant present in the formulation, much like that of ergosterol or 
cholesterol in the membrane of a cell. Analysis of the solubility of Vitamin D in differing cream 
formulations can inform how vitamin D is best encapsulated. The characterisation and quantitation 
of vitamin D is applied over several heterogeneous model formulations with varying composition 
of elements, thus allowing for analysis of, for example, the dynamic range, complexity and 
quantitative composition of the different compounds within our mixtures. This allows for 
subsequent analyse of how different formulations affect the Limits of Detection (LOD) and Limits 
of Quantitation (LOQ) of smaller analytes (106) (107). 
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In summary; this investigation needs to be aware of factors which influence the trueness of our 
results: Solubility, peak integration issues such as resolution (overlapping of signals) and sensitivity 
(S/N), Dynamic Range (Receiver gain), when quantitatively analysing our samples. 
 
1.5.2.3 Ex vivo skin analysis 
These methodologies will then be used to analyse tape strips used for ex vivo extraction of skin with 
topical application of Physiogel Hypoallergenic Calming Relief A.I. Body Lotion (AI), Physiogel 
Hypoallergenic Daily Moisture Therapy Body Lotion (P), Bluewater vehicle formulation excluding 
lower abundance actives (V), Bluewater formulation (BW) and Bluewater formulation with skin 
heated to 70 degrees Celsius before tape stripping (BW70). 12 tape strips per treatment group will 
be acquired to avoid extraction of nucleated cells, which would cause greater ethical concerns and 
be less indicative of the horny layer of the skin. With the knowledge of furrows in the skin and 
expected variability between individual layers due to skin furrows, grouping of tape strip extractions 
into 3 groups, from extraction 1-4, 5-8, and 9-12 is done. The aim is to acquire data on the NMF 
abundances of the skin using the semi-automated metabolite quantitation software Chenomxtm 
and calculate permeation profiles of formulation components using NMR methodology employed 
in previous model formulations and formulations from the bottle. Statistical analysis is then used 
to elucidate whether formulation permeation and abundance of certain components in skin tape 
extracts is affected by formulation design and application design. How individual or groups of 
formulation compounds may affect the variability of other topical components and/or NMF 
abundances in the skin is also investigated. Subsequent determination of how the results seen 
corroborate with previous findings on the skin will allow us to evaluate reliability and comment on 
the potential of NMR as an adjunct or replacement to other more commonly used dermatological 
methodologies. 
 
1.5.3 The impact it will have on skin research 
In this project, biologically active compounds in the Stratum corneum are investigated using novel 
NMR techniques. This will allow for determination of the strengths and limitations of validated NMR 
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techniques in complex Stratum corneum models with concentrations of key compounds at in vivo 
ranges from μM to nM concentrations. The limitations expected will include the limit of detection 
and quantitation of these techniques as the sensitivity of NMR is less than ideal for these models, 
unless many scans are run (n >1024). A further complication is resolution of unseparated and 
unpurified formulations, e.g.  Metabolite mixtures, where many different compounds have a large 
dynamic range and overlapping signals. There are also limitations seen with 2D NMR sensitivity, 
despite its ability to improve the resolution of spectra, required to characterise key peaks in a 
complex model mixture. For 2D techniques, which require a multiple of the number of scans 
depending on the number of transients in the indirect dimension that is added, take a lot more time 
to acquire which means that increasing the scan number is a less favourable option for overcoming 
sensitivity issues when analysing complex mixtures as experiment time will become untenable. The 
implementation of novel ultra-fast 2D scans using NMR pulse sequences which allow an increase in 
scan number with an acceptable increase in acquisition time has been investigated to attempt to 
remedy this limitation (108). Determination of factors that increase the LOD and LOQ with novel 
techniques is a major contribution to the validation of NMR in characterisation and quantitation of 
complex mixtures with large dynamic ranges of abundances.  
 
The real impact will however be shown the presentation of a novel proof of concept tape strip 
extraction method used in conjunction with NMR analysis on ex-vivo human skin samples which 
has not been observed in the literature up to 2020. The analysis will also bring together diffusion 
NMR to separate biological mixtures based on respective compound tumbling properties and 
subsequent generation of permeation profiles of multiple bioactive compounds from several 
topically applied treatments all from one instrument using automated acquisition of data. Partner 
this with semi-automatic characterisation and quantitation of NMFs using Chenomx™ and 
Statistical analysis (PCA) of tape strips and the potential of NMR for this application seen.  
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The novelty of this work is clearly demonstrated through NMR spectrometry not being used before 
to measure biologically active compounds from in-vivo tissue and this study demonstrates the great 
potential of these techniques for improving diagnostic speed and specificity for biomarkers relevant 
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2.1 Vitamin D2, D3 and cream formulation analysis 
 
2.1.1 Sample preparation 
The compounds used for this project were all ordered through SIGMA and provided by GSK. 
Quantification targets: Vitamin D2 (Cas Number: 50-14-6); Vitamin D3 (Cas number:  67-97-0) 
ordered from SIGMA ALDRICH. Cream formulation componenets: Glycerol (CAS number: 56-81-5); 
Caprylic triglyceride (CAS number: 73398-61-5); Isostearyl Isoterate (CAS number: 41669-36-1); 
Niacinamide (CAS number: 98-92-0); Phospholipon (CAS number 92128-87-5); Vegetable Oil/Corn 
Oil (CAS number: 8001-30-7); Panthenol (CAS number: 81-13-0); Pentylene Glycol (CAS number: 
111-29-5) provided by GSK. 
 
Sample preparation was done using VWR pipettes (2-20µL, 20-200µL and 100-1000µL) for liquid 
state mass measurements, alongside a Mettler MT5 used for solid state mass measurements.  
 
To prevent the observed separation of more lipophilic compounds from hydrophilic compounds 
that are included in the formulation a high shear mixer was employed for emulsification of all 
samples 
 
2.1.2 NMR  
NMR tubes used were Wilmad 5mm, thin-walled tubes (Product No: 535-pp-7); throughout the 
experiments run during the project. Only one NMR instrument, Bruker Avance III 600MHz FT-NMR, 
will be used throughout the project, so as to not add variance, introduced due to inter instrument 
inhomogeneity for validation. This however does limit the work in measurements of reproducibility 
on different instruments but for this stage of optimisation we did want confuse power level settings 
etc in the parameter sets that can be automatically optimised on different instruments. An example 
of this was from implementation of University of Manchester experiment parameters that had to 
be extensively optimised for use on our instrument despite same magnetic power (600MHz). This 
changes included shape pulse lengths and powers, pulse program delays and the gradients that are 
used for specific broadband acquisitions, specifically in pure shift acquisitions. Each sample was run 
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in triplicate to allow for repeatability analysis. All scans were run in batch automation, interleaved 
to prevent the effects from time dependence of each sample. 
 
Quantitation was done through the primary ratio method analysis of integrals. Internal standard, 
TSP, with concentration set relative to that of the gravimetrically determined concentration of the 
target analyte Vitamin D2/3. LOQ is when the required S/N for quantitation is no longer achieved in 
an idealised, separated sample, where reported values for this range from 15 to 150 S/N values, 
the value set as limit for S/N to determine if LOQ has been reached is 50 as this was predominantly 
used in previous studies (107)(157)(158). 
 
Top-Spin was used for assignment of peaks (1D 1H, COSY and HSQC) to identify which peak is best 
for integral selection when running integration. Automation of the quantitation process was done 
on the software plugin qNMR for MestReNova.  
 
2.1.3 Statistics 
Statistical analysis is automatically done by MestReNova to give RSD values for each sample; 
however these values were added to excel for further statistical interpretation: repeat sample 
variation; inter sample variation, in regards to sample complexity, analyte concentration and 
experimental parameter variation. 
 
A Cole-Parmer LabGEN high shear homogenizer (UY-04727-89) was used to prepare the full cream 
formulations to allow for emulsification of the different components within the mixture. 
 
2.1.4 Fatty acid  
All seven fatty acid compositions (Lauric Acid, Myristic Acid, Caprylic Acid, Capric Acid, Caproic Acid, 
Palmitic Acid and Stearic Acid) were purchased from Fisher-Scientific (Loughborough UK). 
Deuterated chloroform containing 0.03 % (v/v) TMS of analytical grade, 99% purity purchased from 
Sigma-Aldrich (Dorset, UK).  




All seven single sample analysis were prepared  up to 100mM of sample dissolved with 1ml of CDCL3 
with 0.1ml added to 0.9ml of deuterated chloroform. 0.6mL of sample was transferred into 5mm 
NMR tube for acquisition. Two component mixtures were prepared by dissolving 2mg/µl in 1ml of 
CDCl3 in separate 5ml vials, 0.05ml from each was extracted into 0.9ml CDCl3 to make up 100mM 
of total fatty acid. Preparation of three fatty acid samples was achieved through addition of 32µl of 
each fatty acid into 1ml of CDCl3. For complete mixtures with 6 and 7 compounds, samples were 
made up in CDCl3 with a final fatty acid concentration of 100mM. 
 
2.2 Ex vivo skin analysis 
2.2.1 General  
Volumetric measurements were done using VWR single‐channel pipettes, mechanical, variable 
volume, Ergonomic High Performance (EHP). A Mettler MT5 scale was used for solid state mass 
measurements.  
 
2.2.2 Tape Stripping 
Normal human skin samples were collected by Genoskin from donors who underwent 
abdominoplasty procedures and had given informed consent. Pathological skin biopsy was 
obtained by Genoskin for unused material from dermatology department of hospital with informed 
consent of the patient. Full ethical approval for the study protocol was obtained from local research 
ethics committee, and authorization given from the French Ministry of Research (AC‐2011‐1443) 
following Human Tissue Authority codes and practices for research on excised anucleated tissue 
samples for transport, storage and use. All studies were conducted according to the Declaration of 
Helsinki protocols. The experiments in this study were conducted on samples collected from a single 
donor women aged 42 years. Skin samples were collected immediately after surgery and processed 
immediately as nativeskin®. Upon receipt of the nativeskin®, the culture  dish was incubated for at 
least 1 hour at 37 °C, 5 % CO2, and 95% relative humidity before performing the first experiment. 
Skin samples were subsequently separated into 6 groups and treated respectively; Native skin with 
Chapter 2 Materials and Methods 
83 
 
no topical treatment applied (Ctrl), Physiogel AI lipid formulation (AI), Physiogel formulaton (P), 
BlueWater formulation vehicle (V), BlueWater formulation (BW) and BlueWater formulation heat 
treated at 70Co (BW70). The skin was gently cleaned by swabbing with a cotton pad soaked in 
distilled water at ambient temperature and allowed to dry at room temperature. Skin sites are 
marked with a surgical marker to ensure tapes were consistently applied to the same area. Twelve 
consecutive standard D-Squame® tapes were taken from each nativeskin® sample. A standardised 
pressure device was used to apply 225 g cm-2 of pressure for 5s. Tapes were subsequently removed 
by a single rapid stroke. Tapes were stored in Eppendorf vials at -80oC until further analysis (4). 




The tapes, alongside native deuterated PBS buffer as control, were sonicated in a solution of 
deuterated PBS buffer 0.1mM, pH5.5 for a minimum of 10 minutes in order to remove 85-90% of 
total protein from the tape strip. Low rpm centrifugation removes any cell debris from supernatant 
containing proteins, peptides and active compounds of cells and extracellular matrix.  
 
2.2.4 NMR  
A Bruker Avance III 600MHz FT‐NMR Spectrometer at 300 K was used for all NMR acquisitions. NMR 
tubes used were 5 mm, Ultra-Thin Wall Precision NMR Sample Tubes 7" L, 600MHz, (545-PPT-7), 
from GPE-Scientific. Extracted deuterated PBS supernatant was added to NMR tube at a volume of 
594μL, followed by the addition of 6μL TSP D2O solution (10mM). TopSpin 3.5pl7 was used for 
acquisition preparation and processing of raw data. Quantitative data was acquired with the pulse 
program noesygppr1d, with a scan number of 1024. D1 = 4-10s after initial T1 relaxation 
experiments.  Automatic Fourier transformation, phasing and baseline correction were applied 
followed by manual phase correction and manual integration of peaks with bias and slope manually 
corrected. 
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Quantitation was achieved through the use of the primary ratio method of integrals with an internal 
standard being spiked in samples, Trimethylsilylpropanoic acid (TSP), at a consistent concentration 
(100μM). Triplicate and interleaved experiments for each sample were acquired.  
 
DOSY D20 and P30 values were calibrated through the acquisition of 1D experiments 
(ledbpgppr1d). Pulse sequence ledbpgppr2s was used with ns=64, d1 = 5s, D20 = 0.1s and P30 = 
0.75ms, with 16 transients in the diffusion dimension (F1) for acquisition of 2D DOSY spectra. The 
software package Dynamics centre (Bruker UK Ltd) was used to determine the diffusion coefficients 
using the diffusion fit function (f(g)=I0*e-y^2*g^2*δ^2*(Δ-δ/3)*D).  
 
2.2.5 Data Analysis 
12 sample data sets for each treatment were used (Physiogel, Physiogel AI, BlueWater, BlueWater 
70o and BlueWater Vehicle) with 8 control samples, where no topical treatment was applied, were 
extracted. Controls were used to evaluate whether formulation had effects on extraction of 
uniform layers and first 4 samples were used for optimisation of extraction therefore only 8 samples 
that were extracted in the same way as treatments were analysed. 
 
Tape strip samples were subsequently grouped into layers 1-4, 5-8 and 9-12 (Group 1, 2 and 3 
respectively) to mitigate effects previously seen from skin furrows and variability in number of 
corneocytes extracted per layer of stratum corneum. 
 
2.2.6 Chenomxtm 
Metabolite detection software ChenomxTMused to  identify and quantify compounds through 
reference spectral database fitting of database spectra to acquired spectra for databased 
compounds(11).  
 
The use of reference deconvolution as the fitting algorithm allows for overlapped peaks to be 
distinguished, matching to Spectral Reference Libraries which allows for subsequent identification 
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and quantitation of compounds visible in aqueous samples. The Spectral Reference libraries are 
built upon thousands of reference spectra acquired via single compound NMR analysis and are 
available from pH4 to pH 9. Alongside their own libraries, libraries can be imported for use from 
the HMDB however these libraries are not certified but can be used for characterisation from 
reference deconvolution.  
 
2.2.7 Statistical Analysis 
Statistical analysis was performed using Unscrambler X. Grouped NMF data averages were input 
into 11x15 matrix and normalised with area normalisation. The Principal component analysis model 
has a maximum of 7 components with mean centred data. Each variable was weighted equally with 
cross validation and calculated using the singular value decomposition (SVD) algorithm. Model 
warnings were set with ratio of calibrated to validated residual variance of 0.5, validated to 
calibrated residual variance of 0.75 and residual variance increase limit of 6%. Outlier limits were 
set with warnings at >5% and alarms at 0.5% F-residuals and hotelling T2. PCA overviews were 
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3.1 Importance of Vitamin D in the Stratum corneum 
The effects of vitamin D deficiency have been highlighted since the turn of the 20th century. 
Decreased sun exposure through pollution and mass movement to industrial cities led to the rickets 
epidemic in industrialised western countries. At the height of the industrial revolution it was 
estimated that 80-90% of children in certain industrial cities suffered from rickets (162). The main 
reason that the deficiency of Vitamin D got to this point in the industrial revolution was through 
the lack of vitamin D synthesis in the skin due to insufficient photo-production. 
 
The photo-production of Vitamin D takes place in the skin. Once in the epidermis, it diffuses to the 
dermal capillary bed, where it is transported to the liver by the vitamin D binding protein (163) 
(164). Sufficient UVB proton (255-350nm) levels, to produce Vitamin D3 in the skin are only available 
during a small portion of the day. Absorption of UVB by ozone in the Earth’s stratosphere, which 
varies depending on latitude, decreases the amount of UVB that the skin is exposed to.  
Compounding this fact is that the relationship between skin cancer and sun exposure has 
inadvertently caused a large decrease in Vitamin D production because of UVB being absorbed by 
sun screens and sun exposure being generally avoided. There is also a large effect from the effects 
of skin pigmentation, which leads to a much greater incident rate of vitamin D deficiency in dark 
skinned people living in higher latitudes as a Sun Protection Factor (SPF) of 15 will absorb 99% of 
UVB, therefore the natural melanin SPF of dark skinned people of 13.4 will reduce Vitamin D 
production compared to light skinned people with natural SPF of 3.4 (165) (166) (167) Ageing has 
also been shown to decrease the amount of 7-dehydrocholesterol in the skin (168). 
 
This means that a large number of people do not have sufficient levels of the active form of vitamin 
D; 1,25-(OH)2D (>75nmol/L) for all the physiological functions of 1,25-(OH)2D to function 
appropriately.1,25-(OH)2D has been demonstrated to have a role in the regulation of skin 
differentiation, apoptosis and inhibition of cell proliferation (169) (170). In the skin specifically it 
has been found to regulate the formation of the skin barrier through processing of long chain 
glycosylceramides. Furthermore, it has an induction effect on Toll like receptor 2 and its co-receptor 
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CDl4 which initiates the innate immune response in the skin which induces CYP27B1 and 
cathelicidin production (171) (172). Furthermore the induction of cathelicidin (LL-37) production by 
1,25-(OH)2D highlights another role of vitamin D in facilitating wound healing and tissue repair.. 
Unfortunately studies on whether topical administration of Vitamin D or its analogues can improve 
wound healing or tissue repair are yet to be widely produced. Studies on Vitamin D have also 
suggested roles in mental disorders, infections, autoimmune diseases, cancer, malabsorption, liver 
disorders, obesity, lung function and innate immunity but these are in the early stage of 
understanding with more research required to underpin methods of action (173). 
 
In the advent of studies linking Vitamin D, its active metabolites and respective receptors to roles 
other than the formation and health of bone osteoclasts, there has been a new wave of health 
policy developments informed by these findings. From population based projects, such as in Finland 
which successfully raised the average Vitamin D levels to around 65nmol/l over a ten year program 
from mandatory fortification of dairy products in 2003 followed by a further increase in fortification 
and advisement of supplementation in 2007 which doubled vitamin D levels between 2007 and 
2012 (174), to recommendations for broad nutritional policy (175), and specific nutrition guidance 
for Performance Athletes (176); and Older adults (177). 
 
With more awareness of the detrimental effects of Vitamin D deficiency it is more important than 
ever to be able to correctly diagnose the estimated 1 Billion people worldwide who are deficient in 
Vitamin D. 
 
3.1.1 Scope and Limitation of Vitamin D quantitation using NMR 
techniques 
Validated novel qNMR techniques can be used to diagnose Vitamin D deficiency at a faster sample 
rate than other methods, due to easy sample preparation and relatively fast measurement of all 
analytes of interest at detectable concentrations (178). Because of the non-destructive and simple 
sample preparation of NMR, samples can be prepared which mimic the composition of the Stratum 
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corneum extracellular matrix capillary beds which vitamin D3 diffuses to in the skin (179) (180).  
Alongside this it is shown that the LOD and LOQ for Vitamin D2 and D3 down to in vivo skin levels 
can be achieved with the implemented NMR techniques.  
 
Alongside this characterisation of Vitamin D formulation using these techniques helps the 
innovation of consumer healthcare companies specifically on how they provide dermal delivery of 
Vitamin D for direct supplementation to the skin. Accurate determination of amount that can be 
delivered effectively, stability in bottle and how much is delivered to layers of the skin is therefore 
crucial for formulation chemists and manufacturers of consumer health products. 
 
First experiments were run with controls of Vitamin D2 and D3 were run independently of cream 
formulation samples for assignment and determining the maximum potential LOD and LOQ. The 
cream formulation samples include simple mixtures, of only one or two of the cream formulation 
compounds which showed encapsulation potential and more complex mixtures which consist of all 
cream formulation components with blank controls of each included. This was to ensure the 
integrals being quantified are not that of artefacts, or peaks of the cream formulations that the 
vitamin D is being prepared in. Samples were also prepared in different NMR solvents e.g. D2O and 
DMSO-d6, so that any effects of the solvent system can be determined. The data of samples in 
cream formulations ranging from simple mixtures to complex mixtures have been acquired, 
alongside relevant controls and a range of Vitamin D concentrations from 10mM to 100nM with 
concentration changes in increments of a dilution factor of 10.  Data-sets with Experimental 
variation have also been acquired to analyse the effects upon our datasets: Number of scans (ns); 
Receiver Gain (RG); 1D and 2D techniques and Pure-shift techniques. A lower LOD and LOQ through 
implementation of novel NMR sequences and calibration of experimental parameters for resolution 
and sensitivity enhancement can be reached. More complex sample preparation methods are also 
implemented to allow for greater solubility of target analyte in cream samples. 
  




3.2.1 Assignment of Vitamin D2 and D3 
 The first step in analysing how reliable quantitation of Vitamin D2 and D3 in samples is to fully 
characterise Vitamin D2 and D3 by NMR . This was achieved with 10mM Vitamin D2 and D3 
dissolved in DMSO-d6 and acquisition of 1D 1H proton experiments with large D1 values were 
acquired so that all peaks were relaxed appropriately before acquisition of subsequent transients 
of data.  
 
These spectra were then assigned in comparison to the vitamin D2 and D3 spectra from the HMDB. 
The assignment reported by HMDB (181)  is accurate and useful however some of the 
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multipletsidentified are assigned to more than one proton in the structure through overlapping of 
multiplet peaks.  
This makes it harder to identify derivative changes and possible breakdown products once in a 
topical formulation or in a biological mixture. To improve characterization the acquisition 
3.2.1.1 1D Proton Experiments 
 
 
Figure 23 1D Proton, 256 scan spectra of D2 10mM, with  Vitamin D2 and solvent peaks assigned as best as resolution 
allows. 




Figure 24 1D Proton, 256 scan spectra, Vitamin D3 peaks assigned, solvent peaks of HDO (3.33ppm) and DMSO 
(2.5ppm) left unlabelled 
The spectra of D2 and D3 corroborated the previous assignments in the human metabolome 
database and also assigned the spectra for D3 which has very slight changes to that of the D2 spectra 
but there is a clear difference seen at the peak assigned 3 in the D2 spectra which is not seen for D3 
representing the addition of an alkene group to D2. This differentiation will greatly facilitate the use 
of NMR in determining ratios of D2 and D3 in mixtures. 
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3.2.1.2 HSQC experiments for C13 and H1 assignment 
 
Figure 25 Vitamin D2 10mM HSQC covering whole range of chemical shifts, a = whole HSQC spectral range for D2, b = 
Aliphatic region of HSQC of D2, c = zoomed in region from 4.6 to 6.2ppm of HSQC for D2 
Exploiting the transition into the second dimension through acquisition of HSQC spectra shows 
cross peaks correlating 13C signals to 1H signals. This allowed for further assignment of peaks that 
were overlapping and also shows that several peaks which shared 13C resonances were protons in 
CH2 aliphatic forms. HSQC experiments are however a lot more time expensive than proton 
experiments but since coherence is transferred back to the proton the sensitivity is acceptable. To 
gain the same assignment potential, a pure shift methodology is demonstrated that exploits proton 
acquisition but reduces overlap by multiplet suppression and includes proton peaks from amines, 
alcohols, carbonyls and phosphates etc. that are not bonded to carbon which is very useful 
particularly in biological mixture applications. 
 
Chapter 3 Characterisation and quantitation of Vitamin D2/D3 
94 
 
3.2.1.3 PSYCHE experiment implantation on instrument and optimization of settings 
The most problematic artefacts seen during initial implementation of PSYCHE pulse sequence came 
from the water, however the addition of excitation sculpting elements to the pulse sequence 
reduced these.  Artefacts were also observed from strong coupling effects, which can be reduced 
by the triple-spin-echo version of the sequence however these artefacts were quite small for 
acquired data sets. The default shapes for the parameter set were 10kHz sweep pulses of 40ms 
length (low->high and high->low frequency sweep). This means an additional 80ms delay in the 
sequence, which could cause T2 losses. Changing these to 20ms equivalents and P52 and P53 (Weak 
gradient and double-chirp PSYCHE pulse element durations) set to 20ms, and CNST51 (rf field for 
the shapes) to 630 reduced the T2 losses. After acquisition and processing of initial PSYCHE 
experiments severe artefacts were observed which prevented interpretation of spectra. These 
artefacts were identified as chunking artefacts that appeared for signals off resonance to the center 
of acquisition.  Modification of sweep width and chunk sweep width to make the number of chunks 
a whole integer removed these effects as shown in figure 28. 
 





Figure 26 Visualisation of chunking artefacts at different resonance frequencies, adapted from University of 
Manchester Pure Shift workshop (https://www.nmr.chemistry.manchester.ac.uk/?q=node/421) 
It is observed in figure 26 where sweep width has not been optimised that large artefacts appear 
at a greater intensity for peaks which are more off resonance to the centre of acquisition.  
 
 




 F2 F1 
Sw (ppm) 20.57 0.125 
Sw (Hz) 8223.69 50 
 
Figure 27 (Top) PSYCHE Spectra with chunking artefact (Middle) Zoomed in Spectra at 0ppm (Bottom) Sw2 and Sw1 
values for experiment showing non whole integer difference between F1 and F2 sweep width which causes chunking 
artefacts 
 
The total sweep width frequency in the direct dimension / total sweep width in the indirect 
dimensionequals 164.4737 which is not a whole integer therefore it is expected that artefacts are 
created. After correction of this to make SWH2/SWH1 a whole integer a pure shift spectra with no 
chunking artefacts is produced with no other effects seen. 
 
 
Figure 28 (Blue) Corrected Sw2/Sw1 PSYCHE spectra, (Red) Non-corrected PSYCHE Spectra with chunking artefacts 
present (Green) Difference Spectra between corrected and non-corrected spectra showing only chunking artefacts are 
removed and not signal 
The difference spectra in figure 28 highlights that the only peaks that are changed are the chunking 
artefacts with pure shift peaks unaffected. This showed how crucial the proper setting of 
acquisitions are for artefact suppression. 




An optimised PSYCHE experiment which uses a triple spin echo to reduce coupling artefacts for 
strong coupling binds which can improve the pure shift spectra acquired. However using the 
acquisition parameters for PSYCHE the chunking artefacts arose again even with SWH2/SWH1 





 F1 F2 
Sw (ppm) 9.99 0.13 
Sw (Hz) 3996.80 50 
Figure 29 (Top) PSYCHE-tse (Triple spin echo) Spectra with chunking artefact (Middle) Zoomed in Spectra at 0ppm 
(Bottom) Sw2 and Sw1 values for experiment. 
3996.802/50 = 79.93604, already very close to integer, negligible change in chunking artefact 
expected. These scans were then repeated with the total sweep width frequency in the direct 
dimension / total sweep width in the indirect dimension being set to an integer. 
 




Figure 30 (Blue) Corrected Sw2/Sw1 PSYCHE spectra, (Red) Non-corrected PSYCHE Spectra (Green) Difference Spectra 
between corrected and non-corrected spectra 
Negligible differences are seen for spectra with correction of SWH2/SWH1 compared to non-
corrected spectra for PSYCHE-TSE as highlighted by the difference spectra in figure 30. This means 
that the chunking artefacts observed are being created through a different parameter set issue 
which needs to be investigated further.  
 
Due to substantial resolution and spectra quality improvements already given by standard PSYCHE 
acquisitions, it was decided to use standard PSYCHE acquisition rather than employ PSYCHE TSE due 
the latter’s more complicated pulse sequence design not being suitable for use by non-NMR 
specialists in future applications. 
 
3.2.1.4 Drop point distortion analysis 
Inclusion of drop points (deleted data points at start of acquired FID) has been shown to be necessary as 
modern digital filtering methods distort the first points of a FID. When acquiring multiple FIDs in 
interferogram acquisitions which are combined to form a complete FID, the artefacts added from 
distorted data points at the beginning of each fid are much greater as highlighted in figure 31. 




Figure 31 FID envelopes for non distorted and distorted points at the start of the fids in interferogram and respective 
pure shift spectra 
Deletion of the first 4 data points in the individual fids of the interferogram for PSYCHE acquisitions gave 
the best artefact suppression and the small artefacts that were present after chunking artefacts were 
removed. With 6 drop points in place the small artefacts begin to increase and S/N is reduced from loss 









Figure 32 Reference conventionally acquired 1D 1H spectra in red and PSYCHE aacquired 1D 1H spectra with 4 drop 
points at the start of each chunk of interferogram acquired. (Top) Spectra covering 0.7ppm to 6.4ppm (Middle) 
Spectra covering range 0.4ppm to 2.5ppm (Bottom) Spectra covering 2.8ppm to 6.4ppm. 
 
 
Figure 33 6 Dropped data point PSYCHE acquired 1D 1H spectra 
 
 
3.2.1.5 PSYCHE Experiments for Greater Resolution 
A PSYCHE experiment was then run to further resolve assignment of the crowded aliphatic region 
of proton environments 6 to 12 as seen in previous 1D 1H acquisition (Figure 22/23)  and HSQC 
acquisition (Figure 24) .  
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Figure 34 in red, standard proton experiment, in blue, PSYCHE proton experiment with individual proton assignments 
 
 
3.2.2 Quantitation  
To produce spectra for quantitation, the D1 (relaxation delay) in experiments was increased to 10 
seconds, this guarantees that D1 > 5*T1 of all nuclei in our reference and the compound is being 
quantified. The peaks used for quantitation had to have an S/N larger than 50, otherwise they 
cannot be considered reliable for quantitative analysis. This means that with lower concentration 
analysis the scan number needs to be increased or change the pulse sequence/parameters to 
increase the sensitivity of the spectra. 
 
Peaks chosen for integration and subsequent primary ratio method quantitation were selected 
based upon there multiplicity. Singlets are preferred as they present less variables that determine 
the integral of peaks, and separation from other peaks within the spectra so to avoid overlapping 
of integrals. Isolation from other peaks allows us to integrate 99.9% of the peak through integral 
width selection of 64x the full width at half maximum height. 
 
Primary evaluation of the quantitative reliability of the instrumentation and quantitative parameter 
set was achieved through analysis of TSP concentration intra samples to measure repeatability and 
between samples to measure reproducibility. 
3.2.2.1 Limits of Detection and Quantitation 
 
Limits of detection and Quantitation (LOD, LOQ) for NMR varies from other techniques. In the 
traditional definition, LOD is defined as 3:1 ratio S/N and LOQ is defined as 10:1 ratio S/N. For this 
research and the respective needs of GSK, LOD was defined as a minimum S/N of 3:1 as normal, 
however due to the different resolution and sensitivity of NMR acquisition compared to traditional 
techniques, LOQ was defined as a minimum S/N of 50:1 with reference precedence ranging this 
value from 15-150 but RSD evaluation from preliminary work showed 50:1 S/N ratio gave desired 
RSD values for industrial applications (107). Selection of vitamin D2 and D3 inclusive of formulation 
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components as the eretic references set at 10mM was done to investigate how the below  
formulation samples effects TSP concentrations determined through quantitation in TopSpin. This 
gives a measure of the reliability between samples and whether increasing formulation complexity 
effects the quantitative ability of qNMR techniques, with the formulation detail table shown in the 
Full crème formulation section.  
Table 2 Eretic Sample details 
Sample Components 
B D2O only 
C Glycerol 10% 
D Caprylic triglyceride 5% 
E Isostearylisoterate 2% 
F Vegetable Oil 2% 
G Pentylene Glycol 5% 





Figure 35 Weighed 10mM of TSP with concentration calculated by TSP peaks generated from a reference eretic value 
of 10mM of TSP in control samples of 2B1 and 3B1 (D2O) to compare integrals from different solvent systems 
 
With the eretic referencing from the initial set concentration of 10μM, the relative standard 
deviation between different formulations is <10% and <2% between scans. Samples D to G for both 
vitamin D2 and D3 are not significantly different, with C and H having the same variability from this 
group for both D2 and D3. This suggests that D to G have similar sample properties based upon 
viscosity in the NMR sample, which is supported by the structural properties of the formulation 
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structures. Whereas Glycerol has OH groups but no aliphatic chain. Phospholipon has additional 
properties through its polar head group formed by the negative phosphate and positive amine 
groups present.  
 
These differences demonstrate that different formulations would show variations in the acquired 
signal of reference peaks so eretic quantitation would be inappropriate between different 
formulation mixtures. However, the low standard deviation observed in similar formulation groups 
based upon their structural and chemical properties, alongside variation between samples with the 
same formulation highlights the potential of qNMR between similar formulation samples and 
demonstrates that data values can be reliably reported as quantitative using an internal reference 
in these formulations. 
 
3.2.2.2 Preliminary 1D Proton qNMR in idealised samples 
For initial quantitative analysis of samples, a standard, non-water suppressed 1D proton 
experiment of 256 scans was acquired to see what the starting LOD and LOQ was, alongside the 
reproducibility of these results. This was done with solutions of Vitamin D2 and D3 at gravimetric 
concentrations of 8.3mM then with subsequent samples the concentration was diluted by ten times 
until the peaks used for quantitation were no longer detectable within the noise. 
 
Table 3 Vitamin D2 table of concentrations and variability analysis 
Gravimetric Conc. (mM) Experimental 
Conc. (mM) 
RSD Accuracy  S/N 
0.83 0.776 2.265 0.94 755 
0.083 0.0778 1.725 0.94 107.2 
0.0083 0.00335 13.56 0.4 8.03 
0.00083 0.0012 31.99 1.45 4.13 
8.3 16.7 0.1547 2.012 4881 
 





RSD Accuracy S/N 
0.83 0.4 1.171 0.481 396.5 
0.083 0.0364 2.633 0.439 51.7 
0.0083 0.00338 90.55 0.408 8.23 
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8.3 26.14 0.652 3.149 1462 
 
Figure 36 Log (Gravimetric Concentration (μM)) vs Log (Average S/N), Red line shows cut off S/N required for relative 




Figure 37 Scatter chart showing the Log of the gravimetric concentration versus the log of the average calculated 
concentration for each sample of D2 and D3 with dashed line highlighting S/N cutoff for LOQ (50:1 S/N) 
 




Figure 38 Log (Gravimetric Concentration) versus Average Trueness, shows how the trueness of each sample varies 
from the ideal of 1, red dashed line shows S/N cutoff (50:1 S/N). 
 
Results from Table 2 and 3 show that with standard 1D 1H NMR spectra a limit of quantification 
(LOQ) of 100 μmol/L, with RSD’s of 1.73 and 2.63 for vitamin D2 and D3 respectively can be obtained. 
However, the trueness values vary between D2 and D3, with D2 having a trueness value of 1.294 
(RSD = 0.479) and D3 trueness of 1.354 (RSD = 1.14294). 
 
From these results, identified limitations using this quantitative technique was primarily the 
Dynamic range that the NMR spectrometer used could achieve. This is explained by the fact that as 
gravimetric concentration got closer to the target of 100nM for Vitamin D2 and D3 the NMR was still 
amplifying the free induction decays for the higher abundance peaks in the range of 10mM to 1M 
concentration. This is meant to not overload the Spectrometer, so RG was automatically set too 
low to detect Vitamin D peaks of interest at lower concentrations and they have lower S/N than 
lower LOD. 
 
To reduce signal intensity, concentration of TSP was set relative to the concentration of Vitamin D 
in the sample instead of set at 10mM consistently, with TSP reference set at 1mM, 0.1mM, 0.01mM 
and 1µM for respective sample dilutions down to 100nM . Water suppression was also added to do 
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the same for the broad solvent peak of the water which increases the signal intensity acquired. 
Multiple suppression techniques could also be used to get rid of the DMSO-d6 peaks, but the small 
line width of the DMSO peak and relatively low abundance compared to other impurities meant 
that multiple suppression in  acquisitions was not implemented as this would affect the reliability 
of quantitation through saturation of possible peaks used for integration and concentration 
determination. Frequency selective experiments were also being pursued to eliminate all peaks 
except those of interest in TSP and the quantification target but these gave anomalous results for 
quantitation and setting used for subsequent quantitation were; increasing of the scan number to 
gain more S/N and increase of the relaxation delay between pulses to guarantee quantitative 
conditions were met for our target LOQ. A summary of changes to parameter set for optimization 
is shown in table 4. 
 
Table 5 Optimisation of acquistition parameters 
Parameter Standard qNMR Optimised qNMR 
TSP Conc. 10 mmol/L [Analyte] 
D1 3s 10s 
Ns 256 1024 




TD 64K 64K 
 
 





RSD (%) Trueness S/N 
5 4.54 0 0.908 56988 
0.5 0.46 0.22 0.922 11027 
0.05 0.046 0.45 0.924 1594 
0.005 0.0046 1.145 0.924 230.5 
0.0005 0.000425 18.95 0.85 23.38 
0.00005 0.0000421 9.91 0.842 3.52 
Table 7 Vitamin D2 table of concentration’s and variability analysis*Peak used for quantitation for 5mM sample was 
suppressed by water suppression pulse, unable to give consistent quantitation throughout other samples and 





RSD (%) Trueness S/N 
0.5 0.0733 1.9 0.1466 2503 
0.05 0.00696 1.07 0.1392 214 
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0.005 0.00071 7.53 0.142 25 
0.0005 0.000112 52.16 0.0224 2.58 
0.00005 x x x x 
 
Figure 39 Log graph of determined concentration versus gravimetrically determined concentration, red dashed line 




Figure 40 Log S/N chart of D2 and D3 showing us how the S/N drops by around the same factor as each dilution and 








Figure 41 Trueness chart of D3 and D2 from calculated concentration and gravimetrically determined concentration, a 
drop off in trueness when the concentration goes below the threshold of quantitation as shown by the dashed red 
line. 
 
By optimising certain parameters (Table 4), LOQ was lowered to 10 μmol/L for both vitamin D2 and 
D3 with LOD down to 50 nmol/L for D3 and 500 nmol/L for D2. Vitamin D3 trueness values down to 
100 nmol/L from 10mmol/L has an average value of 0.895 ± 0.035 (RMSD = 3.9%) of the gravimetric 
concentration consistently with RMSD values for each sample’s trueness being below 20% with 
samples within the LOQ having RMSD values <2%. The variances seen between measured LOD 
between Vitamin D2 and D3 is suggested to be through the reduced solubility of Vitamin D2 seen 
consistently throughout the research. 
 
Whereas with D2 trueness values, values of 0.09‐0.08 down to 10 μmol/L are observed with RSD 
below 10% however the trueness increases to 0.135 when the concentration drops down to 1 
μmol/L with an RSD value of 52.2%, this suggest that Vitamin D2 precipitates of solution either 
through solubility issues or subsequent aggregation of vitamin D2 therefore reducing the calculated 
concentration by 10 times for every sample consistently. Interestingly, the D3 spectra is water 
suppressed however in the vitamin D2 spectra suppression of the DMSO peaks occurs, this was 
suggested as an additional possible reason for the differences in the trueness values seen for D2 
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and D3. This effect was not seen in the non-water suppressed samples where the trueness values 
were consistent between D2 and D3, this further supports our suggestion that suppression at 
different points between samples affects the quantitation, which led to multiple suppression 
techniques being avoided to reduce further qNMR error. 
 
With targeted results seen for Vitamin D3 it was decided to progress using D3 in cream formulation 
characterisation and concentration determination analysis since the trueness of results in idealised 
samples was reliable down to the target concentrations for in-vivo analysis. 
 
3.2.3 Separation and isolation of components in a Vitamin D topical 
cream formulation 
Since whole samples are used, which are not chemically or physically separated the samples 
demonstrate in-situ conditions and how cream components interact with one another and affect 
not only analysis but delivery of actives. 
 
Initial characterisation of each component for the full cream formulation was achieved through the 
use of 2D experiments HSQC/COSY and 1D 1H experiments. The 1D 1H assignment of each of the 
compounds with a table of their relative abundances in the full cream formulation model is shown 
below. This allows validation of peaks assigned in the complex mixture are the specific compounds 
of interest and a facilitates acquisition of further DOSY experiments for validation of assignments. 
Table 8 Cream component details and gravimetric measurements 
Cream Component (w/w) Volume in 2ml formulation (μL) 
Glycerol 10% 158.8 
Caprylic triglyceride 5% 105.2 
Isostearyl Isostearate 2% 46.8 
Vegetable Oil 2% 43 
Pentylene Glycol 5% 106.4 
Phospholipon 1.5% 30 
Panthenol 2% 33.4 
 
Comparing the quantitation of separated compound samples to full formulation samples gives 
information on whether emulsification of certain compounds occurs through changes in the 
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detected abundances from the set abundances in formulation. Clear assignments for all 
components are given but are limited by resolution for specific assignment of all protons, 
specifically aliphatic chain protons of fatty acids. Resolution of aliphatic chains was thus decided to 
be studied in a separate research study which is detailed later in this chapter.  
 
 
Figure 42 10% Glycerol, with CH2 peaks assigned at peak number two, and CH peak assigned at peak position 1 
 






Figure 43 Caprylic triglyceride 5%, Integration shows three times the number of protons as assigned on Caprylic acid 
because of the Triglyceride nature of this component. Integrals referenced to 5 where brackets identify 14 CH2 groups 
(C4H8/C4H8/C6H12) present assigned by peak integral 5 with 28 protons giving integral area. 
 
 
Figure 44 Vegetable oil 2%, broad peaks at assignment 4 because of the mix of fatty acids, structures of the most 
common fatty acids by composition in the vegetable oil. 
 





Figure 45 Assigned Pentylene Glycol 5% 
 
Figure 46 Assigned Isostearyl isostearate 2% 
 
 
Figure 47 Assigned Phospholipon 1.5% 




For phospholipon at the aliphatic chain proton region there is broadening of peaks and extensive 
overlap between peaks. This effect is seen mainly from two properties associated with 
phosphlipids, one being that the percentage of each fatty acid is different and secondly through 
suspected micelle/bicelle formation of phospholipon as the polar head group and non-polar tails 
interact to form membrane like structures. This presents as broadening of the peaks and prevents 
appropriate assignment of peaks when not in a solvent that disrupts the formation of 
micelles/bicelles, which is investigated later in this chapter. For targeted characterisation of 
phospholipon and its composition of fatty acids, further work could use 31P NMR acquisitions which 






Figure 48 Assigned Panthenol 2%, splitting at 3 is a doublet of doublets that occurs through ambiguity between 
protons in two different chemical shifts due to OH group causing different J coupling on each proton. 
 








Figure 49 (Blue) Niacinamide 3% w/w, S/N = 10927.65; (Red) 0.3% w/w Niacinamide, S/N = 1742.37; (Purple) 0.003% 
w/w Niacinamide, S/N = 160.91; (Green) 0.0003%, S/N = 32.15, below threshold for accurate quantitation; (dark 
purple) 0.00003% w/w Niacinamide, S/N = 4.39, below threshold for accurate quantitation. 
  
Multiple Niacinamide concentrations were prepared to determine LOD and LOQ, as this is an active 
compound in many topical creams that is important in regards to skin health and is varied 
depending on consumer needs and accurate determination of abundance is relevant for the 
formulation chemist in consumer health. A LOD down to 0.00003% is observed, however the LOQ 
is only down to 0.003% with a standard quantitative experiment as demonstrated by the calculated 
S/N for integrated peaks. 
Table 9 Comparison between gravimetric and calculated concentration of formulation components 
Compound Gravimetric Conc. Calculated Conc. Trueness 
Glycerol 10% 2860 1680 0.58 
Niacinamide 3% 246 261.675 1.06 
Panthenol 2% 97.5 139.2 1.42 
Pentylene Glycol 5% 480 511.85 1.06 
Caprylic triglyceride 5% 90.1 70 0.77 
Isostearyl isostearate 2% 37.2 50.7 1.36 
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Phospholipon 90H 1.5% 25.3 30.54 1.20 
 
 
3.2.3.1 Cream Formulation Mixtures where Vitamin D2 and D3 were detected 
and quantifiable 
After this initial assignment of individual components spectra, preparation of the aforementioned 
full cream formulation samples with Vitamin D2 and D3 added and controls where vitamin D2 and 
D3 was not added was done. 
 
Automatic phase processed HSQC spectra highlight the absence of Vitamin D2/3 peaks in the control 
full cream formulation and presence of corroborating cross peaks in Vitamin D2/3 spiked samples. 
 
 
Figure 50 Magnitude phase processed HSQC spectrum highlighting the absence of Vitamin D2/3 peaks in the control 
full cream formulation and presence of cross peaks in Vitamin D2/3  spiked samples. Blue and red = D2/3 single 
component sample, Blue and dark green = Full cream Formulation with D2/3, Purple and light green = Control full 
cream formulation. a = Full spectra of all peaks, b = zoomed in peak range from 0.9ppm to 2.5ppm, c = zoomed in 
peak range from 4.5ppm to 7.5ppm. 
 
With full cream formulation spiked with Vitamin D2/3, noise prevents us from being able to observe 
with HSQC the cross peaks, however peaks are observed at ≈6ppm which match Vitamin D2/3. 
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Elucidation of vitamin D2 and D3 peaks in HSQC allows us to assign peaks in the quantitative 1D 1H 
acquisition for D2 and D3 respectively which allows for us to quantitate previously validated peaks 
for quantitation from single component D2 and D3 samples.  
 
 
Figure 51 (Top) 1H NMR spectrum of cream mixture (Glycerol, Caprylic triglyceride, Isostearyl isostearate, 
Niacinamide, Vitamin D2, Vegetable Oil, Pentylene Glycol, Panthenol); (Bottom) zoomed in region covering vitamin D2 
















Alongside detection of Vitamin D2 and D3 alkene peaks in the full cream formulation they are also 
observed in caprylic triglyceride and Vegetable oil samples. Formulations containing caprylic 
triglceride at 5% demonstrate an encapsulation of 1%, with vegetable oil at 2% an encapsulation of 
around 0.5% of vitamin D2 and D3 is observed. 
 
Figure 52 Concentration of Vitamin D3 in 5% Caprylic triglycerideCaprylic triglyceride, determined to be 113μM and 




Figure 53 Concentration of Vitamin D3 in 2% Vegetable Oil, determined to be 56μM and 21μM from integration at 
0.5ppm and 6ppm respectively 
The two peaks quantified have very different determined concentrations. Overlap of the singlet 
peak at 0.5ppm, with aliphatic chain peaks for fatty acid formulation components means that values 
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for 6ppm are taken, as quantitatively these are more reliable to the actual concentration of D3 
present in the formulations. 
 
Table 10 Vitamin D2 concentrations from single component formulations caprylic triglyceride (CT) and Vegetable Oil 
(Vo) 
 
CT 5% (μM) Vo 2% (μM) 
0.5ppm 337 79 
6ppm 213 54 
 
Table 9 also demonstrates that vitamin D2 is detected within the 5% caprylic triglyceride 
formulation with measured concentrations at 0.5ppm higher than 6ppm to a similar ratio as D3 due 
to overlap with higher caprylic triglyceride at 0.5ppm. A similar overlap of peak at 0.5ppm relative 
to the reduced overlapping at 6ppm is observed so again the value for 6ppm is taken as being more 
reliable and reported with other formulations. 
 
To prevent the observed separation of more lipophilic compounds from hydrophilic compounds 
that are included in the formulation a high shear mixer was employed for emulsification of the 
samples.  
 
3.2.3.2 Quantitation of Vitamin D2 and D3 in the full cream formulation 
Using the optimised experiment detailed above for quantitation, 1.91mM of D2 is calculated in the 
full cream formulation from gravimetrically weighed sample of 10mM D2.. Homogenisation of the 
mixtures allowed for greater encapsulation than seen in single component samples (caprylic 
triglyceride and Vegetable Oil). 




Figure 54 Homogenised full cream emulsion with gravimetrically determined concentration of 10mM. Peaks of TSP 
(0ppm), and Vitamin D2 (0.5ppm and 6ppm) assigned 
Below 1mM of gravimetrically determined concentration of Vitamin D peaks are not detected 
above the noise, so for the full cream formulation pure shift and projection display of DOSY spectra 
was used to produce single self-diffusion coefficient 1D 1H spectra allowing for resolution and 
quantitation of identified peaks of interest. Within cream formulations, the peaks used for 
quantitation in the vitamin D samples are overlapped by the more concentrated cream formulation 
components. Quantitation is limited to selecting peaks at δ = 6ppm, which are doublets rather than 
singlets, necessitating the integration of both peaks. Another issue is the homogeneity of the 
sample, which even after high shear mixing, there is a distinct loss of free vitamin D concentration 
within the cream, with concentrations of 1.91 mM and 4.47 mmol/L detected from 10 mmol/L D2 
and D3 samples respectively. It is also possible that in our cream formulation, micellisation of the 
vitamin D is taking place, thus reducing the amount of free vitamin D in solution which would have 
a significant impact on the measured Vitamin D with qNMR and can be measured through analysis 
of peak broadening and reduction in measured to expected concentration. This has implications in 
terms of skin permeability and vitamin D penetration into the dermis. It is also the case that the 
large abundance of other analytes to the small detectable vitamin D causes a great loss in S/N for 
smaller concentration peaks. The micellisation of vitamin D can be investigated through the 
acquisition of methanol‐d4 (MeOD) solvent samples alongside that of the D2O samples, which 
causes disruption of any micelles and all vitamin D becoming free in solution. The reason peaks are 
not visible when micellised is because the Vitamin D is incorporated with much larger structures 
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and their tumbling rate is slowed, therefore causing broadening of peaks (Shorter T2 relaxation 
time). This is not seen in MeOD samples as the micelles cannot be formed. Because of this, sharp 
line shapes are observed for the vitamin D peaks. From the formulation made, it is shown that NMR 
methodology can be used to measure the capacity of micellisation and with this the optimal amount 
of drug product or analyte of interest to add into our respective cream formulations. An example is 
shown below for vitamin D3 at a concentration of 10 mmol/L. 
 
Using our previously acquired pure shift Vitamin D spectra in DMSO as a reference, 6 peaks that are 
assigned to vitamin D are observed in our FCF-MeOD samples where micellation is disrupted. The 
same peaks are present for both Vitamin D2 and D3 in MeOD samples at comparable intensities. 
 




Figure 55 Red = Pure shift of Vitamin D3 in DMSO-d6, Blue = Full cream formulation in MeOD; a = full spectrum D3; b-d 
= selected regions zoomed in to highlight D3 peaks 
The ratio of encapsulated to free Vitamin D3 can then be determined by calculating the difference 
between measured amounts in FCF in D2O and FCF in MeOD where no encapsulation can occur. 
This determined ratio is shown in Figure 56. 
 
Figure 56 Determined values of free D3 in FCF through differences seen for non-encapsulated D3 in D2O FCF sample 
and non-encapsulated D3 in MeOD and percentage encapsulation in D2O shown in orange. This demonstrates the 
amount of D3 that has been successfully encapsulated in FCF and  whether added Vitamin D3 has exceeded the 
encapsulation potential of formulation 
3.2.3.3 Implementation and Optimisation of PSYCHEiDOSY experiment 
For this extension of pure shift into DOSY, the pulse program was taken from the Manchester NMR 
methodology group and implemented on  Kingston UniversitiesNMR Spectrometer. This required 
editing of the pulse program and setting up of an automation program to allow for suitable running 
of the pulse sequence to run many samples over a long period of time.  
 
3.2.3.4 Separation of components using PSYCHEiDOSY 
For assignment and identification of individual components and peaks within the full cream 
formulation a diffusion experiment with a pure shift element (PSYCHE) was used. This allows the 
peaks to be separated by the diffusion characteristics of the respective compounds producing the 
peaks with suppression of multiplicity. This collapsing of multiplets reduces the overlap between 
the peaks for the diffusion coefficient calculation therefore giving us a more accurate measurement 
of the diffusion characteristics.  




A sample with exclusively Niacinamide was first acquired with the PSYCHEiDOSY experiment to 
validate the values produced  and whether the results seen corroborated with known values for 
Niacinamide. 
 
Figure 57 Niacinamide PSYCHEiDOSY spectra displaying diffusion coefficient resolved peaks and separation of clear 
self-diffusion coefficients for solvents, TSP and Niacinamide. 
Table 11 Niacinamide reference sample PSYCHEiDOSY results 
Compound Calculated Log 
Diff. Coeff.  
Actual Log 
mw 
Niacinamide -9.48 ± 0.035 2.09 
Water -9.14 ± 0.063 1.26 
DMSO -9.24 ± 0.059 1.89 
TSP -9.60 ± 0.048 2.24 
 




Figure 58 Calibration curve of Log diffusion coefficient values versus Log mw for components of the Niacinamide 
sample from PSYCHEiDOSY experiments to demonstrate linear relationship between calculated diffusion coefficients 
and actual molecular weights for subsequent determination of unknown compounds molecular weight. 
Acquisition of conventionally acquired DOSY spectra of full cream formulation samples allowed for 
characterisation of the separate components to different levels of resolution between components. 
It is observed that lower abundance compounds that have overlapping peaks demonstrate greater 
error, especially for components Vegetable Oil, Isostearyl Isostearate, Caprylic triglyceride and 
Phospholipon. The larger abundance components, Glycerol, Pentylene Glycol and Panthenol have 
another limitation which is due to the extensive overlapping of peaks around 3.4ppm which makes 
the calculated diffusion coefficients for peaks assigned to one compound variable. 
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Figure 59 Conventionally acquired LED DOSY spectra of FCF with lines representing centre of highest signal peak for 
each individual compound (From top; Phospholipon, Isostearyl Isostearate, Caprylic triglyceride, Vegetable Oil, 
Panthenol, Niacinamide, Pentylene Glycol, Glycerol) 
Table 12 Diffusion coefficients for formulation components 
Compound Diff. Coeff. 
+/- RSM per 
spectrum 
log mw mw 
Glycerol -9.43 +/- 
0.18 
1.96 92 
Pentylene Glycol -9.56 +/- 
0.35 
2.01 104 
Niacinamide -9.66 +/- 
0.21 
2.08 122 
Panthenol -10.5 +/- 
0.62 
2.31 205.21 
Vegetable Oil -10.65 +/- 
0.5 
2.44 280 
Caprylic triglyceride -10.95 +/- 
1.28 
2.61 408.57 
Isostearylisoterate -11.12 +/- 
2.25 
2.72 536.97 
Phospholipon  -11.39 +/- 
2.1 
2.89 790.14 





Figure 60 Calibration curve of Log diffusion coefficient values versus Log mw for components of the FCF calculated 
from conventionally acquired DOSY experiment 
 
Figure 61 Zoomed in ppm ranges of reference spectra for each individual formulation component (From top; 
Phospholipon, Isostearyl Isostearate, Caprylic triglyceride, Vegetable Oil, Niacinamide, Panthenol, Pentylene Glycol, 
Glycerol) and 1D 1H positive projection of conventionally acquired DOSY spectra for full cream formulation 
sample(Light blue). a = ppm range from 3.3 to 4ppm; b = 7.4ppm to 9.2ppm; c = 1.55ppm to 2.5ppm; d = 1.2ppm to 
1.5ppm; e = 0.8ppm to 1.05ppm 
 






Figure 62 conventionally acquired DOSY spectra overlaid with reference spectra for Panthenol (Orange), Pentylene 
Glycol (Green) and Glycerol (Purple) 
 
   
Figure 63 PSYCHEiDOSY spectra of Full Cream formulation with each component identified by lines, from the bottom: 
Glycerol; Niacinamide; Pentylene Glycol; Vegetable Oil; Caprylic triglyceride; Isostearylisoterate; Phospholipon 








Compound Log Diff. Coeff. 
+/- 
RMS/spectrum 
log mw mw 
Glycerol -9.55 +/- 0.081 1.96 92 
Pentylene Glycol -9.62 +/- -
0.084 
2.01 104 
Niacinamide -9.61 +/- 0.25 2.08 122 
Panthenol -9.87 +/- -0.60 2.31 205.21 
Vegetable Oil -10.02 +/- 0.11 2.44 280 
Caprylic triglyceride -10.25 +/- 0.5 2.61 408.57 
Isostearylisoterate -10.33 +/- 1.09 2.72 536.97 
Phospholipon* X 2.89 790.14 




Figure 64 Calibration curve of Log diffusion coefficient values versus Log mw for components of the FCF calculated 








Figure 65 Reference spectra for each individual formulation component (From top; Isostearyl Isostearate, Caprylic 
triglyceride, Vegetable Oil, Niacinamide, Panthenol, Pentylene Glycol, Glycerol) and 1D 1H positive projection of 
PSYCHEiDOSY spectra for full cream formulation sample. a = ppm range from 3.3 to 4ppm; b = 6.5ppm to 9.5ppm; c = 
5.2ppm to 5.6ppm; d = 2.1ppm to 2.5ppm; e = 1.55ppm to 1.85ppm; f = 1.2ppm to 1.5ppm; 0.7ppm to 0.95ppm 
 




Figure 66 PSYCHEiDOSY spectra overlaid with reference spectras for Panthenol (Orange), Pentylene Glycol (Purple) 
and Glycerol (Green) 
3.2.3.5 Projection displays to demonstrate accuracy of PSYCHEiDOSY 
From the full cream formulation encapsulation of at least 1mM of Vitamin D2 and Vitamin D3 
observed within our emulsion the obstacle to quantitation is assignment of the peaks which can be 
done through PSYCHEiDOSY, reducing the overlap between the peaks through resolution 
improvement and having enough S/N for quantitation by optimizing receiver gain for amplification 
of signal with no requirement for extra scans. 
 
For the last two obstacles frequency selective experiments have been suggested, with pure shift 
techniques, like that of PSYCHE, also available for these. The group at the University of Manchester 
have shown a sensitivity increase of 2.5x over that of a traditional 1D spectrum, which when 
acquired in real time takes the same amount of time. A processing methodology to give similar 
results to a frequency selective experiment involves calculation of a positive projection using the 
calculated self-diffusion coefficients of respective formulation components and comparing these to 
reference spectra. Looking at the projection displays for the conventionally acquired spectra and 
PSYCHEiDOSY spectra compared to reference spectra of each component, the scope and limitations 
are highlighted. 
 
Due to sensitivity losses for the 2D and pseudo 3D acquisition there is a loss of lower signal 
abundance peaks, especially for the lower in abundance peaks. This is highlighted by the lack of any 
phospholipon peaks seen for the PSYCHEiDOSY spectra and the respective calculated projection. It 
is also observed from the PSYCHEiDOSY projections and PSYCHEiDOSY spectra overlaid with 
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reference spectra of Glycerol, Pentylene Glycol and panthenol that there is an increase in the 
resolution of these peaks and a more consistent measure of the calculated diffusion coefficients for 
each individual component which as a result gives more accurate projections for each of these 











Figure 67 Projection displays from PSYCHEiDOSY (Purple) and conventionally acquired DOSY (Green) calculated from 
determined diffusion coefficients for each component of full cream formulation compared to reference spectra (Blue).  
a = Glycerol; b = Pentylene Glycol; c = Niacinamide; d = Panthenol; f =  Vegetable Oil; e =  Caprylic triglyceride; g = 
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3.2.4 Fatty acid separation and characterisation studies to elucidate 
the scope of lipid mixture separation, characterisation and 
quantitation 
Extensive overlap of fatty acid component peaks for full cream formulations meant that these 
compounds were the largest limiting factor in separation of components based upon their self-
diffusion coefficients determined from DOSY acquisition. To investigate ways that the use of pure 
shift methodology can improve resolution of fatty acid separation and the limitations that still exist 
for NMR methodology multiple single component and multiple component fatty acid mixtures were 
prepared to elucidate which peaks could be targeted for separation and determination of mixture 
components. The below table details the mixtures of fatty acids which were prepared for NMR 
analysis, alongside these, individual spectra of each fatty acid was created as references for 
mixtures. 
Table 14 Prepared Fatty acid samples 
 
 
Previous studies looking at the composition of fatty acids and separation of compounds has 
primarily been achieved through the acquisition of 1D 1H spectra which can differentiate between 
terminal methyl groups between different fatty acids and also shows comparable quantitation for 
linoleic acid in vegetable oils compared to GC methods (182). However most methods for the 
quantitative analysis of fatty acids are for relative abundances of different forms of fatty acid, be 
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that as triacylglycerides, FFA or phospholipids with separation of fatty acids predominantly 
achieved through lipid extractions or chromatographical separation methodologies. 
In this studyanalysis of fatty acids was initially done with 1D 1H for preliminary conclusions made 
on limitations and how far pure shift spectra can increase the scope of fatty acid analysis. 
Observations of these experiments included the extensive overlap of all fatty acid mixtures made 
with peak differences between different components reaching a maximum of 0.05ppm. It is 
however noteworthy to observe that the largest fatty acids peaks aligned and overlapped more to 
each other than to smaller fatty acids which can be exploited for analysis. Single component sample 
analysis in reference to mixtures samples did not help in resolving respective peaks from one 
another. The preparation and acquisition of spectra for two component mixture samples showed 
how limited conventional 1D 1H spectra acquisitions are when characterising and quantifying 
individual components in a complex mixture with all 7 fatty acids showing the same characteristic 
peaks. Characterisation of single compound samples however is easily achieved through integration 
of peaks representing CH2 protons which account for majority of signal abundance in fatty acid 
spectra and can be used as reference for mixture analysis. 




Figure 68 Assigned peaks of fatty acids 
 
Figure 69 Spectra of 2 compound sample, Caprylic Acid and Caproic Acid 
Acquisition of PSYCHE spectra was done to reduce the overlap in several of the peaks. This is shown 
in the figure below where resolution of peaks at 1ppm can be seen alongside collapsing of peaks at 
1.4ppm.  




Figure 70 conventionally acquired 1D 1H spectra (Red) and PSYCHE acquired 1D1H (Blue) of 5.6 
In 5.6 it is observed that for each peak there is separation between the compounds. This separation 
has also allowed characterisation of peaks based upon their integration through the use of PSYCHE, 
despite PSYCHE not using quantitative conditions. This however may not be as big a limitation since 
characterisation is done through self-integral ratio calculation and shows accurate results 
compared to expected values. One spectra that stood out from the other 2 component mixtures 
was that of 5.7 (Caproic and Stearic) which gives the best separation when using PSYCHE acquisition 
with separation for peaks in the regions of 0.5ppm to 1.5ppm, however again no separation at 1.72 
and 2.45ppm is observed which is expected by the subtle proton changes seen near the carboxyl 
protons over the limited range of proton NMR spectra.  This sample is unlike other stearic acid 
mixtures which predominantly have stearic acid peaks overlapping the other component peaks. 
This was suggested to be because of the relative bulkiness of stearic acid in the mixtures.  
 
What these findings demonstrated was that comparisons of peaks between fatty acid with 
relatively large differences between aliphatic chain lengths can be made. The table below illustrates 
the separation achieved for component mixtures containing the relatively small fatty acid Caproic 
acid alongside other fatty acids. All samples which contained Caproic acid and other fatty acids with 
longer aliphatic chains show resolution between peaks assigned 1 and 2 with clear integral ratios 
determined and number of protons calculated for each peak.  
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Limitations arise with more than 2 component mixtures, where partial separation is observed but 
integral ratios between the different peaks are not able to be quantified. Follow up with DOSY was 
done to see if separation of peaks via size and shape differences could elucidate greater resolution 
despite the peak overlap seen even for PSYCHE acquisitions. Despite this, distinguishing different 
mixtures with differences in self-diffusion coefficients seen for overlapped peaks was achievable. 
 
Separation with DOSY mainly occurs at peaks 1, 2 and 3 with distinctively different self-
diffusion coefficients calculated within mixtures of components. This shows that DOSY 
provides a greater scope than only PSYCHE acquisition when considering separation of fatty 
acid mixtures, however complete mixtures struggle to resolve peaks based upon 
independent diffusion coefficients. 
 
Figure 71 Close up of 2.5 Diffusion Ordered Spectroscopy spectra 
The spectra of two component mixture sample 2.5 shows separation for 3 out of 4 peaks, however 
peaks in between the highest determined self-diffusion coefficient and lowest self-diffusion 
coefficient present as an error of overlapping peaks. This spectra does however show us that more 
than one component is present and extrapolation of self-diffusion coefficients for respective 
components is achieved if peaks at the extremes of low and high self-diffusion coefficient are used 
to limit the influence of overlap between the peaks. A qualitative comparison of component 
abundance in the sample mixtures is seen in peaks such as peak 4 which has total overlap and self-
diffusion coefficients which are not significantly different, but vary between samples with average 
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self-diffusion coefficient values for these peaks being lower with a  greater abundance of small fatty 
acids and higher with an abundance of large molecular weight fatty acids. Alongside separation 
seen for two component mixtures with caproic acid and other relatively larger fatty acid, mixtures 
containing 3 components that are relatively smaller fatty acids can be distinguished from one 
another, however larger fatty acids produced large error peaks producing non-significant 
separation between peaks. To attempt to improve this resolution in larger fatty acid chains 
PSYCHEiDOSY spectra were acquired to interrogate the effectiveness and possible improvements 
in separation that can be achieved. Projection calculation of specific self-diffusion coefficient values 
compared to previously acquired 1D 1H PSYCHE experiments can further validate this technique in 
separation and characterisation of mixtures. This is demonstrated nicely in the mixture between 
Lauric and Caproic acid in mixture 1.5 where separation is achieved from diffusion coefficient 
projection allowing for comparison of integrals relative to each component. This demonstrates 
clearly in the below figure that the peaks projected for Lauric acids have a larger abundance of CH2 
protons than other proton environments which corroborates with the increased chain length of 
Lauric acid compared to Caproic acid. To test the reliability and validity of these projections for 
integral determinations, calculation of these values for all two component mixtures are shown in 
table 14. 
 




Figure 72 Diffusion Coefficient projections of two mixture sample 1.5 compared against PSYCHE (1) for visual 
integration comparison of Lauric (3) and Caproic (2) acid. 
From table 14, 2 component mixtures have correct integrals for the fatty acid in the sample when 
compared to Caproic acid, including Stearic acid and Caprylic acid. Whereas for Capric acid and 
Palmitic acid an error of one CH2 from the expected integral is observed. The worst integral 
comparisons are for Lauric acid and Mystic acid which have integral differences of two CH2’s and 
three CH2’s respectively. Interestingly it was first thought that this error was due to large difference 
in abundance as shown in Peak 1 integral ratios, but the largest difference in this value is for 5.6 
which has 1 CH2 change, whereas a low abundance change of 2:1 for 5.4 has the same error 
associated with it. To evaluate the second assumption that values are affected by the overlap of 
peak 2 between Caproic and larger fatty acids causing this error as integrals are observed to be 
lower than expected rather than larger, a plot comparing the self-diffusion coefficients for each 
components and their fitting standard error per spectrum is shown in figure 72 Alongside this factor 
the non-quantitative nature of the projection displays must be considered as errors in quantitation 
of integrals as expected and can be improved upon by implementing experiments such as frequency 
selective experiments which can be set to give qNMR compatible data. 
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Table 15 Integrals and integral ratio of 2 sample mixtures (green = expected CH2 groups; yellow = expected ± 1 CH2 






The charting of self-diffusion coefficients further supported the finding that fatty acids become 
harder to distinguish from one another once they get larger as seen from Caproic acid to Caprylic 
and Capric acid showing resolution between diffusion coefficients however only significant 
differences in diffusion coefficients between Caprylic and Capric acid to Palmitic and Myristic acid 
with no other significant differences observed between the fatty acids. This explains why 
interpretation of the more complex fatty acid mixtures is hindered in comparison to those prepared 
with Caproic and larger fatty acids. Error of calculated diffusion coefficient also increases as the 
length of aliphatic chain increases suggesting that overlap of peaks between Caproic acid peaks and 
other fatty acid peaks play less of a role than the factor of increased proton environment change 
adding more error to the attenuation profile constructed by the DOSY pulse sequence. 
 
Figure 73 Calibration curve of calculated diffusion coefficients for individual fatty acid samples 
Implementation of PSYCHEiDOSY spectra improves the resolution between two component sample 
mixtures and demonstrates resolution between even the three component mixtures, however the 
S/N limitation of PSYCHEiDOSY and time required for experiment limits it use for larger component 
Component Mixtures Peak 1 integral ratio Peak 2 proton ratio Peak 1 PPM Δ  
5.7 3.5:1 (4) : (28 (28)) 0.03 
5.1 3:1 (4) : (12 (16)) 0.03 
5.3 2:1 (4) :   (8 (16)) 0.02 
5.4 2:1 (4) :   (10 (12)) 0.03 
5.2 3:1 (4) :   (14 (22)) 0.03 
5.6 5:1 (4) :   (22 (24)) 0.03 
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mixtures which previous PSYCHE and DOSY experiments showed were too extensively overlapped 
to be appropriate for PSYCHEiDOSY acquisition. 
 






Figure 75 Conventionally acquired DOSY spectra (top) and  PSYCHEiDOSY spectra (bottom) of 3 component mixture 
2.6.7 
Resolution improvements in 3 component mixture samples is observed with the use of 
PSYCHEiDOSY giving 3 resolved peaks for all 1D 1H PSYCHE peaks apart from peak 3 which gives an 
average self-diffusion coefficient for mixture as peaks are extensively overlapped. This is very 
promising for analysis of fatty acids in the future as identified peaks can be targeted for resolution 
improvement, however the error between self-diffusion coefficient values is still high as seen for 
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peak 1 and 4 with no significant differences in self-diffusion coefficient values between respective 
resolved peaks but clear differences in the calculated self-diffusion coefficient values for peak 2 
which is affected by the large overlap of much higher signal abundance of one of the components 
present which shifts all of the peaks to higher self-diffusion coefficients. However the potential for 
this methodology comparable to previous methods is shown by terminal methyl group separation 
and characterisation of other peaks which have relatively lower or higher self-diffusion coefficients. 
 
3.3 Discussion 
In these studies, the whole structure of vitamin D2 and D3 is assigned by 1H NMR and the precise 
assignment of signals on the steroid ring system through the use of 1D 1H pure shift acquisitions. 
This will allow for easier analysis of vitamin D metabolism through the qualitative and quantitative 
tracking of D2/D3 in its ergocalciferol, cholecalciferol, calcifedol, calcitriol (Active form) and 24,25‐
Dihydroxycholecalciferol (inactive form) forms, which all have very similar chemical structures. 
Appropriate quantitative settings required to be in place for accurate determination of amounts of 
target compounds are highlighted and how formulation properties can affect the reliability of 
quantitation of not only actives but also formulation components. NMR can be used to obtain LODs 
at physiological concentrations of vitamin D2/3 in simple samples however there is an interesting 
finding where D2 was measured over several samples, with different experimental settings was 
consistently 10x lower in concentration than vitamin D3. This issue was explored and was assumed 
to be due to solubility differences of vitamin D2 compared to D3 as different batches were used and 
different equipment employed to mitigate any user error.  
 
When these techniques were applied to skin cream formulation models, free vitamin D was not 
observed at the expected concentration in D2O samples. This suggests that in skin cream, 
precipitation or micellisation of the vitamin D is occurring, reducing the apparent amount of freely 
available vitamin D in solution. This result can be demonstrated by the concurrent running of 
experiments in D2O with critical micelle concentrations of surfactants, alongside samples run in 
MeOD, which does not allow the formation of micelles. Whilst it has also been reported that 
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Vitamin D3 can be photodegraded at relatively low intensity of UV, no evidence of this was observed 
in simple solution, and it is unlikely that this is the cause of the lower concentrations observed in 
the skin cream formulations. Free vitamin D is observed at 15%‐40% of the initial concentration 
through identification of peaks unaffected by encapsulations broadening effects. This means that 
15%‐40% of vitamin D is unable to permeate skin in the same way as micellised Vitamin D within 
the cream formulations with the differences in measured values seen from MeOD and D2O solvent 
variable samples. Further validation of free versus encapsulated Vitamin D can be achieved through 
further diffusography analysis to see interactions between Vitamin and surfactant as we will see 
the diffusion characteristics of Vitamin D will vary depending on state, be it micellised or free in 
solution. There is also an issue with overlapping of target peaks by emulsion peaks. Despite 
observation of considerable signal overlap, olefin peaks of vitamin D2/3 at 6 ppm and 0.55 pm are 
resolved well enough to be detected within the mixtures with peaks at 6ppm showing clear 
resolution and minimal effects from baseline distortion by high signal intensities of other 
compounds. The separation of formulation components through pure shift diffusion ordered 
spectroscopy experiments (PSYCHEiDOSY) demonstrated a non‐destructive and automated method 
for complex mixture analysis for formulations and allowed for individual spectra of each compound 
to be constructed. However, there was large error seen for compounds that had fatty acid parts, 
especially with long aliphatic chains present. Investigation of why this was seen and any 
methodologies that could be employed to improve the results was achieved through fatty acid 
mixture analysis. It was initially observed that conventionally acquired 1D 1H NMR spectra provided 
characterisation for single compounds, however it lacked characterisation potential for any more 
than one fatty acid mixtures through overlapping of peaks. Acquisition of PSYCHE 1D 1H NMR 
spectra showed that fatty acid mixture peaks could be resolved from one another, but this was 
limited to comparisons between small and large fatty acids rather than comparisons between larger 
fatty acids which are more common in our formulations and in biological mixtures. Interestingly 
PSYCHE allowed for a degree of quantitative characterisation for resolved peaks where CH2 peaks 
could be integrated to differentiate between the fatty acids within the mixture. When this 
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methodology was partnered with projection displays in DOSY further validation of the 
characterisation of peaks as integral values and self-diffusion coefficient values corroborated the 
identities and abundances of fatty acids within the mixtures for 2 to 3 component mixture samples.  
 
Despite this potential it was observed that a major limitation existed for DOSY based separation of 
peaks that the self-diffusion coefficients calculated for larger fatty acids become significantly less 
variable as aliphatic chain length increase, this meant that DOSY could not distinguish between 
Palmitic, Myristic and Stearic acid even if there was no overlap between peaks. PSYCHEiDOSY 
acquisition allowed for a decrease in error caused by peak overlap which allowed for greater 
resolution seen in 2 and 3 component sample mixtures, unfortunately it was unable to provide 
separation for mixtures with more components than 3. These findings showed that PSYCHEiDOSY 
can be extremely useful for separation of complex mixtures, however for larger, structurally similar 
compounds, fatty acids for example, the limitation is caused by the inherent properties of these 
compounds in solution being very similar and further investigation using techniques such as matrix 
assisted or 3D DOSY (HSQC-DOSY) could elucidate greater resolution and potential for this 
methodology.  
 
The potential of HSQC-DOSY is also demonstrated for this application in a short study on the 
separation potential of two common formulation components, the permeation enhancer 
butanediol and moisturiser panthenol. Alongside these new methodologies an aside an appropriate 
way to compare these results would be through the use of frequency selective pure shift 
experiments (183). This again would be limited to already resolved peak for fatty acids peaks and 
other compounds shown by previous PSYCHE experiments but would be an interesting add on to 
display individual spectra, which in theory would be unaffected by other component effects apart 
from universal effects of the sample’s overall properties which alongside single component spectra 
could demonstrate how formulation effect different parts of a compound. An added benefit of 
frequency selective PSYCHE experiments is the finding that S/N ratio per time unit is more than an 
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order of magnitude more sensitive than a conventionally acquired pure shift experiment, which 
means that acquisition of several frequency selective experiments on peaks of interest could 
actually be faster than a broadband experiment if compounds targeted are previously known and 
resolution of one peak can be shown for a conventional 1D 1H spectra to target frequency to. These 
experiments can then be implemented into a total correlation spectroscopy pulse sequence for 
smaller molecules where magnetization can transfer throughout the whole molecule to give all the 
peaks for a lower abundance compound which would have previously been overlapped or 
completely hidden from the investigator. A graphical abstract in figure 78 details the potential of 
these future methodologies for not only separation, but characterisation and quantitation of 
complex mixtures. If time however does not allow for a 2D selective acquisition, a recent selective 
1D 1H NOESY acquisition named GEMSTONE (Gradient-Enhanced Multiplet-Selective Targeted-
Observation NMR Experiment) has been demonstrated to show selection of peaks which overlap 
with multiplets of itself and other compound peaks to give selective spectra for individual 
multiplets. It has also been highlighted that this pulse sequence is compatible with selective 1D 
TOCSY, COSY, ROESY and relaxation experiments which demonstrates its great potential for mixture 
analysis going forward (184).  
 
3.4 Conclusion 
Appropriate and novel pulse sequences with calibrated parameters can detect down to the in vivo 
baseline level of Vitamin D2 and D3 in an idealised sample environment.  However, for full cream 
formulations, novel techniques, such as PSYCHEiDOSY and projection display analysis need to be 
used for accurate separation, characterisation and quantitation of individual components. This is 
because the dynamic range and complexity of our mixtures is a limiting factor for the NMR 
hardware, as amplification of our low concentration peaks of interest is prevented by high 
abundance glycerol peaks, which would overload the receiver and the overlapping of peaks which 
prevents accurate determination of peak integrals. Therefore, the further implementation of 
PSYCHEiDOSY and addition of frequency selective experiments will allow for greater reliability and 
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further validation for quantitation of in-vivo levels of biomarkers which are present in highly 
concentrated and complex samples in situ, through an automated and non-destructive acquisition 
methodology. 
 
Looking forward, the implementation of real‐time pure shift acquisition instead of interferogram 
through shortening of the pulse sequence time to fit within the dwell time would reduce the time 
required for pure shift experiments. Alternatively post‐processing methods, such as covariance 
analysis, can make experiments possible in a suitably short time period.  The application of NMR 
for detecting physiologically relevant concentrations of vitamin D and highlighting the effects of the 
traditional skin cream matrix on the amount of free vitamin D available has been validated and 
addressed. In Chapter 5 adaption of this approach is done to consider ex-vivo models for the dermis 
and assess active permeation using the optimised techniques reported here for both separation, 
characterisation and quantification. 
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The development of a semi-automated and rapid analytical technique for dermatological analysis 
has become a key aim of many academic and commercial entities through greater awareness of 
people to skin health and its importance in the 21st century. A proof of concept methodology 
demonstrating the use of validated non-destructive, in situ NMR techniques for characterisation 
and quantitation of NMF compounds and actives from topical formulations is presented. This study 
is the first to combine diffusion NMR, semi-automated quantitation and ex-vivo skin samples to 
measure NMF and permeation of actives. This work shows that diffusion NMR allows for resolution 
between formulation components through determination of self-diffusion coefficients. The 
metabolomics software Chenomxtm is used to identify and quantitate individual NMF components. 
Comparable results to previous literature on NMF layers in the skin is demonstrated, alongside 
reinforcing findings on permeation enhancers and heat effects on transdermal delivery of actives 
and formulation components. The presented methodology has shown great potential as an 
effective, non-destructive, fast and versatile technique for dermatological analysis of physiology 
and actives, with future hardware and software developments in NMR making the future of 
dermatological analysis via NMR very promising. 
 
The separation of complex mixtures in skin analysis by HPLC methods is extensively used in the 
characterisation and quantitation of NMF components in the skin. The extraction process requires 
tape strip washing in ammonia solution, evaporation and reconstitution in pure water. Solvent 
systems and columns must be carefully chosen for specific systems and calibrated with reference 
standards (195). Tape strip extraction has also been achieved through centrifugation and shaking 
in KOH solution for at least 2hrs, with alkaline extracts neutralized with acid and shaken again for 
2hrs followed by filtration (196). This requires column, flow rate, mobile phase and retention time 
to be carefully set for each extraction. However with the set out extraction procedure NMR can 
extract and acquire the data for a sample within an hour for a 600MHz NMR spectrometer with no 
cryo-probe (Chapter 2.3.2, 2.3.3 and 2.3.4). 
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Separation of complex mixtures prior to NMR analysis is one of the reasons why it is not more 
commonly used, however the use of pulsed field gradients and spin echoes can be exploited to 
achieve virtual separation. These techniques can calculate differences in translational diffusion 
through fitting of attenuation profiles of compounds to the Stejskal-Tanner equation alongside 
removal of large molecules through relaxation time filtering (197). Differences in diffusion 
coefficients gives resolution between single molecule peaks in NMR spectra and can be optimised 
through the use of pseudo 2D and 3D acquisition techniques. NMR analysis through separation, 
characterisation and quantitation allows the elucidation of multiple concentrations for identified 
compounds of interest within a single sample that has not been chemically or physically treated 
beforehand.  
 
The use of NMR metabolomics software package Chenomxtm has demonstrated the potential of 
NMR as a non‐destructive metabolite quantifier (198), exploiting its capacity for use as a primary 
method for quantification through an integral ratio method (107). The scope for quantitation is also 
increased as a tolerance for hydrophilic and hydrophobic elements within biological mixtures is 
intrinsic to NMR. In addition, NMR demonstrates high sample throughput by automation, with 
potential of remote desktop applications for simplification of use. 
 
For this study analysis is limited to the surface, keratinized, anuclear cells extracted  from the top 
12 layers of the stratum corneum removed via tape stripping . This limitation however does not 
obstruct the analysis of water retention potential and the most important aspect of the skin as a 
barrier to physiological, chemical and microbe attack at the surface Stratum corneum level. 
 
4.1 Initial findings 
Standard 1D 1H spectra from the two control groups and five treatment groups were initially visually 
compared to identify common elements of all spectra, namely PBS buffer, solvent peaks and tape 
strip peaks. These were assigned to remove confusion with treatment compounds and Chenomxtm 
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assignments of NMF compounds. One limitation immediately observed during this initial 
assignment was the overlap of fatty acid peaks from the skin’s intercellular lipid matrix and those 
added in treatment groups. 
 
4.1.1 Assignment and removal of PBS control without tape strip data 
from samples 
Tape strips were prepared as described in section 2.3.2, 2.3.3 and 2.3.4 with initial analysis done to 
normalize all spectra to the internal reference peak which is constant at 100μM for all samples. This 
allowed for visual inspection of spectra and qualitative observations made about each treatment 
type and tape strip layer comparisons.  
 
Figure 77 Comparison between PBS buffer control (a) and Tape Strip control (b) 
Secondly the observation of the two set control groups: no tape strip, deuterated PBS buffer and 
internal reference TSP; tape strip of skin with no treatment applied, deuterated PBS buffer and 
internal reference TSP. This observation allows for the assignment of peaks that are part of the PBS 
buffer, non-treated skin, acetate strip and the treatments added to the skin. Using the control 
containing only PBS, calculation of the difference spectra with all other reference normalized 
sample spectra removes peak interference by solvent peaks that would be consistent throughout 
all sample spectra. One limitation found during this assignment was the overlap of fatty acid peaks 
from the skin surface and those added through the topical treatments applied.  
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Figure 78 Difference spectra between treatments and control sample, positive peaks show increased abundance in 
treatment samples compared to negative peaks with increased abundance in control samples. Yellow = BW70; 
Orange = BW; Purple = V; Green = AI; Blue = P. 
 
Figure 79 Spectral comparison between layer groups 1/2/3 (Blue, Green, and Purple respectively) 
Component signals throughout the layers are observed, especially in the treatment samples where 
peaks, surmised to be topical formulation components, drop in intensity at a much  greater rate 
than peaks representative of skin and tape strip elements seen in the control groups. Detection and 
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quantification of formulation peaks is achieved throughout the twelve layers of each treatment, 
alongside peaks corresponding to skin compounds in the tape strip control. 
 
4.1.2 Regional Analysis 
Since NMR spectra are dependent on resolution through chemical environment of targeted nuclei, 
analysts can compare sample spectra to each other through signal abundance in different areas of 
the spectra when quantitative conditions are met, and abundance of signal is normalized to an 
internal or external reference set at a constant value between samples being compared. 
 
4.1.2.1 Functional Group analysis 
The first method of analysis was regional comparison of spectra. Initial quantitative comparison of 
layers was done by regional percentage abundance of the total signal with the sum of integrals 
normalized to 100, with integrals covering the Aliphatic (0.50 – 2.50ppm), Alcoholic (2.50 – 
4.40ppm), Methoxy/Vinylic (4.9 – 6ppm), conjugated and non-conjugated alkenes (6 – 8.4) and 
carboxylic, aldehydes and amide functional groups (8.40 – 10.30) ranges. Large changes between 
adjacent layers is observed, which can be explained by skin furrows and the inherent heterogeneity 
of skin layers. This led us to group the acquired layers (see more in materials and methods), as seen 
in previous literature (49) to compensate for these discrepancies between individual layers. From 
the regional percentage abundance analysis, clear differences are seen between the Aliphatic and 
Alcoholic regions of treatments when compared to the control tape strips with the abundance of 
alcohol being higher in treatments. This is primarily explained by the addition of glycerol and glycols 
which are common ingredients in formulations designed for skin. In treatments V, BW and BW70, 
an increased abundance in carboxylic peaks is observed. This is explained by the presence of 
Niacinamide in these treatments, which adds signal to the conjugated/non-conjugated alkenes 
region, the carboxylic, aldehyde and amide region.  
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Figure 80 Relative percentage abundances of functional groups for the different treatments, mean ± standard 
deviation. 
Interestingly in figure 80 the most significant changes are observed between groups which are 
shared for all treatments, apart from the carboxylic abundances where only BW, BW70 and V have 
peaks in this part of the spectra. 
 
4.1.2.2 Free fatty acid study using abundance analysis 
It has been previously demonstrated that the lipid composition of the Stratum corneum varies 
between layers.  The compounds of interest in the stratum corneum lipid matrix are phospholipids, 
cholesterol-3-sulphate, ceramide, cholesterol, sterol esters and free fatty acids. However for this 
study through the extraction process used and limitations of NMR acquisition, meant that larger 
molecules such as phospholipids and ceramides are unlikely to be observed through removal in the 
centrifugation step of extraction as they will be separated from supernatant. This means that 
observations and interpretation on the levels of cholesterol, cholesterol-3-sulphate, sterol esters 
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and free fatty acids can be achieved in this study if peaks can be elucidated from the acquired data. 
After observing the limitations of the complex spectra associated with cholesterol, cholesterol-3-
sulphate, and sterol esters, it was decided to evaluate lipid composition in this study primarily on 
free fatty acid levels as a whole mixture rather than individual separated fatty acids.  
 
Qualitative observations can be made on relative abundance and saturation level of free fatty acids, 
however separation of fatty acids as shown in Chapter 3 highlights the limitations encountered in 
single molecule characterisation and quantitation. For free fatty acids it was expected from the 
aforementioned previous studies (207) to see an initial decrease in free fatty acids after level 1, 
with smaller fatty acids decreasing in abundance at deeper layers in comparison to the larger fatty 
acids e.g., C24:0. This also correlated to the observation of reduced unsaturated fatty acids relative 
to saturated fatty acids as layer number increased. These findings however were only done down 
to 5 layers where in this study samples go down to 12 layers, allowing for an increased scope in the 
observation of fatty acid abundance (207). 
 
Here targeting of the methyl, olefin adjacent and carboxyl group adjacent protons of the fatty acids 
present within samples was done. Since significant overlap of these peaks from the complex 
mixture of fatty acids exists the findings from these results are limited. This limitation is highlighted 
in the large abundance discrepancy seen between the methyl peak at 0.8ppm integrated for three 
protons per single molecule to the olefin and carboxyl adjacent protons integrated as 2 per single 
molecule. The discrepancy between these groups is a factor of 10x, where normalization of the 
reference peak to 10 for the methyl peak abundance measurement and to 100 for the olefin and 
carboxyl peaks. However there is a similar trend for the olefin and carboxyl peaks which is absent 
for the methyl peaks where no significant change is seen so this suggests that the methyl peak is 
made from a much larger sample of molecules than the olefin and carboxyl peaks, possibly 
suggesting that ceramides abundance are added here whereas free fatty acids are seen at 2.4ppm 
and 2.5ppm. Multiplet peaks appear at 1.9ppm and 2.2ppm with similar abundances to peaks 
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shown here throughout samples. However, these peaks are overlapped extensively and were not 
suitable for integral comparison.  
 
The methyl peaks highlighted in figure 80 show that there is a large triplet peak with several peaks 
to the left of the peaks that are overlapped. These overlapped peaks are at a relatively similar 
abundance to the other peaks highlighted here but they are completely overlapped by the larger 
triplet peak that quantitation or integral calculation for this peak is inappropriate.  
 
Figure 81 Suspected lipid methyl group peak, triplet, Jhh = 7.54Hz 
 
Figure 82 Grouped average methyl abundances for treatments, normalised to TSP integral set at 10, mean ± standard 
deviation 
Unlike the previous findings which showed a decrease in lipids as layers went from 1 to 3 to 5, no 
significant difference is observed in treatment samples apart from a significant increase from group 
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1 to group 2 in the AI formulation treatment. The large abundance of this peak seen in the control 
sample also makes a significant increase in the average of samples from group 1 (Tape Strips 1-4) 
to 2 (Tape Strips 5-8), however the large contribution by the control sample which is absent from 
group 1 means the findings from this are limited. A significant drop in several of the treatments 
from Group 2 to Group 3 which matches previous findings on a decrease in the lipid composition of 
the skin. One treatment that is the reverse of this trend with the Physiogel treatment 
demonstrating a significant increase in methyl peak intensity in group 3 samples compared to group 
1 and 2 which are relatively high compared to other treatments. This suggests an alternative 
method of action of Physiogel to other treatments in relation to lipid composition in the Stratum 
corneum. 
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Figure 83 Proposed Olefin peak of skin lipids, quintet, 6.98Hz, which suggests 2 alkene groups present 
 
Figure 84 Grouped average olefin abundances for treatments, normalised to TSP integral set at 100, mean ± standard 
deviation 
From the olefin peak abundances a similar trend in the abundances is seen with methyl groups, 
with increases from group 1 to 2, and no significant change to group 3 in the average results. There 
are only significant changes seen between groups for treatment AI and controls. The significant 
changes seen between physiogel treatment groups for the methyl abundances are no longer seen, 
which means that saturated fatty acids are more likely introduced by physiogel than unsaturated 
fatty acids into the deeper layers. 
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Figure 85 Proposed carboxyl peak of skin lipids, triplet, Jhh = 7.86Hz 
 
 
Figure 86 Grouped average carboxyl abundances for treatments, normalised to TSP integral set at 100, mean ± 
standard deviation 
From the average results for the proposed carboxyl peak intensities, a significant increase in the 
average grouped results from group 1 to group 2 with no significant change between group 2 and 
3 is observed. This matches the trends seen for the proposed methyl and olefin peaks. This study 
shows an initial increase in proposed fatty acid peaks for proposed olefin and carboxyl adjacent 
protons from group 1 to group 2 samples, with subsequent reduction in intensity of peaks from 
samples 6 to 11 with a spike at sample 12 seen. These changes are not seen for the methyl peak 
intensities throughout layers, with an initial drop in intensity at layer 4 which corroborates previous 
findings but quickly goes back to levels seen at tape strip 1. These findings are limited by the nature 
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of the analysis as validation of assignment is incomplete as only chemical shift, j-coupling, and 
presence in the skin are confirmed with couplings characterisation of molecules limited by overlap 
and poor S/N for CH2 peaks specifically that would give more detail on identity of fatty acids.  
 
Figure 87 Combined chart of Methyl, Olefin and Carboxyl abundances with integral of TSP set to 100 mean ± standard 
deviation (n = 3) 
 
Figure 88 Combined chart of grouped Methyl, Olefin and Carboxyl abundances with integral of TSP set to 100 with 
mean ± standard deviation (n = 3) 
The other finding that was interesting seen in previous studies was that as you increased the layer 
number the ratio of unsaturated to saturated lipids was decreased. Comparable results to this from 
the abundance data demonstrated an increase in the proposed carboxyl adjacent peaks to olefin 
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adjacent peaks which suggests that the overall FFA composition is made up of more saturated fatty 
acids at these layers from 6 onwards where no significant difference between carboxyl abundance 
and olefin abundance was seen up to tape strip 5. But it is seen that this decrease in the ratio of 
abundance of unsaturated to saturated is only significant to tape strip layer 9 as it is suspected that 
all FFA levels drop at this layer so that the relative abundances of saturated and unsaturated 
become statistically non significantly different as they are within the 95% statistical significance 
threshold determined by the standard deviation calculated from triplicate values. P values were set 
at 0.05 to define statistically significant change etc. 
 
4.2 NMF 
4.2.1 Introduction to treatments, separation, characterization of 
topical components 
Larger compounds; cell fragments, proteins and large peptides will be removed in the extraction 
process, this analysis focuses on the assignment and quantitation of small active compounds that 
permeate through layers of the skin. Niacinamide is found in several topical treatments and is easily 
characterized and can be observed through all the tape strips extracted for the treatments that 
contain Niacinamide. For this stage of the study the semi-automated nature of the metabolite 
software Chenomxtm is exploited which allows for the fitting of the mixture spectra to reference 
databases of metabolites. This allows for accurate characterisation and uniform quantitation of 
NMF compounds which are metabolites of Stratum corneum differentiation and the process of 
desquamation. Identification of NMF compounds and other metabolites related to proper skin 
functioning and hydration was done to give weight to findings. These included hygroscopic amino 
acids and metabolic markers. These were then fitted using Chenomxtm with respective fittings of 
each compound described below and included in appendix.   
 
4.2.2 NMF Chenomxtm fitting 
Hygroscopic compounds, such as glycine and threonine, are excluded from this analysis due to 
extensive overlap with topical components in the treatment samples which makes the fitted 
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concentration of these compounds disproportionate to expected values and other values seen in 
the skin. The values for glycine and threonine are calculated by Chenomx therefore not interfering 
with other fittings through linear deconvolution nature of fitting but values are not realistic for 
these compounds so it is appropriate for them not to be included considering the effects their 
values would have on statistical analysis and conclusions. Below the fitting for each of the 
compounds quantified is described and fitting of assigned ppm values is included in the appendix 
for each individual compound. 
 
Figure 89 Chenomx fittings for Pyroglutamate 
The most common NMF analysed in dermatology is Pyroglutamate (PCA) so successful fitting of this 
in samples from Chenomx showed great potential for quantitative NMR in the field of dermatology. 
Chenomxtm shows reliable fitting for peaks at 4.2ppm, 2.4ppm and 2.04ppm, however a limitation 
was seen where peaks could not be automatically fit at 2.5ppm due to overlap of peaks with peaks 
previously proposed to be olefin peaks related to more abundant fatty acids.   
Chapter 4 Utilising validated NMR techniques for the in-situ characterisation and quantitation of 




Figure 90 Chenomx fittings for Histidine 
Histidine fitting in Chenomxtm shows reliable fitting at all peaks but automatic fitting only occurs at 
8.33ppm and 7.25ppm whereas peaks at 4ppm and 3.3ppm are overlapped by other peaks present 
in close proximity. Urocanate fitting in Chenomx demonstrated automatic fitting for all peaks, this 
is because of the lack of peaks present after 5ppm allowing for peaks to have good resolution and 
subsequent good fitting in Chenomx. Alanine fitting in Chenomx is done automatically at 1.45ppm 
however due to extensive overlap at 3.8ppm fitting is not successful at this location. This is due to 
the abundance of Methoxy/Vinylic groups present in the skin and formulations. Serine showed 
automatic fitting of all peaks, with resolution between peaks seen at 3.85ppm to 4ppm, as the large 
overlap of peaks by glycols and glycerol is avoided at 3.4-3.8ppm. Automatic fitting for aspartate is 
seen at 2.8 and 2.7 with fitting failing at 3.9 due to the multiplicity of the peak making the peak 
below the S/N threshold, it can be manually fitted but quantitation is achieved through the 
automatic fitting. Lactate required manual fitting due to the low abundance and low S/N of peak at 
4.1 and the overlap of peak at 1.3ppm with fatty acid peaks that dominate the aliphatic region of 
the spectra. Creatine is successfully fitted at both its peak sites. Creatine is benefitted by the singlet 
nature of its proton peaks which gives a larger S/N which makes fitting easier. Manual fitting is 
required for citrate due to low S/N and the reliability of quantitation is questionable for this 
metabolism marker. Formate is automatically fitted by Chenomxtm as its one non-labile proton is 
resolved clearly at 8.46ppm. Due to the low S/N of peaks for glutamate and the overlap of these 
peaks by larger peaks and broad peaks means that manual fitting is used for quantitation. This poor 
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fitting shows how the glutamate results are limited when analysing the skin with this extraction 
process and acquisition methodology. 










































4.2.3 Inter-sample analysis of NMF concentration in different layers 
Initial comparison of the total composition of all our tape strips to literature values gave a measure 
of the reliability of our technique compared to validated techniques for NMF quantitation. These 
results gave us confidence that Chenomxtm was reliably picking the correct peaks for each 
respective compound. 
 
Acceptably true results for free amino acids (FAA), PCA, Lactate, Creatinine are seen whereas Citrate 
and Formate levels are a lot higher in calculated composition compared to literature values. This 
discrepancy can be explained by the way that citrate and formate usually exist in biological 
mixtures, with ionic bonding to ions in the skin, which literature values show makes up 12% of NMF 
composition. Since quantitation of sodium, potassium and magnesium is not possible using this 
technique there are a number of assumptions made about the molecular form of formate and 
citrate which are normally maintained in salt forms so the NMF composition of sodium, magnesium 
and potassium would begin to make up the discrepancy seen in our measured values and literature 
values for the chemical composition of NMF (208). 
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Table 17 Percentage composition of NMF compounds in all samples versus individual treatment samples and 
literature values (208) 
Total Calc. (%) Liter. (%) 
FAA 57.56 40 
PCA 15.78 12 
Lactate 10.74 12 
Creatinine  1.73 1.5 
Citrate 3.31 0.5 

























Summing of the NMF values also allows for evaluation of the differences seen between treatments 
and compares the values to the control samples for group 2 and 3 samples. Calculation of the 
average sums of treatments without the contribution of the control samples is done as they do not 
have the results for group 1 where extractions showed anomalous results while extraction was 
being optimised. This allows for a more accurate comparison and trendline to be derived for the 




Creatinine  1.40 
Citrate 3.13 
Formate 8.63 




Creatinine  1.48 
Citrate 3.75 
Formate 14.32 




Creatinine  1.74 
Citrate 3.35 
Formate 12.12 
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summed grouped data. From the trendline, a positive correlation between group and concentration 
with a high R2 value and low standard deviation is seen for averages in group 1 and 3. A large 
standard deviation for group 2 is present but this is clearly through large deviation from other 
treatments by the AI formulation. Despite this large standard deviation, a clear significant increase 
from group 1 to 2 and group 2 to 3 is still observed. With the control samples a different relationship 
between group 2 and group 3 is observed with a decrease in the sum of group NMF, however group 
3 matches the sums for other treatments to a greater degree than the Ctrl sample in group 2 that 
only shows a sum of NMF that is comparable to the AI treatment.  
 
Figure 91 Comparisons of Summed grouped NMF data with trendline illustrating the changes between groups of 
samples using average data points for construction 
Comparisons made on the sum of total NMF in groups for each treatment allows comparisons on 
whether large deviations are present from averages in any of the treatments. All treatments are 
within the standard deviation of the average apart from the control that only accounts for group 2 
and 3 so this sum will be expected to be a third lower and AI which has a distinct increase seen for 
group 2 compared with all other treatments which explains this difference. 
Chapter 4 Utilising validated NMR techniques for the in-situ characterisation and quantitation of 




Figure 92 Comparison of full grouped NMF Sums for each treatment type and average values with mean ± standard 
deviation, * only summed over group 2 and 3 
After showing corroborating total NMF composition results to previous literature, individual NMF 
comparisons between treatments and groups of tape strips was investigated. The 4 main NMFs: 
PCA, Glutamate, Histidine and Urocanate were compared independently of other compounds then 
previously reported correlations were evaluated with the results acquired. 
 
 
Figure 93 PCA NMF values for all treatments mean ± experimental standard deviation (n = 3) 
For PCA a significant increase between 1 and 2 for all treatments apart from BW70 treatments 
observed. On average a significant decrease after group 2 for group 3 samples is seen, but this 
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decrease is considerably affected by the significant changes seen for treatment AI and control 
samples. 
 
Figure 94 Glutamate NMF values for all treatments mean ± experimental standard deviation (n = 3) 
No significant changes for glutamate are seen on average, but significant increases are observed in 
group 1 to 2 for treatment BW and a significant decrease from group 1 to 2 for treatment BW70. 
The significant increase from group 1 to 2 for treatment BW demonstrates a correlation to PCA 
however the significant decrease from group 1 to 2 for treatment BW70 highlights the limitations 
of Glutamate through overlap of peaks with broader underlying peaks highlighted previously for 
the BW70 samples, leading to a lack of automatic fitting of glutamate in Chenomxtm. 
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Figure 95 Histidine NMF values for all treatments mean ± experimental standard deviation (n=3)  
A similar trend for Histidine to that of PCA is demonstrated with an average significant increase 
from group 1 to group 2, with significant increases seen for treatments BW, AI and P.  
 
Figure 96 Urocanate NMF values for all treatments mean ± experimental standard deviation (n=3)  
Urocanate again shows interesting results with significant average increases from group 1 to group 
2 with significant increase in treatments BW, AI and P matching the increases seen in histidine which 
corroborate previous findings that the levels of Histidine and Urocanate are correlated. There is 
Chapter 4 Utilising validated NMR techniques for the in-situ characterisation and quantitation of 
key biomarkers and actives in tape stripped ex-vivo skin 
168 
 
also a matching significant increase in treatment BW from group 2 to 3, however there is an extra 
significant increase from group 2 to group 3 seen in BW70 which is absent for histidine 
concentrations.  
 
Comparing the significant changes seen between groups of tape strip layers in different treatments 
can give comparisons on how the methodologies quantitative potential varies and give a measure 
of how differently treated skin varies in NMF values. For PCA and Glutamate it is expected to see a 
correlation between these two compounds, being that PCA is the cyclic derivative of glutamate, 
however a significant increase which correlates between the two compounds is only seen in 
treatment BW, with all other treatments presenting a significant increase for PCA and no change 
seen for glutamate. An exception is seen in BW70 treatments where PCA shows no change and a 
decrease is seen in glutamate. This lack of correlation for most of the treatments between PCA and 
Glutamate can be explained by the inherent error seen between tape strip layers for glutamate, 
especially in samples where no significant change is observed with a non-significant increase in the 
average values but consideration must be made on the overlap of peaks in the Chenomxtm fitting 
limiting the reliability for findings on glutamate.  
 
The consistent significant increases for PCA across all groups apart from BW70 can be explained by 
high concentrations of PCA in group 1 as concentrations of PCA for group 2 samples in the BW70 
treatments are consistent with those seen for other treatments. This difference of BW70 is seen for 
all 4 of the main NMF compounds where group 1 samples have greater concentrations consistently, 
this illustrates the changes in NMF levels after thermal treatment of the skin which may be a 
response to retain moisture at surface layers to mitigate drying from a warmer external 
environment. 
 
Significant changes vary between different NMF compounds, with expected correlation of changes 
seen for Histidine and Urocanate for group 1 to 2 for all samples, with treatments AI, P and BW 
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showing a significant increase in both Histidine and urocanate. However, treatment V and BW70 
show no change, this can be explained for BW70 as its peaks are seen to be higher for layers 1 – 4 
when compared to all the other treatments, alongside effects from heat treatment. The treatment 
V shows no significant change between group 1 and 2 but does demonstrate a non-significant 
increase but the error between individual tape strip samples prevents a statistically significant 
increase to be observed.  
Table 18 Group 1 to 2 significant changes 
Compound AI P V BW BW70 Average 
PCA Increase Increase Increase Increase No Change Increase 
Glutamate No Change No Change No Change Increase Decrease No Change 
Histidine Increase Increase No Change Increase No Change Increase 
Urocanate Increase Increase No Change Increase No Change Increase 
 
For group 2 to 3 there are consistently no significant changes seen for all treatments which 
correlates the NMF compounds nicely together. Apart for the AI treatment where a consistent 
decrease is observed across PCA, Glutamate and Histidine, with no change in Urocanate 
concentrations. For all the other treatments, they match the no change seen for the average, 
however increases in Histidine and Urocanate for V, BW and BW70  is seen which shows that the 
formulation that these treatments share may have an effect on the levels of histidine and 
Urocanate that AI and P do not have. 
Table 19 Group 2 to 3 significant changes 
Compound AI P V BW BW70 Average 
PCA Decrease No Change No Change No Change No Change No Change  
Glutamate Decrease No Change No Change No Change No Change No Change  
Histidine Decrease No Change Increase Increase No Change No Change  
Urocanate No Change No Change No Change Increase Increase No Change  
 
After the interpretation of these significant change tables it was postulated that it may be prudent 
to start classifying P and AI together as their base formulations are both Physiogel. Alongside this 
grouping V, BW and BW70 were compared more as a group since their base formulation was that 
of the Bluewater formulation. 
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These main NMF compounds have been extensively quantified and their correlations to each 
investigated widely but significant differences between groups for other compounds relevant to 
skin health and hydration is seen, specifically hygroscopic amino acids and metabolic markers. 
 
The first hygroscopic amino acid analysed was Serine, as it is one of the most hygroscopic amino 
acids, therefore it is appropriate to monitor its abundance throughout samples (209) alongside 
serine, glycine and alanine are hygroscopic amino acids which play a role in water retention in the 
skin (210). This means that if these can be quantified in the skin, conclusions on the water retention 
potential and relative dryness or health of the skin can be made. Characterisation and quantification 
of the acidic amino acid Aspartate, which is shown as a biomarker in the skin for disease conditions 
and also as an immunoreactive agent in inflammatory responses is also a key biomarker to analyse 
for skin health (211) (212). 
 
Observation of the measured concentrations of amino acids and metabolic markers (Creatinine, 
Citrate and Formate) show similar abundances to the NMF compounds, despite creatinine and 
citrate being distinctly the lowest concentrated compounds seen. Interestingly for the amino acids 
and metabolomics markers when compared to the NMF values the large concentrations in group 1 
for BW70 are not seen suggesting that heat has no effect on these compounds’ abundance within 
the skin. This suggests that the NMF compounds (PCA, Glutamate, Histidine and Urocanate) have a 
role in temperature dependent mechanisms whereas amino acids and metabolic markers do not. 
Apart from possibly formate in BW70, but this increase in group 1 samples is also observed in 
treatment P, which could also be explained by addition of sodium formate in the formulations as a 
stabilizer in the treatments which permeate to group 1 layers through high abundance in P 
formulations and increased permeation through temperature treatment in BW70 which does not 
then permeate to group 2 and 3 layers of the skin. 
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Figure 97 Ctrl, BW70, BW, V, P and AI treatment hygroscopic amino acid and metabolomics marker grouped 
concentrations mean ± standard deviation 
 
For the amino acids a consistent increase for group 1 to 2 for AI and P formulations is seen and the 
differences seen with V, BW and BW70 suggest different effects upon the concentration of amino 
acids by these different groups of formulations. However inconsistency for V and BW is observed 
between amino acids with Serine being increased for V and Alanine and Aspartate being increased 
for BW however there are non-significant increases from group 1 to 2 seen throughout treatments 
V, BW and BW70 with varying degrees of increases which could be explained by a later onset of the 
increase in amino acids. This is demonstrated by the significant increase seen between group 2 and 
3 for amino acids.  
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Table 20 Significant increases between Group 1 and 2 for amino acids 
Compound AI P V BW BW70 
Alanine Increase Increase No Change Increase No Change 
Serine Increase Increase Increase No Change No Change 
Aspartate Increase Increase No Change Increase No Change 
 
Significant increases for group 2 to group 3 amino acids shows consistent correlations between the 
two Physiogel formulations, AI and P, where no change is seen between groups. Whereas consistent 
increases for formulations of the Bluewater formulations, in V, BW and BW70 are seen. These 
results combined with the increases demonstrated for group 1 to 2 show that amino acids in all 
treatments increase from group 1 to 3 but the large increase for AI and P is in the earlier layers 
whereas deeper layer increases occur for the Bluewater formulations. This suggests that the actions 
of the Physiogel formulations is pulling the hygroscopic amino acids to the surface, therefore 
drawing water to the surface of the skin, rather than the Bluewater formulations which are keeping 
the water retention in the deeper layers and not having this drawing effect to the surface. Even 
with temperature application that was previously stated to have less of an effect may even 
minimise drawing of hygroscopic amino acids to the surface by preventing an increase from group 
1 to group 2, but this conclusion is limited by the scope of this study.  
Table 21 Significant increases between Group 2 and 3 for amino acids 
Compound AI P V BW BW70 
Alanine No Change No Change Increase Increase Increase 
Serine No Change No Change Increase Increase Increase 
Aspartate No Change No Change Increase Increase Increase 
 
The metabolomics marker showed very little correlation between the two different formulation types, but 
did show correlations between creatinine and formate concentrations changes from group 1 to 2 and group 
2 to 3 with only treatment V and AI having slightly inconsistent significant changes in group 1 to 2 changes 
and group 2 to 3 changes respectively. The correlations between creatinine and formate was formed though 
a universal increase across the 5 treatments, with only Formate in the AI treatment not increasing, but the 
errors between layers for AI in group 2 and 3 are quite large and a non-significant increase is observed. 
Interestingly for lactate there is a decrease for all treatments from group 1 to 3 apart from BW70, this 
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suggests a role for lactate in the acid mantle of the surface of the skin more than formate. There is 
predominantly no change for citrate between groups apart from negatively correlating changes between AI 
and BW70 treatments, with an increase for AI and a decrease for BW70 which suggests that AI may increase 
the pH mediating effects of Citrate whereas the decrease seen for BW70 may be explained by thermal effects 
which also effects the levels of lactate as previously stated. It is seen that all other Bluewater formulations 
demonstrate decreases. This shows that the thermal effects seem to affect the composition of the acid 
mantle of the skin. 
Table 22 Metabolomic markers Group 1 to 2 significant changes 
Compound AI P V BW BW70 
Lactate No Change Decrease Decrease Decrease No Change 
Creatinine No Change No Change Increase No Change No Change 
Citrate Increase No Change No Change No Change Decrease 
Formate No Change No Change No Change No Change No Change 
 
Table 23 Metabolomic markers Group 2 to 3 significant changes 
Compound AI P V BW BW70 
Lactate Decrease Decrease No Change Decrease No Change 
Creatinine Increase Increase Increase Increase Increase 
Citrate No Change No Change No Change No Change No Change 
Formate No Change Increase Increase Increase Increase 
 
4.2.4 Statistical analysis (Principal Component Analysis) of NMF 
variability between layers and treatments  
Observations on the statistically significant differences between NMF values of different treatment 
sample groups can be made, however this is limited when quantifying the variability seen and how 
variability correlates quantifiably between different compounds within our samples. Principal 
component analysis (PCA) can be exploited to calculate principal components of data points within 
a data matrix that are considered as points in p-space. These direction vectors, with vector line 
direction that best fits the data while still remaining orthogonal to the first vector selected are then 
used to perform a change of basis on the data, with minimal number of principal components. The 
PCA plots are made up the principal components that determine the majority of the variation seen. 
Thus all plots are PC1 vs PC2 which explains more than 70% of the variability seen for all plots, the 
addition of extra principal components e.g. PC3, would be superfluous therefore it is ignored.  
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The first analysis done was all the tape strips groups together which demonstrated that the groups 
separate predominantly due to their group number predominantly based upon their principal 
component 1 (linearly uncorrelated variable that explains most of the variance in the data,PC1) 
values, with group 1 values at a range of 0.02 to 0.1, group 2 ranging from -0.3 to 0.2 and group 3 
ranging from -0.6 to -0.2. PC2 does separate groups and explains 28% of variability but shows large 
variability for BW70, AI, P, and V, however the BW treatments have a negative linear trend from 
group 1 to group 3 along the PC2 axis. An outlier is observed for BW1 as it overlaps in the region of 
group 2 samples, with BW70’s group 1 being on the boundary between the two groups, this 
suggests that the formulation of the vehicle does not have the same effects on variability seen and 
is more like that seen for P1 and AI1. The variability between group 3 samples is predominantly 
seen through PC2 with PC1 values for group 3 sample, BW70 aside, being very similar. 
 
 
Figure 98 All treatments tape strip extractions Scores plot for Grouped NMF data, PC1 (46%) against PC2 (28%) 
The correlation loadings seen for all the compounds shows the previously reported close 
correlation between Histidine and Urocanate, with low correlation observed between PCA and 
Glutamate, despite them both being positively loading. Interestingly Glutamate is closer to 
correlating to Lactate and Citrate but again this finding is limited by the reliability of Chenomxtm 
fitting for glutamate. Serine variability demonstrates a very strong influence on PC1 and is not 
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correlated strongly to other amino acids Alanine and Aspartate which are closely correlated. 
Interestingly the metabolism markers Citrate and lactate are very closely correlated but creatine is 
not, this again supports the previous observations of data. Formate is distinct in contribution to 
variability through closer correlations to amino acids than metabolism markers. This is surprising as 
formate and citrate are usually grouped together when calculating NMF’s in the skin.  
 
Figure 99 All treatments tape strip extractions correlation loading plot for Grouped NMF data, PC1 (46%) against PC2 
(28%) 
As previously noted in the previous section it is appropriate when comparing the variability seen 
between the treatments to break up the treatments into Physiogel group P and AI and Bluewater 
treatments; V, BW and BW70. This is especially significant when bringing together the NMF and 
topical components for correlation analysis. For this no real changes are seen in the scores plot 
when analysing the data separately but what is interesting is how the correlation loadings of 
different compounds changes. In the Bluewater formulations serine and creatine now have a strong 
correlation whereas this was not seen before. Glutamate is also more strongly correlated to PCA 
rather than Citrate and lactate which matches more with previous literature findings where PCA is 
a breakdown product of Glutamate. Alanine also becomes distinct in its contribution to variability, 
being closer to the NMF’s PCA and glutamate than the other hygroscopic amino acids Serine and 
aspartate. 
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The scores plot for the Physiogel treatments shows a more group dependent configuration where 
with clear grouping of groups together particularly for group 1 and 3 tape strips with group 2 
samples being separated by PC2 which can be explained by the uniquely large rise in concentrations 
for AI2 samples.  
 
It is demonstrated through the correlation loading plot that the NMFs PCA and histidine are closely 
correlated alongside the hygroscopic amino acid aspartate. Whereas Urocanate and Glutamate 
especially are closer correlated to Citrate and lactate. Contradictorily it is also observed that citrate 
and lactate have negative correlation loadings whereas in the Bluewater formulation they have 
positive correlation loadings with serine, histidine and aspartate showing the same inversion of 
correlation loading. 
 
4.3 Permeation profiling of topical components 
Abundance analysis and semi-automated quantitative analysis of NMF components has been 
extensively studied in previous work but the use of NMR in the study of active compounds and drug 
permeation in the skin is a fruitful area for research considering the current methodologies which 
are time consuming, destructive and require chemical or physical treatment for separation of 
individual compounds.  
 
Demonstration of the previous methodologies that have been validated for use in complex mixture 
characterisation, separation and quantitation use in ex-vivo skin samples is highlighted. Developing 
from the work done on whole formulations from bottle, transitioning to changes in concentration 
once applied to the skin. 
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Figure 100 Illustrative representation of methodology 
 
4.3.1 Characterisation of proposed topical peaks by 2D NMR  
The first step required for this work was the characterisation of peaks that were present in 
treatment samples in the difference spectra. 1D 1H regional analysis highlighted what type of 
compounds were being added into the treatment samples. This analysis was however limited to 
understanding what functional groups exist, but compounds that are added to formulations for 
permeation enhancement, alongside skin health enhancement actives can be understood, 
suspected compounds can be identified and characterised. 
 
For full characterisation of most abundant actives and permeation enhancers 2D spectra, COSY, 
HSQC and DOSY were acquired. COSY spectra showed that all the peaks at 7.6ppm to 9ppm were 
coupled to each other, this further confirmed the suspicion that these peaks were assigned to 
Niacinamide as these peaks and couplings matched the previous chapter’s assignments for 
Niacinamide added into formulations. 
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Figure 101 COSY cross peaks for proposed Niacinamide in bluewater formulations 
Glycerol peaks are also assigned from the previous chapter which have strong couplings to each 
other at 3.5ppm, alongside suspected panthenol and Pentylene glycol which have couplings seen 
at 2ppm-3.2ppm/3.6pmm and 3.4-3.45ppm respectively.  
 
Figure 102 COSY cross peaks for proposed Glycerol, Pentylene Glycol and Panthenol in bluewater formulations 
 
4.3.2 DOSY validation of peak correlations 
To confirm the peak correlations seen in the 2D COSY and HSQC spectra are for the proposed 
molecules, Glycerol, Niacinamide, Panthenol and Pentylene Glycol DOSY spectra were acquired. 
This allows for assignment of peaks to specific diffusion coefficients and subsequent 
characterisation of a respective peaks molecules shape and size.  
 
DOSY spectra with peaks selected for the proposed molecules, Glycerol, Niacinamide, Pentylene 
Glycol and Panthenol are acquired. Initial survey experiments were run to optimise the P30 and 
D20 values required for full attenuation profiling of 2% gradient power to 98% gradient power with 
these scans highlighted in figure 102. 
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Figure 103 1D DOSY Survey scan with varying D20 and P30 times: Blue = 2% GPZ6; Green = 98% GPZ6, P30 = 750μs, 
D20 = 0.1s; Purple = 98% GPZ6, P30 = 850μs, D20 = 0.1s; Orange = 98% GPZ6, P30 = 1050μs, D20 = 0.1s. 
With P30 set at 850μs the attenuation profile of higher abundance compounds is best described 
through reduction of signal down to 2.5%, whereas when P30 is set at 750μs the attenuation is only 
described down to 10% signal intensity. It is also shown that once the P30 values are raised to 
1050μs that signal needs to be amplified over 200x to observe any signal seen for the largest peak 
height, this shows the limitations past 850μs P30 value, as detail of attenuation profile will be 
explained over a limited power range. 
 
With the P30 values and D20 values optimised for the attenuation profile a 2D DOSY spectra is 
acquired. Self-diffusion coefficients were then assigned for each component peak and the value for 
highest intensity for individual compounds taken for calibration curve formulation and construction 
of projection display. 
 
Figure 104 Annotated 2D DOSY spectra to show independent self-diffusion coefficient values identified 
Once these values are determined the mean square error per spectrum for each peak gives us the 
contour size in the exported DOSY spectra in topspin and the error reported here for calibration 
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curve determination. This gives reference for how much contours when at max intensity overlap 
with each other but when intensity is modulated in TopSpin software it clearly distinguishes these 
peaks and no overlap is seen between them. 
 
Table 24 Calibration curve table with assigned compounds for BW70 tape strip layer 1, log diff coeff. values mean +/- 








Compouds log diff coeff. (m2/s) log FW  FW (kg/mol) 
Methanol -8.87 +/- 0.034 1.51 32 
Acetone -8.95+/- 0.074 1.76 58 
Acetate -9.04 +/- 0.08 1.78 60 
Glycerol -9.11 +/- 0.048 1.96 92.1 
Pentylene Glycol -9.17 +/- 0.11 2.02 105 
Niacinamide -9.12 +/- 0.040 2.09 122 
Proposed fatty acid -9.27 +/- 0.10 2.41 256 
Panthenol -9.28 +/- 0.055 2.31 205 
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Figure 105 Calibration curve for formulation components with linear trendline calculated from Log diffusion 
coefficients vs Log Fw values. 
 
Figure 106 Assigned DOSY fit spectra peaks representing highest abundance peaks of each compound 
From the calculated calibration curve constructed there is a linear correlation of y = -1.998x – 
16.206, with a R2 value of 0.9402 highlighting the strong correlation between log diffusion 
coefficients and log FW for the identified formulation compounds. With higher abundance 
compounds the error is lower, such as Niacinamide and Glycerol, but low error is also observed for 
compounds that have minimal overlap with other peaks like methanol. Unfortunately for Panthenol 
and Pentylene glycol their peaks have greater error which is due to partial overlap of peaks chosen 
for diffusion coefficient calculation. This effect of peak overlap on the error of diffusion coefficient 
calculation is exemplified by the peak for the free fatty acid composition of the samples.  The error 
for the calculated diffusion coefficient alongside the calibration curve suggests a range of molecular 
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weight for the free fatty acid of 105 to 305 Daltons. This shows the limitations of this technique for 
the accurate determination of molecular weight determination, but scope of the technique for 
separation and promising recent work done by Evans et al at Aston (213) and Gareth Morris’s group 
at Manchester (214) is making this tool powerful for the analytical chemist.  
 
Constructing projection displays at middle points of the contours for each compounds specified by 
their formula weight and calibration curve allows us to acquire individual spectra for each 
compound and identify peaks that may have been omitted from analysis or not observed 
previously. 
 
In the glycerol projection the glycerol peaks are clearly observed in the projection and are well 
resolved. This is because of the large S/N of the original spectra glycerol peaks and through the low 
overlap with other abundant peaks. However, some peaks have different intensities to other peaks 
in the projection display and this is due to partial overlap with peaks adjacent to it. This is observed 
by an increase in the size of peak relative to other peaks at 3.54ppm which has peaks present for 
other compounds present at ppm range 3.48ppm to 3.53ppm. 
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Figure 107 1D Diffusion coefficient projections of 2D DOSY spectra correlating to individual compounds 1D  
These peaks are then seen in the Pentylene glycol projection which has peaks at 3.48 to 3.51, where 
the peak at 3.5ppm is higher than the adjacent peak at 3.51ppm due to the peak at 3.51ppm peaks 
partial overlap with glycerol peaks. 
 
Figure 108  Niacinamide derivative identified through ODSY projection 
The peaks for panthenol are illustrated clearly at 0.8, 1.2, 1.4, 3.2 and 3.85ppm, with its peaks at 
3.5ppm to 3.6ppm being resolved but also greatly affected by extensive overlap with Glycerol in 
the spectra. This produces large errors in the diffusion coefficient calculation. Despite this overlap 
however these peaks are observable and can be assigned to the panthenol molecule.  
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Niacinamide projection displays show very low error due to the clear resolution of the peaks from 
other peaks present in the spectra. The coupling constants, appropriate relative integrals and also 
the number of peaks matches those expected for Niacinamide as shown in previous chapter. 
 
Figure 109 Zoomed in region of 3.2ppm to 4ppm highlighting resolution of previously overlapping peaks in 
PSYCHEiDOSY projections of Glycerol, Pentylene Glycol and Panthenol (bottom) compared to reference spectra (Top) 
 
Peaks are seen in the Niacinamide projection at 7.85ppm and 6.9ppm shown in figure 108, when 
looking at the j-couplings in the proton spectra it can be characterised as a Niacinamide derivative. 
The 8.8-8.9Hz J coupling observed for each peak doublet suggests the formation of an Niacinamide 
derivative that is formed from substitution of an alky group to the aromatic ring from small fatty 
acids through radical substitution. Assumed structure of these peaks from previous literature 
investigation implies that Niacinamide reacts with alkyl radicals, specifically Ethanoic acid, and 
forms 3 compounds preferentially. It is assumed to be formed through a reduction pathway to 
produce piperidine-3-carboxamide, 1,4,5,6-tetrahydropyridine-3-carboxamide and 1,4-
dihydropyridine-3-carboxamide (215). The 2,6-dimethylpyridine-3-carboxamide matches the 
coupling constants 8.8-8.9Hz when compared to much lower coupling constants for the other two 
preferential compounds (216). Identification of breakdown products like this is important when 
determining changes in composition from bottle to skin, alongside giving an opportunity to evaluate 
time from excision of sample to acquisition of data. 
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4.3.3 Quantitative permeation profiling of topical components 
identified 
Once all peaks have been identified for each compound, quantification can be done. Selection of 
peaks for quantitation takes into account peaks that have; low to no overlap, highest relative signal 
to noise and either singlet peaks or the lowest multiplicity peaks for each compound respectively . 
This allows for the greatest reliability of quantitation and scope of quantitation down to the 
concentrations seen for limit of detection and quantitation in previous chapters (100nM - 10μM). 
 
4.3.4 Niacinamide and derivative permeation profiling 
Levels of Niacinamide were quantified as the main active in the Bluewater formulations and how 
the different formulations and application of them affected the permeation of Niacinamide in the 
skin was analysed. There are clear increases in permeation from tape strip layer 1 to 9 for the BW70 
formulation. Significant permeation increases for Niacinamide are observed in formulation BW 
compared to V for tape strip layers 1 and 2, alongside this the trend line shows relatively higher 
permeation down to layer 7. These changes show that thermal treatment increases the permeation 
of Niacinamide in these formulations extensively, considering this is the only variable between BW 
and BW70. The uncharacterized actives that are present in BW compared to V also explain the 
increased permeation in relation to these two treatments. It is also shown that these trends are 
shared with the Niacinamide derivative, which can be quantified down to layer 7 in BW70 however 
in BW and V it can only be quantified to layer 3 with the trendlines for V and BW crossing over one 
another. This demonstrates that conclusions can be made on BW70 compared to V and BW but it 
is not appropriate to make conclusions on concentrations in BW and V for this compound. There is 
also a correlation between the levels of Niacinamide and derivative, through observation of 
increased permeation of Niacinamide for BW70 to layer 7 and detection of derivative to the same 
layer. 
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Figure 110 Permeation profiles of Niacinamide (top) and Niacinamide derivative (Bottom), in treatment tape strips 
(BW70 = Blue; BW = Orange; Vehicle = Grey;), mean +/- SD. With equations and R2 values for each treatment power 
trendline. 
 
4.3.5 Glycerol permeation profile 
Glycerol, which was present in all the formulations was selected next for quantitation and profiling 
of permeation. The findings were comparable to Niacinamide where the trendline for BW70 
permeation is higher than all other treatments. Conversely though, permeation of glycerol in the 
first layers of the samples is not the highest in the BW70 samples with BW, P and AI formulations 
having higher initial glycerol permeation into the skin. After this initial difference, BW70 has 
consistently higher permeation than all other treatments up to and including layer 3. The order of 
permeation for glycerol is BW70, P, BW, AI then V, with Physiogel classified mainly as a moisturiser, 
where Glycerol induces drawing of moisture to the surface is key, has a lower permeation than 
BW70 on average for the first 3 layers. Also its tape strip layer 1 permeation abundance in 
comparison to BW is contrary to this design where the BW formulation permeates glycerol at layer 
1 to the highest levels. Glycerol permeation is lowest for the vehicle formulation with distinctly low 
permeation at tape strip 1 in comparison to other treatments at around 10-15% the permeation of 
other treatments. This finding is interesting to see that Pentylene glycol which is present in all 
formulations apart from Physiogel which does not have much effect on the permeation of glycerol 
and other elements, which is contrary to its purpose as a permeation enhancer to mediate 
permeation. The other main permeation enhancement property would be how soluble glycerol is 
in the formulations and able to be delivered into skin layers. 
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Figure 111 Permeation profiles of Glycerol in treatment tape strips (BW70 = Blue; BW = Orange; Vehicle = Grey; 
Physiogel = Orange; AI = Red), mean +/- SD. With equations and R2 values for each treatment power trendline 
demonstrating a correspondence to Fickian diffusion described previously. 
 
4.3.6 Pentylene Glycol permeation profile 
Since Pentylene glycol is a permeation enhancer for actives and drug compounds in formulations it 
is important to measure where this permeates too so that understanding of where delivered actives 
will end up in the skin. Again BW70 has the highest permeation and is consistently highest 
permeating throughout all tape strips to a significant amount. The permeation profiles for 
Pentylene glycol show an interesting trend where the drops in concentration are less than those 
seen for other compounds. Despite this observation however all other treatments are relatively 
consistent in the concentrations of Pentylene glycol in layers and differences between layers are 
not significant after layer 2, apart from permeation seen in BW70 samples. The power value for the 
negative correlation for Pentylene glycol are also similar to Niacinamide so this suggests a 
correlation between Pentylene Glycol level and Niacinamide levels as they permeate through the 
skin at similar rates. 
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Figure 112 Permeation profiles of Pentylene Glycol (BW70 = Blue; BW = Orange; Vehicle = Grey; AI = Red), mean +/- 
SD. With equations and R2 values for each treatment power trendline. 
 
4.3.7 Panthenol permeation profile 
Panthenol is an active found in the Bluewater group of formulations and is predominantly used for 
moisturisation alongside a reported antimicrobial activity. It can be compared to glycerol 
permeation, despite being applied at much lower concentrations initially as seen by tape strip layer 
1 concentration. Again, like the other compounds in the Blue water formulations, BW70 has 
significant increases in permeation from BW and V for layers up to 10. It is also observed that BW 
has significantly higher permeation than V for the first 4 layers of the skin. The closest power value 
of negative correlation for panthenol is to glycerol which suggests a similar mechanism of 
permeation for both these moisturisers as there is a large drop in permeation from tape strip layer 
1 to 12. 
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Figure 113 Permeation profiles of Panthenol (BW70 = Blue; BW = Orange; Vehicle = Grey), mean +/- SD. With 
equations and R2 values for each treatment power trendline 
For reference, the values and standard deviation for each of the compound permeation profiles, 
and highlighted outliers, are included in the appendix. 
 
4.3.8 Statistical analysis of topical treatment data (PCA)  
Quantification of the correlations and variability seen between the permeation for different 
compounds by principal component analysis is done.  
 
For this analysis data was grouped for ease of observation and interpretation of the data, 
specifically to investigate the proposed correlation between the different formulation compounds. 
Preliminary analysis of the data sets for Bluewater formulations was done as these samples 
contained all the compounds quantified. The scores plot is useful to see how variability differs 
between groups of the samples. As for the BW1, its variability is distinct to that seen for all the 
other groups of samples. This demonstrates that group 1 samples for BW1 have high levels of 
permeation but group 2 and 3 have very low relative permeation demonstrating a large drop in 
permeation from group 1. BW70_1 and BW70_2 are very close to each other on the scores plot 
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which highlights the increased permeation seen throughout group 1 and 2 for all compounds and 
that variability seen in these groups are very similar. V1 is close to BW70_1 and BW70_2 however 
V2 is much closer to V3 which highlights the low starting permeation for V1 which is comparable to 
variation in permeation for both BW70_1 and BW70_2. There is a large change which means that 
the scores point for V1 is distinctly different in variability to V2 and V3. The main finding is that BW1 
relative to BW2 and BW3 is very similar to V1 relative to V2 and V3, whereas BW70_3 shows an 
inverse relationship to BW70_1 and BW70_2. This demonstrates nicely how BW70 treatment 




Figure 114 Grouped Bluewater formulations (BW, BW70 and V) permeation profile data of Pentylene glycol, 
panthenol, glycerol and niacinamide PCA scores plot with PC1 (96%) against PC2 (3%)  
The correlation loading plots also confirms the previously proposed correlations between 
Pentylene glycol and Niacinamide variability. However the proposed correlation between Glycerol 
and Panthenol, all be it is present but it is much weaker than the correlation between Pentylene 
Glycol and Niacinamide. 
 
Chapter 4 Utilising validated NMR techniques for the in-situ characterisation and quantitation of 




Figure 115 Grouped Bluewater formulation permeation profile data PCA correlation loadings with PC1 (96%) against 
PC2 (3%) for scores plot in figure 114 
4.3.8.1 BW sample formulation component variation analysis 
For further clarification of the above findings and to evaluate the individual compound groupings 
individual treatment datasets were analysed. From the scores plot it is seen that BW1 contributes 
most to the variability seen for group 1 when compared to group 2 and 3 with all samples from 2 
to 12 showing a gradual change in variation but no distinct difference. 
 
Previous findings on correlations corroborate with these findings, but correlations are reduced for 
Niacinamide and Pentylene Glycol in the samples. This is suggested from previous discussions to be 
due to Pentylene glycol not permeating through the skin as much as BW70 which means that the 
permeating influence on Niacinamide concentrations is reduced. 
4.3.8.2 BW70 sample formulation variation analysis 
For the BW70 scores plot an almost inverse relationship is seen where deeper layers, 9 to 12 are 
distinctly separated from the rest of the samples, with samples 2 to 6 especially showing very close 
relationships between their variabilities. 
 
The correlation loadings for the compounds match those seen before a much closer correlation 
between Pentylene glycol and Niacinamide, with a higher correlation seen between Panthenol and 
glycerol. This shows that the effects of each of the compounds when permeating at higher levels 
may have a much greater effect on other formulation components. 
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4.3.8.3 V sample formulation variation analysis 
With the analysis of the V treatments similar scores plot to BW is seen, except that the PC2 is 
inversed for the samples. This is explained by the negative correlation for panthenol seen in this 
treatment. With all other correlation loadings not being significantly different to BW correlation 
loadings. This finding is interesting as it shows that variability for panthenol is positively correlation 
loaded for BW and BW70 but with V, which only lacks actives its variation becomes inversed. 
 
4.3.8.4 Formulations containing Pentylene glycol and glycerol (AI, BW70, BW 
and V) variation analysis  
The AI formulation is added to the data sets to interpret how its variability in Pentylene glycol and 
Glycerol compares with the Bluewater formulations. Panthenol and Niacinamide data are not 
included in this analysis as this would skew the results as AI does not have any detectable levels of 
either. Initial inspection of the AI treatments show a close scores plot to BW for group 1, however 
the relationship between group 2 and 3 variability is not the same where these are distinct from 
one another unlike BW and V.  
 
With the AI added the same correlations for Glycerol and Pentylene Glycol as previously noted are 
seen with only slight changes in PC2 correlation loading. 
4.3.8.5 Combination of topical compounds with NMF data for statistical 
variance analysis 
It was decided to see whether topical components being added to the analysis would resolve groups 
or the treatments to a greater degree and also elucidate any relationships between permeation of 
actives to NMF concentrations. The results showed that the addition of NMF datasets to the 
analysis gave greater resolution between the groups, specifically groups 2 and 3 for BW and V and 
groups 1 and 2 for BW70. There was no improvement in resolution for treatments as variability was 
predominantly explained by PC1 with only 6% of variability explained by PC2. 
 
The correlation loadings plot shows the most likely compounds to affect the NMF levels would be 
Pentylene glycol and Niacinamide relatively, with Panthenol and Glycerol having an inverse 
Chapter 4 Utilising validated NMR techniques for the in-situ characterisation and quantitation of 
key biomarkers and actives in tape stripped ex-vivo skin 
193 
 
correlation loading to all NMF values. The correlation loading plot however does demonstrate the 
limitation of comparing these two groups of variables from topical application and skin NMF levels. 
With the Physiogel results the same results are seen with groups resolved to a greater degree, but 
treatment resolution is lacking. The same correlation loading plot where all NMFs correlation 
loadings are distinctly different to that of Glycerol is seen. Scores plots and correlation loading plots 
for these findings are included in the appendix as they did not show significantly different findings 
than previous scores and correlation loadings plots. 
 
4.3.9 Oneshot-HSQC of Butanediol and panthenol 
Implementation of suggested experiment from Chapter 3, HSQC-DOSY was done on a permeation 
enhancer, Butanediol and the previously described moisturizer panthenol to demonstrate potential 
for resolution improvement when determining diffusion coefficients and producing single 
component HSQC spectra. 
 
The 3D acquisition of HSQC-DOSY uses the One-shot DOSY pulse sequence with 1H13C correlation 
achieved via double inept transfer elements added to the pulse sequence. This pulse sequence 
design allows for the acquisition of DOSY spectra in one scan which is important when considering 
the time required for a 3D acquisition. 
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Figure 116 Butanediol and panthenol Oneshot DOSY  
The One-shot DOSY spectra demonstrates the large overlap of peaks for butanediol and panthenol 
which introduces the large error seen for the calculated diffusion coefficients of respective 
compound peaks. It is seen that for peaks at 3.5ppm show 3 distinct diffusion coefficients rather 
than the two expected and these have large errors especially for peaks suspected to be for 
Butanediol. Panthenol peaks show a smaller range of diffusion coefficients for respective peaks but 
still show clear differences between peak diffusion coefficients which causes larger error when 
determining average molecule self-diffusion coefficients from individual peaks. 
 
The acquisition of HSQC-DOSY spectra demonstrates clear resolution between respective 
compound peaks with clearly resolved HSQC projections being constructed from self-diffusion 
coefficient values for Butanediol and Panthenol respectively. The observation of more than the two 
expected diffusion coefficient values in the conventionally acquired one-shot DOSY experiment is 
also resolved and the expected number of diffusion coefficient values are observed. Despite clear 
resolution between compounds the diffusion coefficient error is quite large for each peak, so for 
any studies on more complex mixtures the experiment will need to be optimised with changes to 
D20 and P30 values to interrogate the best settings for each mixture type and complexity. This 
methodology could also be implemented on studies set up with matrix assisted samples for analysis 
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of fatty acid containing compounds to determine the degree that resolution can be improved 
beyond previously discussed methods. 
 
 
Figure 117 (Top) Pseudo-3D DOSY plot of One-shot−HSQC spectrum of butanediol and panthenol sample, (bottom 
right) 2D projection along F2 (1H) and (bottom left) 2D projection along F1 (13C) 
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Figure 118 2D slice extracted from the 3D spectrum of the results of Oneshot−HSQC experiment on a mixture of 
Panthenol and Butanediol in DMSO-d6 and TSP. a)2D spectrum obtained by integrating the region between 0 × 10−10 
and 9.03 × 10−10 m2 s−1 in the diffusion dimension, where all peaks are observed, (bottom left) 2D spectrum obtained 
by integrating the region between 6.44 × 10−10 and 6.46 × 10−10 m2 s−1 in the diffusion dimension, where butanediol 
peaks are observed, (bottom right) 2D spectrum obtained by integrating the region between 0 × 10−10 and 4.84 × 10−10 
m2 s−1 in the diffusion dimension, where panthenol and TSP peaks are observed 
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For dermatological analysis applications these results highlight the scope and limitations of NMR 
techniques from characterisation of tape strip extractions to conclusions on how varying 
concentrations of formulation components affect active delivery in the skin and how these effects 
correlate to NMF variation in skin layers.  
 
The method of qualitative abundance analysis allowed for rough fingerprinting of the different 
topical treatments applied to our skin samples and compared their overall formulation permeation 
which would allow at a glance differentiation between a topically treated skin sample and controls. 
This however is greatly limited in that it does not give information on specific compounds within 
the formulations or how the treatment affects the overall effectiveness of permeation. 
Concentration analysis of proposed fatty acids from FW determination via diffusion coefficient 
determination however cannot be done as FW determination could not be validated. So this led to 
free fatty acid (FFA) relative abundance measurements being done, with the assumption that the 
free fatty acids are a mix of palmitic acid and linoleic acid predominantly in the skin. This abundance 
analysis does however make assumptions that all the lipophilic elements of the extracellular 
elements of the skin are collected and the membranes of corneocytes on the surface of the skin. 
4.4.1 NMF 
Sum of NMF composition in treatments, and averaged values being in accordance with previous 
literature values demonstrates the reliability of this analysis and allows for confidence in further 
analysis of the skin layers.  
 
In the treatments the trends for each NMF component are very similar, as seen in figure 3, such 
that as the tape strips go from group 1 to group 3 layers trends match for each NMF. The significant 
changes detected for NMF levels match that of previous findings that levels of NMF increase as 
layers go deeper into the Stratum corneum, however at the number of tape strips that was done 
during this study, this conclusion may be premature, and deeper layer analysis would be useful to 
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increase the scope of these findings. Highlighting the significant changes for group to group NMF 
concentration changes allowed us to see that changes vary depending on formulation grouping, 
with correlations seen in Physiogel treatments (P and AI) and Blue water formulations (BW, AI and 
V). 
 
Figure 119 Comparison of NMF concentration determination between NMR Chenomxtm and other commonly used 
techniques (67)(217) 
Through the use of principal component analysis grouping of tape strip groups based upon their 
respective components variability can be achieved however it was unable to determine grouping 
of different treatment types from this statistical analysis. It was able to distinguish between 
groupings of treatments and differences with clear resolution between all groups apart from BW70 
groups 1 and BW group 1 where the differences for BW70 may be explained by the heat effects of 
the skin which make the surface have greater energy kinetics and higher diffusion of NMF’s 
between layers or suggested effects of the increased permeation of topical compounds. The 
variability seen for P could be explained by the drawing effect of treatment P to the surface where 
formulation has been applied and crystallised. The effects seen for BW70 group 3 may be because 
of the heat treatment affecting the heterogeneity of NMF compounds. The correlation loading plots 
also allows us to validate previously reported positive correlations between correlated NMF 
compounds, specifically PCA and glutamate, Histidine and Urocanate. It is however surprising to 
see no specific correlations between metabolic markers, with a few specific correlations seen 
between hygroscopic amino acids. 
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4.4.2 Permeation profiling of topical components 
2D NMR acquisitions (DOSY, HSQC and COSY) were used successfully to identify individual topical 
molecules within the tape strip extractions. Using DOSY, eight compounds with distinguishable self-
diffusion coefficients are determined. These identified compounds are then used to build a 
calibration curve which further validates assignments from COSY and HSQC experiments. The 4 
selected topical compounds were detected for all the Bluewater formulation treatment tape strips. 
Alongside these known formulation components, characterisation and quantitation of a 
Niacinamide derivative from DOSY projection analysis was possible. Identification of breakdown 
products like this is important when thinking of the changes in composition from bottle to skin.  
 
NMR also allows determination of the structure of new derivatives formed and with increases in 
resolution and sensitivity of NMR spectroscopy being seen at exponential rates through hardware 
and software innovations. This provides real scope for the measurement and correlation of 
derivatives to environment, formulation type and skin condition. 
 
NMR was also able to show permeation enhancement through chemical enhancers, specifically 
here with the example of Pentylene glycol which does not demonstrate increased permeation for 
all compounds, with only Niacinamide showing correlations to Pentylene Glycol. 
 
4.4.3 Conclusion 
This study corroborated previously reported findings about NMF values and how permeation of 
formulation compounds can be varied by formulation composition and thermal treatment. As an 
analytical method it demonstrated a non-destructive method unlike most commonly used 
analytical techniques, while allowing for sample retention and in-situ analysis. The relatively simple 
extraction procedure, quick sample preparation using a semi-automated approach to NMR 
quantitation and comparison provides further benefits of NMR over other analytical 
methodologies.  
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The benefits of this method is the time required for extraction to acquisition of NMR spectra which 
can minimise the effects of degradation and derivatisation of target analytes while allowing for 
monitoring of derivatives as demonstrated by Niacinamide derivative permeation profile. It also 
presents analyte concentrations which are non-chemically treated and illustrates in-situ relative 
concentration.  
 
In future work this methodology can be supplemented with Stratum corneum/vehicle partition 
coefficients (Km), maximum flux (J), enhancement factor (EF), and 24-h receptor concentration 
(Q24h) determination for formulation evaluation and permeation enhancement candidates. It can 
also be employed in the analysis of NMFs in different skin types, areas and models to validate 
previous findings and provide additional information that other methods cannot provide in a set 
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6.1 Project introductions 
Several projects were done during this research that were of consumer health research interest 
but out of the scope of the research story of this thesis. They are detailed here for reference 
purposes from main text when considering separate project idea and interesting research ideas 
that arose but were not fully accomplished by the author independently. 
6.1.1 Squalene 
 
A compound of interest is Squalene which is a skin surface lipid making up 15% of the sebum 
produced by the sebaceous gland. It has also been identified as having a key role in protection from 
oxygen radicals produced through photolysis of porphyrin by UVB and UVC after sun exposure. It 
has been suggested that oxidation followed by polymerisation of squalene occurs and could be a 
causative agent for comedone (black head) production through the encapsulation of keratin, when 
the polymers of squalene fill the sebaceous gland and prevent desquamation of cells on the outer 
layer of the Stratum corneum.  
 
6.1.2 Antimicrobial peptides 
 
Antimicrobial peptides are evolutionary conserved innate immune defensive compounds that were 
initially only thought to have bactericidal activity from initial discovery of lysozyme by Alexander 
Fleming.  This perception has changed dramatically since this first AMP, with a more fitting name 
for antimicrobial peptides being defensins, such as the alpha and beta defensins present in 
mammalian cells.  
 
AMPs have been shown to have several other key active roles apart from bactericidal activity 
involving several up-field pathways for wound healing, immune system activation e.g. 
inflammation, and vasculature development. Key indications of these roles are shown in the altered 
levels of antimicrobial peptides in dermatological pathologies. Specifically psoriasis, which can be 
used as a model of an inflammation environment and has been utilised to discover multiple AMPs: 
alpha, beta Defensin’s; psoriasin; RNase 7. Research has also shown the importance of AMPs for 
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skin infection resistance and immune response through the targeted deletion of certain AMPs. One 
example of this was the use Metallopreotease-7-deficient mice where all alpha-defensins were 
deleted and showed reduced clearance of bacteria and significantly higher mortality rates upon 
pathogen challenge. 
Antimicrobial peptides (AMP) are present in Stratum corneum secretions; their major role is in 
innate immunity, acting as inhibitors of microbial pathogens. This inhibition occurs because of the 
ability of the AMP to attach, align with and then insert into the microbial phospholipid bilayer. As 
this occurs, the peptide will form transmembrane pores that lead to the disruption and 
destabilization of the bacterial cell membrane, eventually leading to bacterial lysis. AMPs have been 
observed to preferentially target replicating bacteria at the site of division. 
 
AMPs are well characterised by analytical techniques, including NMR. However, the quantitation of 
the structural and affinity information of AMPs by Saturation Transfer Difference (STD) has only just 
started to be explored, with Sivertson et al (1) demonstrating the use of STD NMR on AMPs. This 
project will look at the interaction of human AMPs with membrane models using quantitative STD 
NMR. 
 
Alongside the detailed bactericidal activity of AMPs, it also serves several other roles in the innate 
immune system, wound healing and inflammation. These roles are mediated through the stimulus 
or inhibition of certain active compounds 
 
 
6.1.3 Dermal and commercial formulation analysis 
Elucidation of how these NMR methodologies can be exploited in studies of dermis based 
compounds apart from NMF will include investigation of squalene in light of its proposed role in 
comodonegenesis and the scope of ligand binding studies with non-isotopically enriched AMPs with 
model membranes at in-vivo concentrations.  
Chapter 6 Appendix 
227 
 
6.2 Results  
6.2.1 Application of NMR analysis to various compounds and 
formulation actives 
 
In this chapter the use of NMR methodology for characterisation and quantitation of various dermis 
compounds, including squalene and the AMP cathelicidin (LL-37) is evaluated. Highlighting of Syn-
Up is also done as a promising ingredient in dermatological treatments and evaluation of NMR’s 
potential for its characterisation and quantitation in different real world topical formulations and 
how respective peaks can be shifted depending on formulation. Optimisation of STD-TOCSY is also 
achieved through parameter changes and the use of processing methodologies which allow for 
resolution and S/N gains though reduction of transients without loss of information using a model 





The assignment of Syn-Up peaks was achieved with NMR mini-suite experiments 1D1H, 1H-1H COSY 
and 1H-13C HSQC. Using the multiplicity and J coupling constants of the peaks in relation to 
database and prediction software values, accurate assignment of each peak to an aromatic proton 
environment is achieved. This allowed peaks to be identified for quantitation of Syn-Up in different 
mixtures. 






Figure 120 Assigned 1D1H spectra and 1H1H COSY spectra showing couplings for  Syn-Up in 50-70% Glycerol  
 
Aromatic peaks are the only peaks visible in the 50-70% glycerol sample as all peaks for the aliphatic 
protons are close to the peaks for glycerol and are thus overlapped.  
 
Figure 121 Syn-Up in glycerol(Green), Physiogel with 50% glycerol (blue) and Physiogel Spectra (red), Glycerol and 
Physiogel Syn-Up peaks labelled (G + P). a = zoomed in region of 7.6ppm to 7.7ppm; b = 7.15ppm to 7.5ppm 
One aspect of the work that was interesting was that when the percentage of glycerol was made 
around 50-70% the peaks of Syn-Up shifted and line shape narrowed. However when glycerol is 
added to Physiogel to a percentage around 50-70% the peaks split into the peaks similar to those 
seen in glycerol at 50-70% in Syn-Up raw and Physiogel.  
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When identified in Physiogel (Fig 83) through sample mixing, peaks for 24-28 are the best for 
quantitation as they can be reliably identified from the reference spectra of Syn-Up, as peaks do 
not move or overlap with other peaks. A much greater S/N for these specific Syn-up peaks in most 
of the mixtures tested is observed which gives greater reliability of quantitation. 
6.2.1.3 Quantitation 
 
Figure 122 qNMR of Syn-Up in Glycerol, and different Physiogel batches 1-3, *Peaks used for quantitation as other 
peaks have overlap with Niacinamide peaks 
From the qNMR of the different batches received it was determine that the 3 Physiogel samples 
have varying concentrations of Syn-Up present within the formulations. With Physiogel 192324228 
having a concentration of 66µM, Physiogel 192324247 having 25.59µM and Physiogel 192324478 
having no Syn-Up detected in the sample. A consistent difference is observed in the concentration 
of Syn-Up within the Syn-Up raw through the Physiogel samples, where the next dilute sample has 
[Syn-Up] = n-1[Syn-Up] / 3 as shown in figure 84. 
 




 Figure 123 Syn-Up Log concentration values for the samples 
6.2.2 AMP characterisation, deuterated DPC synthesis and STD 
TOCSY implementation and optimisation  
 
NMR fragment-based drug discovery has been recognised as a widely applicable screening method 
(185). Lepre has reviewed the construction of a fragment library through development of NMR 
screening and what to do following a screen to improve drug discovery based upon the findings of 
the screens (186). Saturation based methodologies are a crucial element of screening with NMR 
through the effect of equalising the spin-state populations of nuclei under the influence of a static 
magnetic field (B0). As the molecular weight of a protein increases, its correlation time tc will 
become larger and spin diffusion becomes more efficient, this means that larger proteins and 
peptides sizes can be exploited to transfer magnetic saturation through efficient spin diffusion. The 
observed operational limit for studying protein-ligand interactions by STD-NMR is in the millimolar-
to-nanomolar dissociation constant (kD) ranges. Additional experiments such as the Carr–Purcell 
Meiboom–Gill (CPMG) pulse sequence, provide a useful supplement to both STD NMR and 
WATERLOGSY approaches for drug discovery screening and interaction analysis. In STD pulse 
sequences, a spin lock is implemented which dramatically reduces the broad background protein 
signal to provide a relatively flat baseline which reduces effects on target drug peaks and also 
increases SNR. In standard proteins a spin lock of 30ms works well, however in protein studies 
where the molecular weight is over 100kDa a more suitable time is 10-20ms. Smaller molecular 
weight proteins inversely require longer spin lock times, with times up to 50ms being reported.   
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The calculation of STDamp which gives quantitative values for protein – ligand interaction depends 
on the below equation and also the stoichiometry and kinetics of binding between ligand and 





)  𝑥 𝐿𝑖𝑔𝑎𝑛𝑑 𝐸𝑥𝑐𝑒𝑠𝑠 
Group Epitope Mapping (GEM) provides definitive information regarding ligand binding orientation. 
GEM was first applied in 2001 with the 120-kDa protein lectin Ricinus Communis Agglutinin I 
(RCA/20) and its binding relationship with saccharide ligands (187). 90 and 180 degree Hard pulses, 
cover essentially broadband width of chemical shifts; whereas the use of soft pulses, covers a small 
range of chemical shifts for targeted saturation of protein resonances which can prevent improper 
saturation of ligand peaks. Non-square wave pulses are designed for “soft” pulse applications to 
limit this unwanted excitation. Soft square pulses create irradiation sidebands in addition to the 
central excitation band which must be considered when placing the saturation pulses for STD. If the 
Gaussian pulse length is reduced from 50ms to 10ms, but the STD off/STDon position is maintained   
7.7 times improvement in S/N is observed. Eburp2 with 50ms was selected as the S/N increase is 
useful but greater STDdiff data was observed with 50ms as its excitation profile prevented 
inappropriate excitation of ligand peaks which were otherwise excited with shorter Gaussian pulse 
lengths. A NOE difference experiment would ideally use a 50ms Gaussian pulse because the tip of 
the excitation profile is very narrow, the STD methodology was used for this project as it showed 
higher spectra quality. Saturation points were swept for detection of the safest on-resonance 
setting that did not distort relative intensities, but provides the most efficient saturation transfer, 
hence greatest S/N, and this point is shown in the 1D 1H STD spectra for tryptophan. As the STDamp 
is saturation time dependent, data was acquired over a range of times and created the STD build-
up curve for each resonance peak of tryptophan which demonstrated with our instrument and 
experimental set up that 4s gave the best spectral quality and a plateau SNR and STDamp. 
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Further analysis of data can allow for calculation of STDFIT which gives a realistic measure of 
proximity for each ligand proton to respective protein and an improved measure on STDAMP for GEM 
analysis. Calculation of these for the 1D 1H STD experiments of tryptophan and HSA however for 
the acquisition of STD TOCSY experiments this was not done as acquisition of 5 different time 
experiments was very time consuming and also showed breakdown changes for compounds 
investigated in the >6 hours required for all experiments acquired on our instrumentation. 
Calculation of STDFIT is illustrated in the below equations. 
Equation 6 
𝑆𝑇𝐷𝑎𝑚𝑝 =  𝑆𝑇𝐷𝑎𝑚𝑝𝑚𝑎𝑥(1 − 𝑒
−𝑘𝑆𝑇𝐷𝑡) 
𝑆𝑇𝐷𝐹𝐼𝑇 = 𝑘𝑆𝑇𝐷 ∗  𝑆𝑇𝐷𝑚𝑎𝑥 
STDmax and KSTD define the plateau of STDamp and the STD rate constant, these can be used to obtain 
the slope for each curve when saturation is zero (STDzero)The relative STDFIT is therefore, a realistic 
measure of the proximity of each ligand proton to the protein and an improved measure of STDdata 
for GEM analysis. Limitations of STD experiments however is that when directly correlating 
dissociation constants, there is no discrimination observed between specific and non-specific ligand 
binding. For this study 1.5mM of ligand is needed astransfer to STD-TOCSY requires the largest S/N 
possible in regards to experiment time and number of transients.  
The use of a 2D 1H STD experiment, STD-TOCSY is introduced which is an additional route into 
determining the bound conformation of ligands through increased resolution of more complex 
ligands and their interaction to respective proteins. Data from STD-TOCSY experiments highlights 
changes in the relative TOCSY cross peak resonances which demonstrate how coupling changes 
between protons which is in proximity to saturated ligand and can be used to detect proximity of 
amino acids of respective larger peptides and proteins to saturated target through differences seen 
for the fingerprint region of NH cross peaks seen in the TOCSY spectra of our selected peptides. 
When acquiring the STD-TOCSY spectra a lower F1 resolution and 32 points of linear prediction to 
circumvent this lower F1 resolution was used. It is also demonstrated how covariance processing 
can be done to not only increase resolution greatly but allows for even lower F1 transients to be 
acquired. These processing methodologies are implemented to reduce the experiment time which 
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is substantially longer with the addition of the STD steps to the 2D acquisition  as two 2D spectra  
are acquired and calculation of small differences seen between them where increasing the S/N is 
so important to avoid low abundance peaks being below the LOD. STD-TOCSY data analysis also 
requires the standard TOCSY spectrum to be acquired for calculation of STDamp as the current STD-
TOCSY experiment is a difference only acquisition as the STDon and STDoff are subtracted via phase 
cycling with the data processed and only STDdiff spectrum being produced. A 1D 1H STDdiff 
spectrum is acquired first and then optimised settings are evaluated and transferred to the 2D STD 
experiments for the STD components of the STD-TOCSY pulse sequence.  The 2D components of 
the pulse sequence are the same as that of a conventional Mlev TOCSY acquisition; however the 
experiment is acquired increased scan number and fewer f1 points due to exploitation of linear 
prediction and covariance processing methods. Additional experiments that should be run in the 
future would be 2D NOESY, STD-NOESY and STD-HSQC alongside already acquired NOESY, HSQC, 
TOCSY and STD-TOCSY. However with the non-isotopically enriched peptide being investigated as a 
ligand rather than a saturation target during this study ways to speed up 2D STD experiments were 
evaluated with how reliable these methods are compared to each other. Methods for this speeding 
up of acquisition include NUS, covariance processing, and parameter optimization.  
 
6.2.2.1 Saturation transfer difference results 
6.2.2.1.1 STDamp factor enhancement 
 
Calibration of the on resonance pulses for protein saturation and transferred magnetisation to 
ligand increases is achieved by the placement of saturation shown below but enhancement of 
STDamp can be achieved through increasing saturation time until a STDmax is reached which 
prevents experimental time loss but also have the best spectral quality. 




Figure 124 HSA, 7-methyl Tryptophan STD reference spectra (red) and STD spectra (Blue) with calculated Astd values 
for each respective proton which demonstrates saturation transfer 
 
Before acquiring STD-TOCSY spectra, acquisition of a TOCSY spectra for reference and also 
investigating how much resolution is effected through implementation of covariance processing 
which can afford with only 16 transients set in the indirect dimension compared to the 128 
transients set in the non-covariance processed spectra. 
 
Figure 125 Red = Covariance processed TOCSY (16 F1 TD) (red) and the non-covariance processed TOCSY (128 TD in F1 








Figure 126 Purple = non-covariance processed STD-TOCSY, Red = Covariance processed STD-TOCSY with added scans 
at same time scale with reduced transients in F1, Blue = TOCSY with covariance processed spectra with reduced F1 
transients. a = zoomed in region from 2.3ppm to 4ppm; b = zoomed in region from6.8ppm to 7.6ppm 
 
 
Figure 127 Comparison of covariance processed TOCSY spectra (a+ b) versus non covariance processed TOCSY spectra 
(c + d) 
 




Figure 128 Comparison of TOCSY spectra with varying saturation pulse time 
 
 
Figure 129 Saturation time vs stdAMP values 
 
  




Figure 130 Non covariance processed STD-TOCSY (a + b) and Covariance Processed STD TOCSY (c + d) spectra with 
numbered peaks 
 
Table 25 Integrals for STD TOCSY and STD TOCSY Covariance processed peaks and rankings 
Cross Peak STD TOCSY STD TOCSY Cov 
1 21.03 43.65 
2 9.97 35.03 
3 5.16 108.76 
4 0.24 38.70 
5 0.88 3.35 
6 1.91 5.16 
7 15.51 5.44 
8 0.81 48.02 
9 0.53 0.83 
10 0.76 2.48 
11 12.16 1.39 














Figure 131 Comparative calculated stdAMP for STD TOCSY and covariance processed STD TOCSY 
 
 
















Figure 132 3D Contour representation of covariance processed STD tocsy spectra shwing the relative intensitry of 
cross peaks 
 
After implementation of STD-TOCSY and  demonstration of how optimisation gives results for qualitative 
analysis of GEM, the synthetic routes for deuterated dodecylphosphocholine (DPC) was evaluated through 
initial synthesis of DPC followed by deuterium/hydrogen exchange. This synthetic work would then lead to 
subsequent micellation and STD-TOCSY analysis for LL-37 binding studies to micellised deuterated DPC. 
 
6.2.2.1.2 Synthesis of DPC 
 
 
Figure 133 Dodecyl Phosphocholine 31P HMQC projection (Red) and total positive projection of all 31P HMQC 1H peaks 
Peak 3 has a splitting error, believe this is from the intensity of overlapping peaks in this area. 






Figure 134 Comparison of 1H projections from 31P-1H HMQC spectra 
 
The spectra of the starting material for the trimethylamine addition step is around two times the 
concentration of the final DPC product as shown by the scaling of peaks, this is not quantifiably 
reliable but gives an indication that the reaction did not go to completion.  
This could be because of the reaction temperature being too low during parts of the experiments. 
This would require a longer experiment time for completion of the reaction. There is also a limiting 
factor in the trimethylamine diluted in ethanol, which means less trimethylamine is available for 
the ring breaking and substitution on the phosphine synthon. 
6.2.2.1.3 Lauric Acid deuteration 
 
After successful synthesis of DPC from lauric acid, phosphoryl chloride and trimethylamine as 
starting materials, evaluation of deuteration protocols for lauric acid deuteration was done as 
previous studies have demonstrated H/D exchange in fatty acids of varying aliphatic chain lengths 
to differing degrees with varying reaction conditions. 












Table 26 Deuteration %’s for experiments 1, 2 and 3 
Chemical shift LA_D1 
(%D) 
LA_D2 (%D) LA_D3 (%D) 
0.8ppm 0 84 70 
1.25ppm 0 82 50 
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1.55ppm 0 82 50 





6.2.2.2 LL-37 assignment 
 
Since our cathelicidin (LL-37) was not isotopically enriched in N15 and C13 which would increase 
S/N for 2D spectra automatic assignment and structure characterisation software predominantly 
used in drug discovery fragment analysis was not possible as this would require 2D NOESY, 2D COSY, 
2D TOCSY, 2D HSQC and 2D HMBC experiments to be acquired for proper amino acid numbering 
assignment and dihedral angle determination between amino acid. These acquisitions would 
require experiment times beyond the scope of our instrumentation and sample concentrations due 
to solubility of materials. However investigation of the scope of our instrumentation and 
determination of methods which can be used to improve spectral quality can be done. Spectral 
quality for peptides can then be reviewed by looking at the fingerprint region, where the number 
of backbone NH’s should roughly match the number of non-proline residues. Spin-system-
identification is found at the spectral region: NH-αH-βH (TOCSY: F2 = 6.5-12ppm; F1 = 0-5ppm). 
Alongside the sequence specific assignment using the fingerprint region of COSY/TOCSY and NOESY 








Figure 137 Region assigned 1D 1H Spectra, TOCSY with fingerprint regions highlighted and zoomed in fingerprint 
region of covariance processed LL-37 TOCSY highlighting cross peaks associated with amino acids. 
 
Table 27 Amino Acid Reference table for LL-37 AA assignment 
AA NH α β Others 
Gly 8.39 3.97 
  
Val 8.44 4.18 2.13 γCH3 0.97, 0.94 
Ile 8.19 4.23 1.9 γCH2 1.48, 1.19     
γCH3 0.95     
δCH3 0.89 
Leu 8.42 4.38 1.65,1.65 γH 1.64     
δCH3 0.94, 0.90 
Pro 
 
4.44 2.28,2.02 γCH2 2.03, 2.03     
δCH2 3.68, 3.65 
Ser 8.38 4.5 3.88,3.88 
 
Thr 8.24 4.35 4.22 γCH3 1.23 
Glu 8.37 4.29 2.09,1.97 γCH2 2.31, 2.28 
Lys 8.41 4.36 1.85,1.76 γCH2 1.45, 1.45     
δCH2 1.70, 1.70     
εCH2 3.02, 3.02     
εNH3 7.52 
Arg` 8.27 4.38 1.89, 
1.79 
γCH2 1.70, 1.70 
    
δCH2 3.32, 3.32     
NH 7.17, 6.62 
Asn 8.75 4.75 2.83, 
2.75 
γNH2 7.59, 6.91 
Gln 8.41 4.37 2.13, 
2.01 
γCH2 2.38, 2.38 
    
δNH2 6.87, 7.59 
Phe 8.23 4.66 3.22, 
2.99 
2,6H 7.30 
    
3,5H 7.39     
4H 7.34 
 
Table 28 27 out of 37 assigned amino acids for LL-37 
AA F2 (ppm) F1 (ppm) 
Lys 4.097 7.9253 
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Leu 4.278 8.599 
Leu 3.972 8.225 
Leu 4.021 8.12 
Leu 4.067 8.6601 
Ser 4.0521 8.22 
Ser 4.29 8.15 
Phe 4.408 7.965 
Phe 4.494 8.176 
Lys 4.146 8.035 
Lys 4.179 8.12 
Lys 3.837 8.3731 
Lys 3.801 8.3862 
Arg 4.11 7.929 
Arg 4.148 8.0426 
Arg 4.177 8.193 
Arg 4.273 8.3894 
Val 4.288 7.975 
Val 4.3 8.2239 
Thr 4.242 8.082 
Glu 4.2571 8.0611 
Iso 4.109 8.2715 
Iso 4.156 8.1288 
Iso 4.2421 8.0625 
Asn 4.575 8.241 
Phe 4.458 8.0521 
Pro 3.9161 8.3741 
 
 
The following sequence is shown with proposed amino acids that are not detectable in spectra due 
to overlap and low SNR; LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES. Assignment of 27 out of 37 
amino acids was possible and highlighted in red the amino acids that were unable to be assigned in 
this research. Further assignment would require enriched peptide or a higher magnetic power 
instrumentation but this shows the scope of characterisation of small peptide fragments with the 
instrumentation and a non-enriched peptide. Therefore it was decided to test with these 
assignments whether transfer of saturation could be seen to the amino acids that were assigned. 
Interestingly all amino acids that could not be identified were part of the alpha helix structure so 
this may limit this research however it also may give reasons as to why assignment failed through 
overlap of peaks rather than low sensitivity. 
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6.2.2.2.1 Ligand Binding limitations encountered 
Despite experimental optimization of STD-TOCSY done previously saturation transfer from 
deuterated DPC to LL-37 was not observed. This was interpreted to be because of no active spins 
allowing for spin diffusion throughout the DPC micelle, therefore preventing NOEs from taking 
place between LL-37 and deuterated DPC. Partially deuterated DPC could be an alternative however 
again it would need to be tested to see if saturation transfer was large enough to transfer through 
NOEs from DPC micelles to LL-37. Non-deuterated DPC is inappropriate as it does not form large 
enough micelles to reduce T2 time enough to broaden its respective peaks so this ends up with 
overlap of lower abundance LL-37 peaks. Further investigation of the use of STD-TOCSY for LL-37 
and other AMP interaction analysis would require different models of bacterial membranes or 
viable membranes prepared in PBS buffer to give LL-37 interaction analysis and GEM, rather than 
structural analysis previously shown with LL-37 and DPC micelles. 
 




Comedonegenesis and premature skin ageing are two of the most common dermatological 
conditions that are diagnosed on non-dermatologically pathogenic individuals. Both of these 
conditions have been linked to compositional changes and production rate of the sebum(188)(189). 
For this study investigation of how one of the components of sebum; Squalene, is affected by 
temperature induced free radical reactions and photochemical induced reactions; which allows to 
model the effects of sun damage on the skin.  
Squalene was chosen as it has been identified as an oxygen radical quencher by conversion to 
squalene epoxide. Squalene epoxides have been shown to induce comedogenesis (190). 
 
Comedones result from abnormalities in the proliferation and differentiation of ductal 
keratinocytes4. Abnormalities in sebaceous gland lipid composition have been implicated in the 
induction of ductal keratinocyte hyperproliferation leading to comeodogenesis (191).  
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An increase in fatty free acids and squalene has been blamed for inducing comedones. It has been 
shown that squalene peroxides are highly comeodogenic whereas squalene itself is not3. Squalene 
peroxides are seen to be formed from UVA irradiation and identified as highly UVA sensitive SSL 
breakdown products (192).  
 
Suggestions of Squalene epoxides role in the accumulation of keratin in comedone affected 
pilosebaceous units (193). Squalene is a skin surface lipid which makes up 15% of the sebum 
produced by the sebaceous gland. It has also been identified as having a key role in protection from 
oxygen radicals produced through photolysis of porphyrin by UVB and UVC from sun exposure 
(194).  
The proposed mechanism for comeodonegenesis is polymerization of squalene, alongside the 
demonstrated peroxidation that occurs when this event takes place. This process can be a causative 
agent for comedone (black head) production through the encapsulation of keratin when the 
polymers of squalene fill the sebaceous gland. 
For this work a model system of sebum shall be produced with squalene, free radical initiators and 
a stable solvent system. This model system shall be exposed to varying amounts of UVC radiation 
to determine the amount of irradiation required to produce polymerization; alongside or in the 
absence of oxygenation.  These experiments will contribute to the knowledge of comedone 
prevention, through analysis of the degree of polymerization, polydispersity of squalene polymers, 
alongside understanding the limits of polymerization in our model. 
 
Preliminary experiments were done with a known mechanism for free radical initiation with 
temperature set to the breakdown temperatures of Initiators AIBN and BP (Reflux condensation 
reaction in Toluene done). Photochemical experiments with UVC irradiation of free radicals were 
then implemented to commence initiation of free radical polymerization between initiator and 
monomer. This was done in the presence of oxygen and also in an oxygen free environment with 
nitrogen flowing over it. The Solvent toluene was removed for the oxygen excluded experiments 
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because of its known absorbance of UVC which would could prevent break down and initiation of 
free radicals. Photochemical experiments are a better model for skin surface lipid interactions and 
composition studies as it allows the exposure time of UVC to be based upon a relative time in the 
sun. 
 
Rampant free Radicals: AIBN; Benzoyl Peroxide are used to make polymers from vinyl monomers 
(small molecules containing carbon – carbon double bonds).The carbon – carbon double bond in a 
vinyl monomer, has a pair of electrons which is very easily attacked by the free radical. As a model 
for the production of free radicals in the skin; since the effects of reactive oxygen species (ROS) on 
squalene has been shown in in previous literature this investigation will determine the effects of 
other free radicals on skin surface lipids and whether it is possible that the application of skin 
creams, or bacterial processes may have an effect on the composition of the sebum on the skin. 
 
Intensity of sun that reaches Earth is very low relative to the power of the UVC bulb used for photo 
induction experiments to compare the relative effects of these two phenomena. The sun has a 
power of 1360 watts per square meter whereas a 8.14 eV 254nM UVC bulb is used which sees the 
effects of a long exposure to the sun in a short period of time for our investigation. 
6.2.3.2 Results 
 




Figure 138 1D NMR spectra showing characterisation of Squalene 0.5% w/w; 256 scans, and same squalene 
concentration as polymerization experiment samples 




Figure 139 DOSY Spectra characterising relevant cross peaks of squalene and its respective diffusion coefficient 
6.2.3.2.1 Experiment 1; Temperature induced initiation of free radicals 
In our first experiment decomposition of AIBN and Benzoyl Peroxide to free radicals is achieved 
thermal decomposition by setting the temperature of the reaction mixtures above that of their half-
life at 10 hours; 65 degrees Celsius for AIBN in toluene and 70 degrees Celsius for Benzoyl Peroxide 
in benzene. 85oC for AIBN and 90oC for Benzoyl Peroxide was used for initiation of free radicals. 
Below their melting point’s; but high enough to allow for the majority of the initiator to be 








Figure 140 Benzoyl Peroxide/Squalene sample, post polymerization (3 Days) time 11.  
Sterol cross peaks formed which demonstrates the intramolecular reduction cascade occurring 
from free radical initiation but no polymerization reaction as expected. 




Figure 141 AIBN/Squalene time 13 (3 days), post polymerization  
AIBN initiated reaction shows polymerization has occurred to the point of a trimer, as shown in 
table 15. Like that of Benzoyl Peroxide, the Intramolecular reduction cascade occurs to form a peak 
characteristic of a sterol. DOSY spectra shows that there are three possible intermediates formed. 




Figure 142 AIBN/Squalene Time 13, covering alkene peaks 
Alkene groups have reduced in intensity for the trimer cross peak, suggestive of free radical 
polymerization varying across the different olefin groups as intensity is not consistent across the 
cross peak like that of squalene 
6.2.3.2.2 Experiment 2; Photo induction, 50mM initiator, in Toluene, in the presence of 
oxygen 
Comparison of Photo-chemical induction of the free radical initiation of squalene polymerization 
through the decomposition of AIBN and Benzoyl Peroxide to free radicals to thermal decomposition 
results will demonstrate whether a model system of the sun can illicit the same response as a 
classical thermal decomposition of free radical initiators. 
It has been shown that photochemical decomposition applies a lot more energy for bond breaking 
than thermal decomposition so it was hoped that this would allow for a faster transformation of 
squalene to a polymer form. 
Samples were made up in toluene so that UVC irradiation would be incident upon a 15% squalene 
sample; with 50mM of the initiator (AIBN or Benzoyl Peroxide). 
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Several control experiments were run as well to make sure what was observed was not a 




Figure 143 Lines showing squalene peaks at -9.55 log(m2/s) and proposed squalene polymer peaks at -9.83 log(m2/s) 
 
 
Figure 144 AIBN Squalene and Toluene sample DOSY scan showing  two distinct compounds with different diffusion 

















Figure 145 DOSY spectra, analysed in Dynamics centre highlighting the squalene peaks and proposed polymer peaks 





Figure 146 DOSY spectra, analysed in TopSpin highlighting the squalene peaks and proposed polymer peaks after 55 
mins of UVC exposure on the sample 
 
Using the software UCC polymer prediction; http://www2.ual.es/NMRMBC automatic calculation 
of the molecular weight from the calculated diffusion coefficients of our proposed polymer can be 
done. The calculated value when water was calibrated to was Squalene at a molecular weight of 
1992.16 Da and the Squalene oligomer at 22858.18 Da. Determined value when methanol was 
calibrated to; Squalene 5034.34 Da, Squalene oligomer; 57830.66 Da. This suggests that our 
oligomer terminates at around 11 monomer units when comparing the ratio of oligomer to 
monomer unit. 
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Figure 147 1D Proton of Squalene sample with 50mM Benzoyl Peroxide and 1D Proton with attenuated gradients 
applied to suppress all peaks apart from polymer peaks in sample 
 
 
Figure 148 Methyl and CH2's of squalene/oligomer mixture, squalene in red box and proposed oligomer in blue box 
and Alkene groupsof squalene/oligomer mixture, squalene in red box and proposed oligomer in blue box 
 
Figure 149 COSY Hydrogen couplings of proposed oligomer shown, shows that the end methyl groups couple to an 
additional hydrogen environment in the olefin groups which corresponds to our proposed structure. Squalene in blue 
box and proposed oligomer in red Box. COSY Hydrogen couplings of olefin groups and CH2 chain hydrogens, no 
observable change in these so this further suggests that the free radical attack occurs at the terminal olefin bonds. 
Squalene in blue box; proposed oligomer in red box. COSY Hydrogen couplings of terminal methyl groups and chain 
CH2 hydrogens; showing no new couplings, only the more hydrogenated forms of the same couplings. Squalene in 






















Pure Shift PSYCHE allows us to collapse the multiplicity of peaks and only see the chemical shift of 
each respective proton; thereby giving the name pure shift. This is useful for mixture analysis and 





Figure 150 Comparative spectra of squalene with different acquisition methodologies, Red = PSYCHE (with water 
suppression), Blue = Proton (without water suppression); Whole spectrum of squalene and zoomed in regions 
 
The Olefin and CH2 peaks in the pure shift experiments can easily distinguish the 3 double bond 
environments present and the 5 CH2 chain environments present within squalene which before 
with standard proton experiments was very hard to do. This will allow us to determine which of 
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these environments is being affected by polymerization and give us a greater understanding of the 
free radical polymerization mechanism. 
1D PSYCHE of Squalene and Oligomer mixture 
 
Figure 151 Blue = PSYCHE (with water suppression), Red = Proton (without water suppression); Whole spectrum of 




Figure 152 Zoomed in view of squalene peaks (red boxes) and Oligomer (Blue box) for Olefin groups, CH2 Chain groups 
and Methyl groups 
PSYCHE confirms to us that in the oligomer has three different methyl end group environments 
rather than being related to splitting; which is coherent with our predicted spectra where methyl 
groups which are not involved in the free radical polymerization, and two which are  present in a 
monomer that is attached to one or two other monomers. This can also been seen in the HSQC’s 
above. 
All the other peaks are equivalent to squalene so propagation must be through retention of the 
double bonds next to the methyl groups. 




Figure 153 Proposed Squalene Oligomer structure 
 
6.2.3.3 Discussion and conclusion 
With initiator (AIBN and Benzoyl Peroxide) concentrations at 50mM, under different experimental 
conditions, DOSY NMR detects the formation of a molecule with a larger diffusion coefficient.  
The new compound has very similiar chemical shifts and coupling as squalene. This insinuates that 
the nuclei environments of these compounds is very similar to squalene. This suggests from the 
relationship between diffusion coefficient and molecular weight that compounds are forming that 
have a greater molecular weight than that of squalene with a very similar structure. The conclusion 
is that these are most likely oligomers of squalene. The UCC polymer prediction software gives the 
result of an 11 monomer unit oligomer. 
Determining polydispersity of the new compounds becomes more of an issue when looking at the 
error seen in the diffusion coefficients of the DOSY spectra. In the oxygen excluded experiments 
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there are two resolved diffusion coefficients present a the diffusion coefficient region of the new 
compounds. To observe these the contour intensity needs to be measured at a very low signal 
intensity and is indistinguishable in the other DOSY spectra where it would be expected..  
To resolve this issue implementation of PSYCHiDOSY which allows for greater resolution in the F2 
dimension through reduction of overlap between peaks; therefore peaks chosen for diffusion 
analysis are well resolved.  
Further DOSY experiments can also be run with more diffusion incremements as a large range in 
the diffusion coefficents are present within samples. Therefore some compounds in the mixtures 
will have less accurate diffusion coefficents as there signals are attenuated much faster than others 
and will have few data points for the fit of the diffusion ccoefficient. 3mm tubes should also be 
implemented for convection related issues with DOSY results as the larger molecules require 
shorter D20 times and longer little delta times which in DMSO cause convetion effects to a much 
greater degree in 5mm tubes but can be greatly reduced in 3mm tubes. 
6.3 Experimental 
 
6.3.1 Saturation Transfer Difference Spectroscopy (STD) and STD-
TOCSY 
 
Saturation Transfer Difference spectroscopy function through the fact that a weak binding ligand 
with a binding dissociation constant Kd which range from 10-8 mol per litre to Mol per litre. With 
binding dissociation constants in these range of values exhibits exchange between bound and free 
states of ligands. The targeted protein or large molecular weight molecule that has large spin 
diffusing ability, is saturated selectively to produce an on-resonance spectrum through irradiation 
at a chemical shift region that does not contain resonances for ligand and is exclusively broad 
protein/large molecule resonance. This on resonance spectrum produces signal intensities labelled 
Isat which are subsequently subtracted from signal intensities I0 from the recorded off resonance 
spectrum to produce signal intensities ISTD which produce the difference spectrum. The difference 
spectrum thus only contains signal intensities which have received saturation transfer from on 
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resonance protein saturation via spin diffusion through nuclear overhauser effects. Nonbinding 
small molecules will therefore not experience this nuclear overhauser effect so Isat and I0 
intensities will be the same and no peaks will arise. Signal intensities which do arise can then be 
quantified and gives information on binding and how the small molecule orients itself in the binding 
pocket of larger molecule/proteins. This means that regions that are closer in proximity to the 
saturated protein will display larger signal intensities in difference spectra as spin diffusion of 
saturation is more efficient as nuclear overhauser effects are increase (159). 
6.3.2 Syn-Up 
6.3.2.1 Sample 
For each Physiogel and Syn-Up raw sample, 10mg of sample is dissolved in 660µL of deuterated 
methanol, spiked with 1mM TSP internal reference and transferred to a 5mm NMR Tube  
6.3.2.2 NMR 
Quantitative NMR spectra were acquired with 1D 1H NOESY experiments with presaturation 
applied during the relaxation delay and mixing times. Relaxation time was set to 10s and the 
number of scans was set to 1024. Automatic processing was done with 2x zero filling of TD, with 
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6.3.3 Synthesis of Deuterated Dodecyl Phosphocholine 
 
 





Figure 155 Synthetic pathway for Dodecyl Phosphocholine 
 
 
6.3.4 Lauric acid Deuteration 
 
These tests were carried out in 20% KOD solution in D2O 160 ml with palladium Catalyst 10% 2mg, 
40ml of NaOD and 10mg anhydride dodecanoic acid stirred for an 8 minute acquisition, broken into 












ethyl acetate at 0-20oC
2h
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microwave treatments which were set to 40 degrees, microwave power up to 300 watts for 10-30 
seconds then down to zero once target temperature was reached for experiment 1 (160). The 2nd 
and third experiment were carried out in a Parr pressure reactor, instead of a microwave reactor 
with same sample composition which was loaded into the Parr pressure reactor. The reactor was 
then degassed by purging with N2 gas, sealed and heated to 220°C (5 bar) and 250°C (5 bar), for 2nd 
and 3rd experiment respectively with constant stirring for 3 and 5 days respectively.  D2O was 
necessary to achieve an efficient H-D exchange, with the rest of the procedure taken from (161) 
 
6.3.5 LL-37 Assignment 
6.3.5.1 Samples 
LL-37 (human) was purchased from Sigma Aldrich in the lypholised form LL-37 trifluoracetate salt 
and assayed to >95% by HPLC. Dodecylphosphorylcholine-d38 was purchased from Sigma Aldrich 
with 98 atom % D.   
NMR samples were prepared by dissolving LL-37 in an aqueous solution of 10% D2O, 90% H2O) 
containing 300mM  DPC-d38 and 20mM phosphate buffer at pH ∼3 at a final concentration of 1.5 
mM. pH 3 was selected to increase peaks seen in fingerprint region through promotion of NH+ 
groups present. 
6.3.5.2 NMR 
LL-37 and DPC resonances were assigned with COSY,TOCSY and NOESY NMR spectroscopy. 2D STD-
TOCSY spectra were recorded with 32 scans. A total of 128 t1 increments were collected in an 
interlaced mode for the on‐ and off‐resonance spectra. For TOCSY a MLEV‐17 spin‐lock sequence 
with a 10 kHz RF field strength and a mixing time of 80 ms was used. Direct Covariance processing 
was done automatically in TopSpin to give covariance processed spectra with calculation of a square 
root of covariance matrix (time/freq) (SVD) to increase resolution along the F1 dimension. The 
selective saturation for STD experiments were targeted at ppm values where respective protein 
peaks did not overlap ligand peaks ,(30 ppm for off resonance spectra) with 40 Gaussian‐shaped 
pulses (50 ms; 1 ms delay between pulses, γB1/2π=110 Hz), total saturation time of 4 s. 
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 Enhancement intensity calculation was performed by direct comparison of STD‐NMR spectra and 
reference 1D 1H NMR spectra. The saturated and reference spectra were acquired simultaneously 
by creating a pseudo‐2D experiment. The STD spectra was constructed by subtraction of the 
saturated spectra from reference spectra performed by phase cycling after manual processing and 
phasing. The relative STD effect was calculated by (I0−Isat)/I0.  
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6.5.2 Vitamin D characterisation and quantitation in complex 
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6.6 Thesis Supplementary Data 
 
Table 29 BW70 Permeation of topical components 
 Niacinamide Glycerol Pentylene Glycol Panthenol Niacinamide deriv. 
1 215.33 ± 2.79 586 ± 6.12 78.26 ± 0.32 82.2 ± 0.65  14.61 ± 0.41 
2 145.03 ± 0.83 342.9 ± 0.26 54.73 ± 0.17 55.53 ± 0.076 10.59 ± 0.48 
3 156.46 ± 0.57 334.36 ± 6.48   38.53 ± 2.12 47.9 ± 0.46 8.08 ± 0.033 
4 57.13 ± 0.79 134.5 ± 1.64 21.5 ± 0.01 20.56 ± 0.65  4.11 ± 0.13 
5 44.56 ± 0.14 102.16 ± 1.05 16.6 ± 0.13 14.66 ±0.45 3.5 ± 0.18 
6 40.23 ± 0.77 96.5 ± 1.53 17.86 ± 0.80 11.8 ± 0.30 2.78 ± 0.39 
7 43.9 ± 0.35 85.1 ± 0.73 17.13 ± 0.16 10.23 ± 0.36 2.98 ± 0.44 
8 23.56 ± 0.25 53.1 ± 0.54 12.3 ± 0.2 5.47 ± 0.28  
9 36.6 ± 0.18 71.13 ± 1.02 19.53 ± 0.46 5.86 ± 0.28  
10 23.25 ± 0.035 31.15 ± 0.17 12.65 ± 0.49 4.89 ± 0.039  
11 18.9 ± 0.086 33.63 ± 0.80 11.46 ± 0.25 2.28 ± 0.13  
12 22 ± 0.05 34.53 ± 0.79 12.73 ± 1.02 2.04 ± 0.089  
 
Table 30 BW Permeation of topical components 
 Niacinamide Glycerol Pentylene Glycol Panthenol Niacinamide deriv. 
1 81.53 ± 0.10 936 ± 3.9 19.3 ± 0.30 34.53 ± 0.38 3.84 ±0.018 
2 49.73 ± 0.46 119.73 ± 0.40 9.64 ± 0.25 17.26 ± 0.29 2.29 ± 0.24 
3 39.7 ± 0.38 100.06 ± 0.41 9.01 ± 0.10 14.7 ± 0.31 2.36 ± 0.23 
4 29.86 ± 0.61 73.03 ± 0.53 8.04 ± 0.13 11 ± 0.25  
5 28.7 ± 0.18 61.7 ± 0.58 6.16 ± 0.18 7.78 ± 0.21  
6 28.16 ± 0.80 67.66 ± 1.05 8.58 ± 0.26 7.81 ± 0.17  
7 26.4 ± 0.05 54.96 ± 0.11 7.76 ± 0.16 7.19 ± 0.19  
8 21 ± 0.15 43.43 ± 0.8 6.67 ± 0.24 3.37 ± 0.12  
9 22.56 ± 0.10 36.8 ± 0.76 6.27 ± 0.32 2.37 ± 0.21  
10 23.33 ± 0.19 46.46 ± 0.74 9.28 ± 0.36 2.27 ± 0.14  
11 11.93 ± 0.21 23.86 ± 0.41 6.2 ± 0.22 1.43 ± 0.13  
12 21.46 ± 0.13 32.7 ± 0.28 7.31 ±0.20 2.17 ±0.085  
 
Table 31 V Permeation of Topical Components 
 Niacinamide Glycerol Pentylene Glycol Panthenol Niacinamide deriv. 
1 64.9 ± 0.65 115.5 ± 0.15 24.23 ± 0.14 19.96 ± 0.076 4.69 ± 0.25 
2 39.96 ± 0.16 214.4 ±0.25 15.26 ± 0.28 12.53 ± 0.53 3.50 ± 0.16 
3 36.9 ± 0.34 68.56 ± 1.01 12.73 ± 0.076 10.40 ± 0.39 1.43 ± 0.15 
4 38.6 ± 1.12 53.13 ± 0.45 11.3 ± 0.67 7.11 ± 0.69  
5 21.96 ± 0.28 28.76 ± 0.16 8.46 ± 0.26 6.19 ± 0.56  
6 35.2 ± 0.73 50.56 ± 0.43 14.2 ± 0.05 6.18 ± 0.17  
7 19.76 ± 0.33 25 ± 0.77 8.04 ± 0.03 2.20 ± 0.18  
8 18.43 ± 0.26 23.66 ± 0.25 8.23 ± 0.36 1.37 ± 0.072  
9 20.5 ± 0.39 25.2 ± 0.75 8.64 ± 0.24 1.59 ± 0.07  
10 17.26 ± 0.33 22.1 ± 0.3 8.4 ± 0.085 1.51 ± 0.22  
11 20.9 ± 0.13 24.16 ± 0.45 9.2 ± 0.52 1.22 ± 0.083  
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12 11.76 ± 0.26 14.9 ± 0.13 5.14 ± 0.09 1.03 ± 0.056  
Table 32 P Permeation of Topical components 
 Glycerol 
1 743.63 ± 5.62 
2 141.06 ± 0.45 
3 173.13 ± 0.35 
4 129.06 ± 0.39 
5 72.26 ± 0.20 
6 81.23 ± 0.35 
7 85.96 ± 0.93 
8 125.6 ± 0.28 
9 47.7 ± 0.48 
10 89.36 ± 0.25 
11 21.76 ± 0.10 
12 45.13 ± 1.20 
 
Table 33 AI Permeation of Topical Components 
 Glycerol Pentylene Glycol 
1 630.23 ± 3.52 33.56 ± 0.076 
2 178.86 ± 0.68 11.46 ± 0.12 
3 114.7± 0.86 7.95 ± 0.10 
4 24.66 ± 0.28 2.15 ± 0.26 
5 69.33 ± 0.64 8.96 ± 0.49 
6 78.43 ± 0.71 11.26 ± 0.27 
7 45.96 ± 0.37 8.87 ± 0.13 
8 26.73 ± 0.21 3.33 ± 0.030 
9 24.46 ± 0.10 3.81 ± 0.47 
10 15.83 ± 0.076 7.15 ± 0.37 
11 17.56 ± 0.15 3.64 ± 0.26 
12 24.56 ± 0.076 5.12 ± 0.18 
 




Figure 156 Grouped Bluewater formulation permeation profile data PCA scores plot with PC1 (96%) against PC2 (3%) 
 




Figure 157 Grouped Bluewater formulation permeation profile data PCA correlation loadings with PC1 (96%) against 
PC2 (3%) 
 
Figure 158 Grouped BW formulation permeation profile data PCA scores plot with PC1 (96%) against PC2 (7%) 
 




Figure 159 Grouped BW formulation permeation profile data PCA correlation loadings with PC1 (91%) against PC2 
(7%) 
 
Figure 160 Grouped BW70 formulation permeation profile data PCA SCORES PLOT with PC1 (89%) against PC2 (8%) 
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Figure 161 Grouped BW70 formulation permeation profile data PCA correlation loadings with PC1 (89%) against PC2 
(8%) 
 
Figure 162 Grouped V formulation permeation profile data PCA scores plot with PC1 (93%) against PC2 (6%) 
 
Figure 163 Grouped V formulation permeation profile data PCA correlation loadings with PC1 (93%) against PC2 (6%) 
 




Figure 164 Grouped Bluewater and AI formulations permeation profile data PCA scores plot with PC1 (100%) against 
PC2 (0%) 
 
Figure 165 Grouped Bluewater and AI formulations permeation profile data PCA correlation loadings with PC1 (100%) 
against PC2 (0%) 
 




Figure 166 Grouped Bluewater formulations permeation profile and NMF data PCA scores plot with PC1 (93%) against 
PC2 (6%) 
 
Figure 167 Grouped Bluewater formulations permeation profile and NMF data PCA correlation loadings with PC1 
(93%) against PC2 (6%) 
 




Figure 168 Grouped Physiogel formulations permeation profile and NMF data PCA scores plot with PC1 (99%) against 
PC2 (0%) 
 
Figure 169 Grouped Physiogel formulations permeation profile and NMF data PCA correlation loadings with PC1 
(99%) against PC2 (0%) 
 
